Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" AARS2 "AARSL, bA444E17.1, KIAA1270" ENSG00000124608 "Alanyl-tRNA synthetase 2, mitochondrial" Q5JTZ9 6 44299654-44313326 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding" "Cancer-related genes, Cardiomyopathy, Disease mutation, Premature ovarian failure, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035636, HPA061396" Approved Enhanced Mitochondria Mitochondria "HPA035636: AB_10670837, HPA061396: " "unprognostic (1.56e-1)" "unprognostic (3.24e-2)" "unprognostic (2.58e-2)" "unprognostic (2.04e-3)" "unprognostic (2.83e-1)" "unprognostic (1.69e-1)" "unprognostic (8.83e-3)" "unprognostic (5.12e-2)" "unprognostic (3.64e-2)" "unprognostic (1.38e-1)" "unprognostic (2.19e-2)" "unprognostic (1.37e-2)" "unprognostic (1.74e-1)" "unprognostic (1.84e-1)" "unprognostic (1.48e-1)" "unprognostic (1.08e-1)" "unprognostic (2.02e-1)" 8.6 10.7 15.9 16.2 11.8 11.4 9.9 23.5 19.8 11.4 14.5 11.4 13.0 15.3 14.1 10.4 17.2 13.4 15.9 10.4 13.2 8.9 10.3 12.6 10.9 13.4 12.4 14.3 17.1 13.8 16.2 14.2 10.1 11.1 13.2 9.8 11.2 14.4 14.6 10.2 16.8 18.3 12.1 8.8 14.1 12.3 12.9 14.1 14.7 12.3 10.4 13.4 10.2 13.9 7.1 3.2 3.7 3.4 3.7 5.5 2.8 10.4 7.9 10.3 19.0 6.1 5.7 13.7 8.7 4.5 9.2 8.9 8.5 5.7 11.5 13.9 3.7 7.9 11.4 12.4 3.6 8.1 18.3 13.4 7.7 10.0 4.0 12.4 11.9 4.8 7.9 7.4 7.9 7.8 15.8 11.3 4.9 11.7 10.4 10.7 7.7 7.7 12.4 6.3 7.9 4.8 9.5 24.6 8.9 7.5 8.4 11.6 7.8 16.2 6.6 10.0 10.0 6.1 10.8 6.7 6.2 11.9 5.6 11.0 17.1 3.7 2.4 0.0 3.4 3.3 5.5 3.6 4.8 4.4 2.6 7.1 4.7 4.3 0.7 3.7 3.4 3.2 3.0 2.8 15.9 11.8 23.5 19.8 13.2 8.9 12.4 14.3 11.1 14.1 AASS "LKRSDH, LORSDH" ENSG00000008311 "Aminoadipate-semialdehyde synthase" Q9UDR5 7 122075647-122144280 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 26.1;NTERA-2: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.5" "Group enriched" "Detected in many" 4 "B-cells: 1.0;granulocytes: 3.5;T-cells: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020637, HPA020728, HPA020734" Enhanced Enhanced Vesicles,Mitochondria 17000 Mitochondria Vesicles "HPA020637: AB_1844415, HPA020728: AB_1844416, HPA020734: AB_1844417" "unprognostic (4.84e-2)" "unprognostic (2.29e-1)" "unprognostic (7.91e-4)" "unprognostic (6.08e-2)" "unprognostic (1.49e-2)" "unprognostic (8.00e-2)" "prognostic favourable (9.81e-4)" "unprognostic (4.48e-3)" "unprognostic (2.38e-1)" "unprognostic (1.47e-1)" "unprognostic (1.98e-1)" "unprognostic (1.99e-1)" "unprognostic (7.76e-3)" "unprognostic (8.56e-3)" "unprognostic (1.55e-1)" "unprognostic (6.50e-2)" "unprognostic (2.67e-1)" 13.9 9.5 7.4 4.8 11.8 1.6 11.2 2.7 9.8 16.0 8.1 12.5 8.2 2.2 16.8 11.6 6.4 14.9 6.7 12.6 8.8 3.7 14.4 35.8 9.1 3.3 15.2 5.0 36.7 10.7 14.9 10.4 7.1 9.9 9.2 3.8 9.2 5.4 10.4 11.3 4.4 5.5 9.3 12.1 5.2 9.0 5.1 13.2 0.8 7.8 8.3 3.1 11.0 9.0 1.0 0.4 3.5 0.1 0.3 1.2 0.1 0.1 0.0 16.2 26.1 13.5 8.7 6.3 4.4 4.7 4.6 6.7 7.4 0.2 0.0 0.3 3.1 2.8 18.6 8.4 6.3 0.0 6.8 5.6 3.6 4.8 11.1 0.0 1.8 7.6 0.2 5.5 5.8 11.0 1.5 10.3 3.1 0.0 0.5 0.0 25.5 1.0 8.4 8.6 0.3 2.1 1.8 1.6 0.5 1.4 0.0 2.7 0.4 0.0 5.0 9.0 2.7 4.1 4.2 2.2 1.6 0.0 3.3 0.5 3.4 3.5 0.1 0.0 0.7 0.0 0.1 0.5 0.8 0.0 0.4 1.0 1.2 0.5 0.0 0.3 0.0 0.0 0.7 0.1 7.4 11.8 2.7 7.3 8.8 3.7 15.2 5.0 9.9 13.2 AC139530.2 ENSG00000262660 17 81703371-81720539 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 6.4;MOLT-4: 18.0;SK-BR-3: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA022853, HPA023043, HPA023048" Approved Enhanced Mitochondria Mitochondria "HPA022853: AB_1854099, HPA023043: AB_1854100, HPA023048: AB_2301950" "unprognostic (2.36e-3)" "unprognostic (1.17e-1)" "unprognostic (2.87e-1)" "unprognostic (3.83e-1)" 2.4 3.6 2.3 2.3 3.0 1.5 6.3 2.7 5.7 2.3 4.6 0.8 2.7 13.8 3.4 1.5 4.6 2.3 2.7 16.3 2.4 2.3 4.9 16.6 3.0 4.2 2.5 1.5 2.3 9.9 3.6 2.3 3.4 2.2 2.4 1.5 1.1 3.1 2.4 15.5 2.4 5.9 1.6 2.3 3.3 2.6 2.6 0.6 3.0 2.4 12.6 3.0 2.3 2.3 0.0 0.4 0.0 0.1 0.8 0.6 0.1 1.2 0.6 1.8 4.6 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.3 0.3 0.9 0.3 0.0 2.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.2 0.0 0.6 0.3 0.0 6.4 0.0 0.8 18.0 0.7 1.0 0.0 3.2 0.3 1.1 0.0 0.0 3.2 1.5 0.0 6.8 1.8 2.9 1.5 0.0 0.5 1.1 1.0 1.7 0.6 0.0 0.7 1.1 0.5 2.4 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.1 2.3 3.0 2.7 3.7 2.4 2.3 2.5 1.5 2.2 0.6 ACAD9 "MGC14452, NPD002" ENSG00000177646 "Acyl-CoA dehydrogenase family member 9" Q9H845 3 128879596-128916067 "Disease related genes, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037716, HPA046720" Supported Enhanced Mitochondria Mitochondria "HPA037716: AB_10673638, HPA046720: AB_2679773" "unprognostic (1.04e-1)" "unprognostic (1.28e-2)" "unprognostic (1.15e-1)" "prognostic unfavourable (3.05e-4)" "unprognostic (3.61e-1)" "unprognostic (2.83e-1)" "prognostic unfavourable (3.67e-6)" "unprognostic (1.30e-1)" "unprognostic (3.74e-1)" "unprognostic (3.25e-2)" "unprognostic (1.37e-1)" "unprognostic (6.96e-3)" "prognostic favourable (4.32e-8)" "unprognostic (1.52e-1)" "unprognostic (2.64e-2)" "unprognostic (6.56e-2)" "unprognostic (9.96e-2)" 18.1 20.6 14.0 13.1 15.4 8.0 15.4 14.7 17.9 13.6 13.4 15.9 21.1 11.3 16.9 13.1 21.6 15.6 16.4 21.6 10.7 13.2 15.8 24.0 11.6 10.4 13.6 17.8 13.1 21.1 30.6 14.2 13.8 13.6 13.0 12.4 16.0 19.0 16.0 30.8 45.0 10.1 13.8 10.2 12.1 14.6 19.5 10.8 13.9 14.8 18.2 14.9 12.6 14.0 7.2 14.0 4.1 18.1 5.0 7.5 8.9 25.0 13.1 10.6 7.8 16.4 11.5 11.3 12.5 13.8 24.0 20.6 18.5 15.3 18.6 11.7 15.7 21.0 18.4 24.4 15.9 12.3 12.6 16.9 26.6 13.0 12.0 13.3 7.9 12.5 9.6 13.9 15.8 19.3 8.0 9.0 15.9 25.3 19.5 11.0 6.4 18.8 15.2 9.9 18.9 16.8 16.0 12.3 7.9 19.4 18.3 12.1 24.1 28.7 11.5 10.1 8.7 10.1 11.8 9.0 4.3 16.2 16.0 12.4 12.6 3.1 12.0 4.1 7.5 14.7 7.2 7.2 6.8 6.4 14.0 4.9 5.7 7.3 1.0 5.0 18.1 7.9 6.5 8.9 14.0 15.4 14.7 17.9 10.7 13.2 13.6 17.8 13.6 10.8 ACADM "ACAD1, MCAD, MCADH" ENSG00000117054 "Acyl-CoA dehydrogenase medium chain" P11310 1 75724347-75787575 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 89.7;skeletal muscle: 82.8" "Cell line enhanced" "Detected in all" "Daudi: 75.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006198, HPA026542" Enhanced Enhanced Mitochondria 1200000 Mitochondria "HPA006198: AB_1078087, HPA026542: AB_1844469" "unprognostic (9.04e-3)" "unprognostic (2.36e-1)" "prognostic favourable (7.30e-4)" "unprognostic (5.09e-3)" "unprognostic (1.61e-3)" "unprognostic (5.68e-2)" "unprognostic (6.75e-2)" "unprognostic (1.11e-1)" "unprognostic (8.02e-2)" "unprognostic (4.95e-2)" "unprognostic (9.40e-3)" "unprognostic (3.35e-1)" "prognostic favourable (3.83e-8)" "unprognostic (1.27e-1)" "unprognostic (4.09e-2)" "unprognostic (3.56e-2)" "unprognostic (1.24e-1)" 18.1 25.0 12.3 11.3 13.0 3.9 18.0 12.0 10.8 8.4 21.6 8.3 10.1 25.1 6.7 8.6 21.9 7.6 6.7 49.7 10.5 11.2 71.1 89.7 6.3 9.4 13.0 9.2 10.5 10.3 8.1 12.0 4.2 14.3 9.2 12.1 8.0 9.0 11.7 82.8 5.6 25.1 9.8 10.7 12.3 12.0 8.5 11.0 11.0 12.2 42.1 10.0 9.5 8.1 29.7 16.7 14.1 13.8 16.8 20.0 13.2 6.9 5.5 17.4 7.6 15.0 12.3 4.9 13.0 10.6 12.8 10.8 10.3 11.1 75.9 11.5 9.3 6.4 14.7 11.0 15.9 29.3 7.2 24.9 16.9 15.8 10.5 21.2 6.9 14.2 6.4 11.1 6.7 10.0 25.3 17.2 13.7 2.6 24.9 10.0 14.0 13.3 32.5 22.9 7.9 21.2 18.3 9.4 11.9 10.5 31.4 27.1 9.3 26.9 5.4 8.7 8.6 7.4 21.3 11.2 16.0 33.7 7.4 17.3 9.9 10.7 9.6 14.1 13.2 13.8 20.0 29.7 13.8 15.9 14.3 18.0 15.8 17.6 0.8 16.8 12.7 16.7 13.8 13.2 12.3 13.0 12.0 10.8 10.5 11.2 13.0 9.2 14.3 11.0 ACADS "ACAD3, SCAD" ENSG00000122971 "Acyl-CoA dehydrogenase short chain" P16219 12 120725735-120740008 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 58.4;skeletal muscle: 50.7" "Cell line enhanced" "Detected in many" "HMC-1: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004799, CAB019284, HPA022271" Enhanced Enhanced Nucleoplasm,Mitochondria 15000 Mitochondria Nucleoplasm "CAB019284: , HPA004799: AB_1844471, HPA022271: AB_1844472" "unprognostic (7.14e-2)" "unprognostic (3.03e-3)" "unprognostic (8.15e-2)" "prognostic favourable (5.05e-4)" "unprognostic (1.11e-3)" "unprognostic (5.75e-2)" "prognostic favourable (2.43e-4)" "unprognostic (5.65e-2)" "unprognostic (1.22e-1)" "unprognostic (2.14e-1)" "unprognostic (2.69e-2)" "unprognostic (4.04e-2)" "prognostic favourable (3.33e-6)" "unprognostic (1.23e-2)" "unprognostic (1.81e-1)" "unprognostic (1.21e-1)" "prognostic favourable (6.34e-5)" 19.5 14.5 5.7 10.0 5.2 5.3 18.0 2.3 4.6 2.9 26.2 4.7 4.5 35.8 2.8 5.3 5.0 2.9 9.1 32.6 3.7 3.3 13.2 58.4 5.6 7.8 5.0 4.1 2.3 14.4 3.0 2.4 4.3 3.8 4.1 9.0 5.6 8.9 4.6 50.7 3.4 35.3 6.5 3.8 8.6 9.5 10.7 5.4 4.0 8.1 16.8 4.3 5.0 3.2 6.8 11.4 7.2 14.0 15.3 14.7 10.0 2.0 7.2 0.4 6.3 8.6 3.4 7.3 3.0 3.0 3.9 2.9 5.6 5.1 0.2 7.8 2.5 3.3 4.3 1.3 0.5 10.5 5.3 5.2 2.2 12.0 6.2 0.4 23.7 10.3 2.0 1.7 0.1 4.0 4.2 0.0 1.7 4.2 7.2 12.0 1.3 3.0 5.4 2.7 1.4 7.3 11.6 0.7 4.0 6.2 0.0 9.9 5.0 8.2 4.4 0.1 3.1 3.0 0.6 10.1 5.7 2.5 6.7 4.4 2.6 7.2 13.0 6.4 12.4 14.0 8.8 5.9 11.3 13.0 11.4 6.8 14.7 13.2 1.3 15.3 8.7 9.5 11.9 10.0 5.7 5.2 2.3 4.6 3.7 3.3 5.0 4.1 3.8 5.4 ACAT1 "ACAT, THIL" ENSG00000075239 "Acetyl-CoA acetyltransferase 1" P24752 11 108121516-108147776 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 267.1" "Cell line enhanced" "Detected in all" "RPMI-8226: 85.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004428, HPA007569" Enhanced Enhanced Mitochondria 870000 Mitochondria "HPA004428: AB_1078088, HPA007569: AB_1844482" "unprognostic (3.70e-3)" "unprognostic (2.23e-2)" "unprognostic (7.84e-3)" "unprognostic (4.65e-2)" "unprognostic (3.05e-2)" "unprognostic (1.12e-1)" "prognostic favourable (1.43e-5)" "unprognostic (3.59e-3)" "unprognostic (1.26e-1)" "unprognostic (5.20e-2)" "unprognostic (2.64e-2)" "unprognostic (1.13e-2)" "prognostic favourable (0.00e+0)" "unprognostic (1.96e-1)" "unprognostic (1.68e-1)" "unprognostic (8.06e-2)" "unprognostic (6.62e-3)" 18.8 28.5 8.9 6.9 9.5 5.4 16.9 5.6 11.6 8.5 16.8 8.5 9.4 15.5 8.8 8.9 8.8 7.6 5.1 53.8 7.4 7.4 88.8 267.1 7.3 6.0 9.9 9.9 10.3 27.3 14.3 6.3 3.8 22.4 7.6 13.1 10.6 27.1 15.9 65.0 8.2 10.9 16.4 8.1 7.7 13.9 14.2 7.2 1.7 10.1 32.1 5.2 12.3 6.9 18.8 20.2 2.3 14.7 7.7 20.7 11.6 15.8 13.0 10.3 29.6 33.3 29.5 5.7 15.2 16.3 16.5 19.3 35.8 16.4 8.8 26.2 17.0 16.8 29.8 14.4 18.0 17.5 24.4 25.3 14.8 32.5 23.0 23.9 15.0 26.7 16.0 14.4 27.0 17.5 35.1 13.1 26.3 9.1 14.1 22.3 10.1 29.1 19.7 20.3 85.2 22.6 10.4 16.5 19.6 24.8 32.2 16.6 27.5 19.6 19.5 17.8 10.4 16.2 18.3 4.4 12.9 16.5 7.9 47.9 12.6 0.8 9.8 2.3 15.6 14.7 17.7 18.8 17.6 17.5 20.2 10.2 15.5 14.3 1.0 7.7 14.4 7.0 20.7 11.6 8.9 9.5 5.6 11.6 7.4 7.4 9.9 9.9 22.4 7.2 ALAS1 "ALAS, ALAS3" ENSG00000023330 "5'-aminolevulinate synthase 1" P13196 3 52198086-52214327 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Heme biosynthesis" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 167.6;liver: 136.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 55.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 55.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017498, HPA035860" Enhanced Enhanced Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "CAB017498: AB_2225629, HPA035860: AB_10672992" "unprognostic (1.17e-1)" "unprognostic (1.65e-1)" "unprognostic (1.50e-1)" "unprognostic (7.09e-2)" "unprognostic (2.33e-1)" "unprognostic (6.21e-2)" "prognostic favourable (1.82e-5)" "unprognostic (3.98e-2)" "unprognostic (1.26e-1)" "unprognostic (2.31e-2)" "unprognostic (9.86e-2)" "unprognostic (5.64e-2)" "prognostic favourable (6.06e-7)" "unprognostic (8.45e-2)" "unprognostic (3.91e-2)" "unprognostic (1.07e-1)" "unprognostic (1.75e-2)" 9.2 167.6 7.8 6.7 10.6 39.1 8.9 17.0 15.4 6.0 11.0 12.0 15.3 11.4 6.3 11.8 10.5 4.7 8.7 24.8 8.8 7.0 14.1 136.4 13.5 10.0 7.6 9.9 5.8 6.1 8.5 5.8 13.4 12.2 7.3 11.1 8.3 15.7 16.9 24.6 6.8 17.4 6.5 7.3 6.3 12.2 9.7 5.0 7.5 7.4 11.4 9.6 12.1 7.6 6.8 8.4 55.0 12.2 8.8 11.3 6.3 10.4 16.2 11.5 10.6 18.0 13.4 31.4 15.4 14.3 20.6 20.0 21.6 19.8 9.8 3.9 10.7 6.2 16.5 12.6 16.9 19.0 6.4 12.6 12.8 16.4 25.5 20.4 25.3 16.7 11.9 32.7 10.9 18.8 7.4 8.1 18.7 8.5 9.6 31.0 9.9 28.2 5.8 7.2 15.5 18.1 63.4 6.1 4.0 24.9 12.3 13.9 7.0 29.0 13.5 11.5 11.4 23.7 22.2 12.0 20.8 14.8 12.9 22.1 18.3 55.0 9.2 27.8 6.9 12.2 11.3 6.8 7.2 7.7 8.4 6.0 6.5 7.0 14.2 8.8 10.2 4.8 9.7 6.3 7.8 10.6 17.0 15.4 8.8 7.0 7.6 9.9 12.2 5.0 ALDH1L2 "FLJ38508, mtFDH" ENSG00000136010 "Aldehyde dehydrogenase 1 family member L2" Q3SY69 12 105019784-105084577 "Enzymes, Predicted intracellular proteins" "One-carbon metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "pancreas: 48.9;salivary gland: 31.6" "Cell line enhanced" "Detected in many" "ASC diff: 22.6;ASC TERT1: 30.9;fHDF/TERT166: 35.1;HHSteC: 19.9;HSkMC: 25.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.3" "Lineage enriched" "Detected in single" 6 "dendritic cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039481, HPA059282" Approved Enhanced Mitochondria Mitochondria "HPA039481: AB_10795465, HPA059282: " "unprognostic (5.99e-2)" "unprognostic (1.42e-1)" "unprognostic (1.10e-1)" "unprognostic (1.36e-3)" "unprognostic (1.76e-1)" "unprognostic (8.86e-2)" "unprognostic (1.75e-1)" "unprognostic (2.92e-1)" "unprognostic (5.74e-2)" "unprognostic (1.51e-1)" "unprognostic (1.01e-1)" "unprognostic (1.61e-1)" "unprognostic (8.19e-8)" "unprognostic (3.21e-3)" "unprognostic (1.33e-1)" "unprognostic (2.53e-3)" "unprognostic (2.52e-5)" 4.2 1.2 3.2 2.7 1.9 0.7 2.7 5.3 2.7 5.5 2.2 0.9 3.3 2.4 2.9 3.2 1.5 2.6 2.7 2.9 1.6 2.0 0.7 0.4 2.7 2.0 2.0 2.1 1.0 48.9 0.7 2.8 1.1 2.5 3.6 2.3 4.8 31.6 4.5 1.0 1.5 1.3 5.4 5.3 1.2 3.7 0.8 1.3 0.0 2.2 1.4 3.0 3.9 2.2 0.2 1.3 0.0 0.1 0.0 0.1 0.1 4.3 0.4 0.2 9.4 22.6 30.9 0.5 14.0 9.0 1.8 4.8 0.5 0.0 0.0 0.5 35.1 0.0 0.0 0.3 2.3 0.0 0.1 0.2 0.0 1.1 19.9 1.7 0.0 25.0 1.1 4.7 8.9 1.0 0.7 12.6 3.6 0.0 0.0 0.1 0.5 0.1 0.0 0.0 1.3 0.0 0.0 3.3 1.6 0.0 2.9 7.1 2.0 14.9 0.1 1.4 1.3 0.0 0.7 15.7 4.1 0.0 5.7 6.4 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.1 3.2 1.9 5.3 2.4 1.6 2.0 2.0 2.1 2.5 1.3 ALDH6A1 MMSDH ENSG00000119711 "Aldehyde dehydrogenase 6 family member A1" Q02252 14 74056850-74084493 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "kidney: 140.0;liver: 134.5" "Cell line enhanced" "Detected in all" "T-47d: 29.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 25.5" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029072, HPA029073, HPA029074, HPA029075" Enhanced Enhanced Mitochondria 9100 Mitochondria "HPA029072: AB_10599176, HPA029073: AB_10601877, HPA029074: AB_10601000, HPA029075: AB_10602005" "unprognostic (1.45e-1)" "unprognostic (5.38e-2)" "unprognostic (6.89e-2)" "unprognostic (6.95e-3)" "unprognostic (1.46e-1)" "unprognostic (7.93e-2)" "unprognostic (1.11e-3)" "prognostic favourable (4.22e-4)" "unprognostic (1.58e-1)" "unprognostic (9.10e-2)" "unprognostic (3.11e-2)" "unprognostic (2.13e-1)" "prognostic favourable (2.00e-15)" "unprognostic (4.59e-1)" "unprognostic (1.92e-1)" "unprognostic (6.05e-3)" "unprognostic (1.12e-1)" 14.1 6.9 31.3 2.8 30.9 2.3 6.7 11.6 26.4 8.0 11.0 20.1 4.6 11.0 5.5 5.5 5.0 6.2 4.8 15.6 21.1 14.2 140.0 134.5 4.7 3.0 19.4 18.5 12.3 11.8 16.4 3.2 4.0 14.8 11.0 7.2 7.1 7.8 7.8 10.5 3.4 9.3 5.6 13.1 3.1 9.6 7.4 18.7 2.0 12.1 4.0 3.1 6.3 3.3 4.5 5.6 25.5 3.8 5.5 6.7 2.8 4.6 4.0 5.7 12.1 20.8 10.2 9.2 3.2 6.1 3.5 6.0 9.0 5.2 5.4 7.2 6.9 2.7 12.9 3.6 7.7 4.8 1.8 2.5 4.2 9.9 23.7 1.3 1.2 15.0 6.5 4.5 11.4 6.1 4.0 7.5 2.4 17.7 3.7 2.0 4.5 2.7 7.6 5.9 7.1 5.6 3.5 2.3 3.6 10.7 11.6 2.8 29.6 4.8 1.9 4.0 4.9 6.2 1.2 5.1 9.1 5.5 5.2 1.6 3.8 13.3 3.8 25.5 4.5 2.9 6.7 4.5 5.1 5.3 5.6 3.6 6.5 4.6 1.5 5.5 2.4 3.2 3.6 2.8 31.3 30.9 11.6 26.4 21.1 14.2 19.4 18.5 14.8 18.7 ARMC10 "MGC3195, SVH" ENSG00000170632 "Armadillo repeat containing 10" Q8N2F6 7 103074881-103099764 "Predicted intracellular proteins, Predicted membrane proteins" "Growth regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011036, HPA011057" Enhanced Enhanced Mitochondria Mitochondria "HPA011036: AB_1080139, HPA011057: AB_1080137" "unprognostic (7.03e-3)" "unprognostic (2.44e-1)" "unprognostic (8.18e-2)" "unprognostic (3.53e-1)" "prognostic unfavourable (8.90e-6)" "unprognostic (3.85e-3)" "prognostic unfavourable (3.58e-4)" "unprognostic (5.57e-2)" "unprognostic (3.49e-2)" "unprognostic (7.90e-2)" "prognostic unfavourable (2.49e-6)" "unprognostic (1.02e-1)" "unprognostic (5.78e-2)" "unprognostic (1.47e-1)" "unprognostic (2.76e-1)" "unprognostic (1.14e-2)" "unprognostic (5.67e-2)" 21.6 21.7 28.0 12.6 25.0 9.1 24.5 11.4 28.0 24.4 18.6 24.7 20.8 14.0 20.4 24.2 22.2 23.2 20.0 16.7 26.2 26.2 27.4 30.2 15.0 15.7 26.3 24.2 26.5 28.7 26.0 12.0 15.4 19.7 22.2 18.8 17.6 15.7 23.4 15.8 21.6 12.8 20.3 25.5 14.4 19.8 14.1 19.6 21.5 30.7 15.6 15.7 22.3 20.5 5.1 6.8 6.6 5.4 3.9 4.7 2.2 12.5 10.7 6.4 12.3 13.3 12.7 6.4 8.8 9.6 6.4 7.8 5.8 14.9 22.6 19.1 7.7 11.3 8.9 9.8 9.1 8.4 10.2 8.0 4.6 2.7 13.4 21.8 9.6 8.2 17.4 8.0 13.2 14.5 19.4 14.0 11.3 23.2 16.0 16.9 14.2 11.6 9.7 6.6 29.3 16.1 8.8 7.2 9.8 12.0 18.2 13.3 7.3 10.9 9.6 9.9 9.5 23.2 13.2 21.5 33.7 18.2 11.2 20.4 12.4 0.0 4.4 6.6 2.6 5.4 4.5 4.0 4.1 4.4 6.8 5.1 4.6 4.7 0.9 3.9 2.8 5.3 4.2 2.2 28.0 25.0 11.4 28.0 26.2 26.2 26.3 24.2 19.7 19.6 ATP5F1B "ATP5B, ATPSB" ENSG00000110955 "ATP synthase F1 subunit beta" P06576 12 56638175-56646068 "Enzymes, Plasma proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001520, HPA001528, CAB017527" Enhanced Enhanced Mitochondria 100000000 Mitochondria "CAB017527: AB_1121153, HPA001520: AB_1078243, HPA001528: AB_1078242" "prognostic unfavourable (7.17e-6)" "unprognostic (5.69e-2)" "unprognostic (1.08e-2)" "unprognostic (7.24e-2)" "unprognostic (8.39e-2)" "unprognostic (1.84e-2)" "unprognostic (2.12e-3)" "unprognostic (1.92e-2)" "unprognostic (8.19e-3)" "unprognostic (2.38e-2)" "unprognostic (1.44e-2)" "unprognostic (2.11e-2)" "prognostic favourable (1.43e-9)" "unprognostic (2.79e-1)" "unprognostic (3.22e-1)" "unprognostic (1.33e-1)" "unprognostic (3.30e-2)" 41.3 66.2 32.4 34.1 53.4 39.3 33.1 55.4 92.6 26.1 73.0 34.4 36.1 68.1 27.9 28.5 58.6 28.5 36.9 225.0 33.2 34.9 95.2 85.7 28.3 39.2 40.5 35.5 25.1 42.7 85.2 30.1 31.3 69.6 29.0 78.5 42.8 64.7 38.1 236.2 42.3 74.6 35.5 24.9 33.5 51.0 31.4 18.3 47.5 38.4 123.6 45.8 36.6 32.8 41.2 91.7 40.2 90.1 36.3 46.6 105.6 65.7 80.0 63.6 98.1 57.4 61.4 112.4 66.9 62.5 115.7 65.9 129.9 73.4 117.0 72.5 82.4 88.2 134.0 81.1 104.8 54.8 92.8 128.3 74.7 79.6 71.1 143.5 90.9 75.2 81.9 90.4 116.8 95.0 115.5 134.9 97.0 61.0 106.3 84.4 107.0 154.1 102.4 71.2 149.1 126.0 117.2 72.8 64.7 102.2 146.4 113.7 137.4 108.5 64.4 45.6 50.8 66.5 72.2 65.1 80.9 121.0 68.6 96.0 69.8 40.2 64.6 34.6 40.2 80.6 44.9 41.2 38.0 42.7 91.7 31.7 31.1 36.7 17.8 36.3 90.1 46.3 46.6 105.6 32.4 53.4 55.4 92.6 33.2 34.9 40.5 35.5 69.6 18.3 ATP5IF1 "ATPI, ATPIF1, ATPIP, IP, MGC1167, MGC8898" ENSG00000130770 "ATP synthase inhibitory factor subunit 1" Q9UII2 1 28236109-28246906 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027999 Supported Enhanced Mitochondria 1800000 Mitochondria "HPA027999: AB_10600984" "unprognostic (2.80e-2)" "unprognostic (3.72e-2)" "unprognostic (2.95e-1)" "prognostic favourable (6.38e-8)" "unprognostic (2.04e-1)" "unprognostic (1.76e-1)" "unprognostic (6.57e-2)" "unprognostic (2.93e-2)" "unprognostic (1.40e-2)" "prognostic favourable (8.20e-4)" "unprognostic (5.94e-2)" "unprognostic (3.52e-1)" "unprognostic (6.15e-3)" "unprognostic (4.68e-2)" "unprognostic (2.02e-1)" "unprognostic (2.79e-1)" "unprognostic (1.48e-3)" 17.1 35.1 65.9 32.1 64.0 58.5 20.9 41.8 71.7 24.6 54.5 15.7 33.8 78.2 18.6 24.1 26.4 31.9 38.4 135.2 51.8 60.7 60.2 55.4 20.1 28.7 46.8 58.7 20.5 33.8 20.7 37.6 19.4 53.0 30.4 30.5 24.8 34.5 34.4 135.2 26.3 58.7 15.4 31.0 25.9 45.0 72.4 26.2 24.3 25.0 44.6 23.5 17.9 18.6 56.5 64.2 35.7 35.2 39.1 64.8 55.2 45.1 23.4 13.8 13.0 10.4 11.4 16.4 20.3 10.0 17.4 17.1 22.5 33.1 31.9 30.5 12.3 27.5 15.7 20.2 13.8 23.8 53.0 27.3 101.5 30.3 11.3 20.8 27.7 13.1 33.5 15.5 12.5 16.6 48.2 29.2 12.4 30.0 30.9 38.5 45.8 29.0 29.6 15.3 45.1 33.8 30.0 27.9 20.0 25.1 26.2 25.8 38.9 23.1 17.1 5.6 15.5 22.0 23.9 75.6 45.5 44.1 26.7 57.1 6.5 30.3 35.2 35.7 46.5 31.7 46.2 56.5 49.6 49.1 42.3 43.7 46.7 45.0 30.9 39.1 28.3 64.2 64.8 55.2 65.9 64.0 41.8 71.7 51.8 60.7 46.8 58.7 53.0 26.2 ATP5MGL "ATP5K2, ATP5L2, dJ222E13.5" ENSG00000249222 "ATP synthase membrane subunit g like" Q7Z4Y8 22 42639803-42640601 "Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 3.9;bone marrow: 4.5" "Cell line enhanced" "Detected in some" "RT4: 2.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA044629 Uncertain Supported Mitochondria Mitochondria "HPA044629: " "unprognostic (4.53e-2)" "unprognostic (3.46e-2)" "unprognostic (1.20e-2)" "unprognostic (5.67e-2)" "unprognostic (3.01e-2)" "unprognostic (3.36e-2)" "unprognostic (1.31e-2)" "unprognostic (1.70e-2)" "unprognostic (6.74e-2)" "unprognostic (4.40e-2)" "unprognostic (1.26e-1)" "unprognostic (1.51e-1)" "unprognostic (1.51e-1)" "unprognostic (1.17e-1)" "unprognostic (4.17e-1)" "unprognostic (5.12e-2)" "unprognostic (1.85e-3)" 0.4 0.7 0.4 0.0 0.4 4.5 0.3 0.6 0.5 0.0 0.2 0.4 0.4 2.4 0.3 0.4 0.4 1.2 0.3 0.4 0.4 0.7 0.2 1.0 0.3 0.5 0.4 0.0 0.4 0.0 0.3 0.0 0.9 0.1 0.7 3.1 0.5 0.0 0.3 0.4 1.0 0.3 0.5 0.1 0.5 0.2 1.2 1.0 3.9 1.2 0.6 1.0 1.1 0.2 0.0 0.4 0.7 0.0 0.0 0.0 0.8 0.0 0.0 0.3 1.6 0.3 1.0 0.2 0.6 0.2 0.0 0.0 0.8 0.6 1.2 0.0 2.0 0.7 0.0 0.0 1.2 0.0 0.0 0.9 0.5 0.8 0.0 1.3 0.0 0.5 0.8 1.7 1.5 0.0 0.2 0.0 0.6 0.0 2.4 0.2 0.1 0.0 0.7 0.2 0.2 0.0 0.0 1.2 0.8 0.8 0.6 0.6 1.1 0.1 0.3 0.7 0.9 2.3 1.2 0.7 0.6 0.6 0.5 1.2 0.9 0.6 0.5 1.2 1.0 0.7 3.9 0.6 0.7 1.0 0.7 1.1 ATP5PO "ATP5O, ATPO, OSCP" ENSG00000241837 "ATP synthase peripheral stalk subunit OSCP" P48047 21 33903453-33915980 "Plasma proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB016209, HPA041394" Enhanced Enhanced Mitochondria 4000000 Mitochondria "CAB016209: AB_631361, HPA041394: " "unprognostic (2.08e-1)" "unprognostic (4.77e-3)" "unprognostic (3.30e-1)" "unprognostic (6.12e-3)" "unprognostic (1.51e-1)" "unprognostic (1.46e-1)" "unprognostic (1.48e-1)" "unprognostic (2.34e-1)" "unprognostic (8.47e-2)" "unprognostic (1.42e-1)" "unprognostic (3.27e-1)" "unprognostic (1.81e-1)" "prognostic favourable (9.34e-4)" "unprognostic (1.03e-1)" "unprognostic (1.37e-2)" "unprognostic (3.26e-2)" "unprognostic (7.89e-3)" 32.6 26.8 49.3 27.7 43.5 34.9 37.8 35.0 44.8 28.7 45.0 21.6 24.2 48.2 25.1 34.3 44.2 28.9 30.3 139.4 40.8 36.7 61.3 57.5 20.6 31.5 45.6 38.4 38.0 40.1 29.5 19.2 25.1 46.4 32.5 52.4 27.2 38.8 28.6 130.6 28.7 57.5 34.8 29.3 27.3 43.2 25.4 20.1 42.7 37.4 98.0 36.2 39.4 26.5 71.9 94.0 48.5 71.5 46.8 73.3 112.2 41.9 19.7 54.9 53.8 37.7 48.4 61.1 24.0 42.2 40.4 39.7 57.7 40.7 56.2 20.7 36.4 23.8 59.1 82.0 47.9 41.9 58.9 84.3 31.5 57.3 43.5 63.8 29.2 49.2 50.2 39.1 64.3 55.6 67.6 73.0 51.9 43.2 48.7 62.7 62.6 58.3 50.3 54.2 106.1 110.7 37.3 44.4 25.7 41.2 61.7 54.6 62.2 70.5 31.3 26.6 31.7 47.4 27.2 48.2 52.6 58.9 49.1 109.6 38.3 33.4 69.9 48.5 44.5 71.5 53.0 71.9 58.8 52.9 94.0 59.0 73.3 61.5 17.2 46.8 62.6 55.9 70.1 112.2 49.3 43.5 35.0 44.8 40.8 36.7 45.6 38.4 46.4 20.1 BAD "BBC2, BCL2L8" ENSG00000002330 "BCL2 associated agonist of cell death" Q92934 11 64269830-64284704 "Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004205, HPA028185, HPA062105" Approved Enhanced Mitochondria Mitochondria "CAB004205: AB_626717, HPA028185: AB_10603445, HPA062105: " "unprognostic (1.47e-1)" "unprognostic (3.08e-2)" "unprognostic (1.17e-1)" "unprognostic (8.24e-3)" "unprognostic (2.60e-1)" "unprognostic (6.73e-2)" "unprognostic (1.24e-3)" "unprognostic (1.07e-1)" "unprognostic (1.99e-1)" "unprognostic (1.10e-1)" "unprognostic (1.36e-1)" "unprognostic (1.14e-1)" "unprognostic (8.26e-2)" "unprognostic (9.04e-2)" "unprognostic (2.17e-1)" "unprognostic (1.48e-1)" "unprognostic (7.95e-2)" 23.1 23.2 35.3 12.6 30.7 17.7 20.6 15.9 43.9 21.2 25.7 22.7 20.1 24.0 18.3 19.7 18.8 23.2 22.5 30.3 32.7 23.8 21.4 22.3 17.7 14.3 29.6 20.2 18.8 26.9 19.4 15.2 24.9 18.4 22.9 13.6 23.1 39.9 27.0 23.9 20.4 21.1 17.2 22.9 14.9 37.8 18.6 14.8 19.3 29.2 15.8 14.1 18.2 14.4 26.5 42.0 43.5 32.3 24.0 30.7 23.1 31.9 30.1 8.8 13.2 10.7 13.1 12.9 13.6 15.9 21.0 16.7 18.3 18.4 6.9 24.5 12.7 17.0 5.7 21.4 4.2 26.7 21.0 8.5 27.2 8.7 16.5 7.4 16.0 12.6 18.5 16.1 9.9 13.2 3.2 14.9 9.1 31.8 16.5 16.7 3.4 38.5 15.7 5.2 19.3 12.7 15.1 18.2 24.4 13.7 16.3 16.6 24.5 11.1 10.9 25.7 17.4 39.8 14.9 28.3 21.0 7.0 21.0 5.3 14.0 32.5 32.3 43.5 25.3 24.0 25.8 26.0 26.9 24.6 22.5 26.5 19.4 20.0 41.7 24.0 22.6 42.0 30.7 23.1 35.3 30.7 15.9 43.9 32.7 23.8 29.6 20.2 18.4 14.8 BCL2L13 "BCL-RAMBO, MIL1" ENSG00000099968 "BCL2 like 13" Q9BXK5 22 17628855-17730855 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002052, HPA030994, HPA050377" Uncertain Enhanced Mitochondria Mitochondria "CAB002052: AB_563431, HPA030994: AB_10795024, HPA050377: " "unprognostic (1.59e-1)" "unprognostic (8.17e-2)" "unprognostic (2.18e-3)" "unprognostic (1.86e-1)" "unprognostic (6.27e-2)" "unprognostic (2.69e-2)" "unprognostic (3.38e-1)" "unprognostic (4.97e-2)" "unprognostic (5.04e-2)" "unprognostic (9.46e-2)" "unprognostic (1.45e-2)" "unprognostic (8.21e-2)" "prognostic favourable (1.96e-8)" "unprognostic (3.20e-1)" "unprognostic (1.07e-1)" "unprognostic (4.27e-1)" "unprognostic (2.81e-1)" 15.3 17.4 13.3 7.6 14.2 10.9 17.3 13.0 17.4 9.2 11.9 14.8 8.8 8.3 10.5 10.7 14.5 11.7 10.0 18.9 12.7 12.2 18.9 20.9 10.6 9.3 14.4 13.4 10.4 22.0 25.8 12.3 14.1 12.2 11.1 14.1 15.2 12.4 9.5 61.2 15.5 12.4 11.7 13.0 8.3 11.2 22.9 11.5 12.1 13.5 14.5 12.3 14.6 10.2 6.5 11.3 4.7 17.3 10.4 8.3 9.5 14.0 6.3 10.1 9.6 16.8 16.2 13.4 10.1 17.7 15.0 17.1 7.1 9.4 12.2 7.3 14.4 19.3 11.6 15.5 15.7 11.7 8.8 11.5 5.7 3.7 21.0 16.0 10.0 13.1 18.2 12.8 34.7 13.1 28.5 11.5 16.3 9.5 8.1 5.1 8.0 7.9 8.6 15.6 4.5 15.6 9.7 14.3 9.0 13.3 13.5 24.1 9.2 15.8 13.0 8.9 4.6 12.7 9.6 9.9 8.9 10.5 13.3 12.3 15.2 3.8 17.3 4.7 4.6 15.6 5.7 6.5 6.2 5.7 11.3 5.4 5.5 4.5 4.4 10.4 11.0 5.7 8.3 9.5 13.3 14.2 13.0 17.4 12.7 12.2 14.4 13.4 12.2 11.5 BDH1 "BDH, SDR9C1" ENSG00000161267 "3-hydroxybutyrate dehydrogenase 1" Q02338 3 197509783-197573323 "Candidate cardiovascular disease genes, Enzymes, Predicted intracellular proteins" "Allosteric enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "liver: 156.0" "Cell line enhanced" "Detected in many" "U-937: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030947, HPA058709" Enhanced Enhanced Mitochondria Mitochondria "HPA030947: AB_10669548, HPA058709: " "unprognostic (2.72e-2)" "prognostic favourable (1.09e-4)" "unprognostic (1.13e-1)" "unprognostic (3.93e-1)" "unprognostic (3.35e-2)" "unprognostic (1.07e-1)" "prognostic favourable (9.86e-7)" "unprognostic (2.08e-1)" "unprognostic (3.85e-2)" "unprognostic (4.53e-2)" "unprognostic (5.17e-3)" "unprognostic (5.85e-3)" "prognostic favourable (7.12e-8)" "unprognostic (5.62e-2)" "unprognostic (1.74e-1)" "unprognostic (6.22e-2)" "unprognostic (1.02e-1)" 3.5 2.8 6.6 5.2 11.2 4.7 4.6 18.1 13.8 4.0 13.9 4.6 6.3 9.6 2.1 3.6 12.9 5.5 6.1 19.6 6.3 5.8 6.0 156.0 2.0 4.2 5.9 9.1 3.0 2.8 5.8 3.6 1.4 7.7 4.5 11.1 6.2 8.6 4.4 7.3 8.0 13.7 2.4 3.5 2.3 4.7 1.8 3.6 5.4 5.2 11.3 7.4 3.6 3.6 6.1 4.6 2.9 1.6 4.7 9.9 4.0 10.5 1.4 0.6 5.4 0.9 0.0 0.0 1.2 1.0 5.5 3.1 9.5 3.5 0.0 15.7 0.3 4.9 4.8 2.5 2.1 0.1 0.0 5.6 3.6 3.2 4.0 12.4 5.9 1.6 3.0 2.1 4.6 1.3 0.0 4.2 0.1 18.8 9.5 8.4 4.1 1.9 9.1 2.0 14.4 5.8 4.8 10.0 4.3 3.8 0.5 2.0 12.7 10.4 0.1 0.3 1.8 0.0 9.9 4.9 9.2 0.1 0.3 35.3 0.7 2.9 1.6 0.6 5.9 0.2 8.2 6.1 6.5 5.3 4.2 5.5 9.9 5.9 0.0 4.7 0.3 4.6 4.2 4.0 6.6 11.2 18.1 13.8 6.3 5.8 5.9 9.1 7.7 3.6 BNIP3L "BNIP3a, Nix" ENSG00000104765 "BCL2 interacting protein 3 like" O60238 8 26382898-26505636 "Cancer-related genes, Predicted membrane proteins, Transporters" "Apoptosis, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015652, CAB025371" Enhanced Supported "Nuclear speckles,Mitochondria" Mitochondria "Nuclear speckles" "CAB025371: , HPA015652: AB_1845406" "unprognostic (1.02e-1)" "unprognostic (2.90e-1)" "unprognostic (2.00e-1)" "unprognostic (8.36e-2)" "unprognostic (6.24e-2)" "unprognostic (1.63e-1)" "unprognostic (1.64e-3)" "unprognostic (1.46e-2)" "unprognostic (5.04e-2)" "unprognostic (2.02e-1)" "unprognostic (2.06e-2)" "unprognostic (2.97e-2)" "prognostic unfavourable (5.92e-5)" "unprognostic (8.72e-3)" "unprognostic (5.16e-2)" "prognostic unfavourable (3.95e-4)" "unprognostic (7.59e-3)" 61.7 27.8 32.7 18.2 39.1 79.4 40.1 26.1 39.0 35.0 19.9 32.3 30.7 11.5 27.3 34.0 26.7 26.4 28.0 36.0 36.0 27.4 39.9 22.9 31.3 20.7 43.1 31.9 63.4 10.4 26.8 16.0 51.2 41.0 23.7 14.9 20.9 22.1 39.2 21.0 38.1 14.5 26.5 47.9 19.5 16.7 33.0 43.9 17.8 21.5 12.4 25.2 48.3 30.8 14.2 30.4 68.7 53.9 7.8 17.6 36.3 18.1 6.9 16.6 11.2 46.3 29.2 14.0 18.4 54.1 17.3 38.3 3.1 8.8 5.6 17.4 34.6 9.3 8.2 23.6 57.6 3.6 4.5 23.2 7.2 5.4 25.8 2.0 40.3 35.0 18.6 19.6 11.8 22.1 10.4 13.6 36.2 7.9 14.3 7.6 5.3 7.6 7.7 21.1 11.0 17.9 11.8 17.7 15.8 8.9 1.8 13.9 9.1 4.4 28.9 32.5 14.1 20.3 4.1 20.0 9.0 7.5 49.4 4.2 7.3 49.9 53.9 32.1 7.6 27.8 6.7 12.4 11.4 8.3 30.4 14.2 17.6 12.8 68.7 7.8 17.4 6.9 15.0 36.3 32.7 39.1 26.1 39.0 36.0 27.4 43.1 31.9 41.0 43.9 CCDC90B "MDS011, MDS025" ENSG00000137500 "Coiled-coil domain containing 90B" Q9GZT6 11 83259097-83286407 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011130, HPA011931" Supported Enhanced Mitochondria Mitochondria "HPA011130: AB_1846170, HPA011931: AB_2072332" "unprognostic (5.85e-2)" "unprognostic (1.33e-1)" "unprognostic (7.34e-2)" "unprognostic (9.71e-2)" "unprognostic (1.34e-1)" "unprognostic (7.48e-2)" "unprognostic (2.99e-1)" "unprognostic (3.57e-3)" "unprognostic (5.76e-3)" "unprognostic (3.53e-2)" "unprognostic (6.01e-3)" "unprognostic (2.01e-2)" "unprognostic (1.00e-2)" "unprognostic (2.31e-1)" "unprognostic (3.03e-1)" "unprognostic (1.62e-1)" "unprognostic (2.41e-1)" 15.8 32.0 25.0 11.1 23.3 11.6 18.0 14.3 17.9 15.4 14.5 14.6 17.2 12.1 12.6 29.3 14.3 13.5 15.2 18.2 22.3 25.6 16.4 31.3 11.0 15.0 29.9 14.9 19.4 16.6 15.2 29.5 18.3 24.5 16.3 14.9 8.4 14.5 14.8 12.2 11.6 18.2 14.9 43.9 17.1 13.6 42.2 28.3 15.5 21.6 12.3 13.5 14.8 13.0 18.5 12.7 32.6 19.0 22.5 21.1 12.4 7.3 10.9 18.6 6.0 25.3 19.1 11.4 15.0 12.9 9.5 10.2 12.7 25.5 17.9 19.7 22.2 9.4 8.2 19.2 12.7 12.5 6.5 11.0 7.4 10.6 21.3 11.1 9.6 21.3 26.0 12.2 35.1 21.5 16.3 15.3 34.4 13.0 11.2 14.3 15.4 13.6 13.0 16.7 15.4 19.6 10.9 9.1 21.0 10.5 8.5 9.8 22.0 10.4 20.6 18.6 11.7 34.8 10.1 14.9 19.5 18.2 7.5 9.0 18.3 30.8 8.9 32.6 12.3 19.0 15.6 18.5 17.9 17.0 12.7 16.9 15.5 15.5 4.5 22.5 19.0 9.3 21.1 12.4 25.0 23.3 14.3 17.9 22.3 25.6 29.9 14.9 24.5 28.3 CCM2 "C7orf22, MGC4607, OSM" ENSG00000136280 "CCM2 scaffolding protein" Q9BSQ5 7 44999475-45076469 "Disease related genes, Predicted intracellular proteins" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020273, HPA021669, HPA065815" Supported Enhanced Mitochondria Mitochondria "HPA020273: AB_1846185, HPA021669: AB_1846186, HPA065815: " "unprognostic (4.30e-1)" "unprognostic (1.30e-1)" "prognostic unfavourable (1.79e-4)" "unprognostic (3.17e-1)" "prognostic unfavourable (2.45e-4)" "unprognostic (4.85e-2)" "unprognostic (1.55e-2)" "unprognostic (7.37e-3)" "unprognostic (3.92e-1)" "unprognostic (2.65e-1)" "prognostic favourable (1.16e-4)" "unprognostic (3.03e-1)" "prognostic unfavourable (5.06e-7)" "unprognostic (2.45e-1)" "unprognostic (1.79e-1)" "unprognostic (2.81e-2)" "unprognostic (2.48e-1)" 16.7 18.3 31.6 20.7 52.0 11.2 8.6 21.3 36.1 9.7 12.5 13.9 8.6 10.5 7.2 7.0 10.6 8.4 9.1 13.7 29.8 23.1 7.9 31.6 12.4 30.7 29.0 14.2 8.2 17.9 16.5 11.2 11.5 17.8 7.7 8.8 6.9 13.6 12.6 27.0 13.4 10.6 13.3 14.7 20.8 11.2 10.5 11.5 37.5 7.4 8.2 23.4 15.4 12.6 14.8 7.3 32.4 13.8 17.6 50.6 11.1 14.0 15.5 9.3 18.5 17.6 15.5 6.9 17.0 14.0 12.2 16.5 11.2 14.6 19.8 13.2 21.5 18.3 5.7 22.0 8.1 22.0 11.1 8.8 12.4 7.9 15.6 3.6 23.7 17.5 14.5 21.4 9.2 22.2 10.0 16.1 24.4 21.1 17.3 48.0 10.7 17.3 9.3 5.3 16.1 12.5 13.6 18.0 14.0 13.9 11.0 7.5 12.6 16.5 16.8 16.7 14.1 16.6 16.3 28.9 22.6 40.0 16.3 13.1 20.0 27.1 10.5 31.2 17.3 12.1 11.6 13.6 20.5 18.7 7.2 14.8 19.9 14.7 32.4 17.6 13.8 7.3 50.6 11.1 31.6 52.0 21.3 36.1 29.8 23.1 29.0 14.2 17.8 11.5 CHCHD2 C7orf17 ENSG00000106153 "Coiled-coil-helix-coiled-coil-helix domain containing 2" Q9Y6H1 7 56101569-56106576 "Disease related genes, Predicted intracellular proteins" Transcription Activator "Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 220.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027407, HPA052510" Uncertain Enhanced Mitochondria Mitochondria "HPA027407: AB_10959659, HPA052510: AB_2681856" "unprognostic (8.68e-3)" "unprognostic (2.79e-1)" "unprognostic (8.48e-2)" "unprognostic (2.32e-1)" "unprognostic (3.90e-2)" "prognostic unfavourable (1.90e-5)" "prognostic unfavourable (9.41e-5)" "unprognostic (4.38e-2)" "unprognostic (3.61e-1)" "unprognostic (2.30e-2)" "unprognostic (1.37e-1)" "unprognostic (2.79e-2)" "unprognostic (2.60e-2)" "unprognostic (4.01e-2)" "unprognostic (1.79e-1)" "unprognostic (2.09e-1)" "unprognostic (2.40e-2)" 41.5 112.8 57.2 33.0 59.5 73.0 46.0 39.3 56.9 38.0 46.6 33.2 45.5 51.9 34.2 53.8 50.1 39.2 44.3 75.3 46.8 50.2 56.2 66.9 34.2 62.6 58.3 49.0 43.8 77.8 28.4 42.8 38.4 42.3 41.3 40.1 45.3 56.5 70.0 147.2 33.0 49.3 45.7 42.6 34.1 44.2 27.1 28.1 48.9 62.1 65.9 38.8 38.5 30.9 63.2 107.7 52.6 69.1 51.5 72.8 121.3 220.2 38.6 25.4 52.5 20.1 27.8 18.8 32.4 30.8 41.8 40.5 35.3 36.9 64.6 42.9 19.8 37.5 32.2 35.5 33.7 41.9 58.5 38.1 32.5 50.2 37.5 51.3 61.6 24.7 40.6 31.3 38.5 31.2 79.9 39.3 34.0 30.5 69.0 158.9 55.0 61.5 46.6 24.8 106.0 37.4 28.8 48.5 60.4 25.5 63.0 40.7 72.0 73.4 24.9 25.8 60.5 106.8 47.6 36.3 51.7 115.2 40.6 55.4 32.0 40.5 69.1 52.6 53.1 61.0 54.8 63.2 57.2 56.3 79.5 57.8 51.6 52.8 37.0 51.5 59.5 107.7 72.8 121.3 57.2 59.5 39.3 56.9 46.8 50.2 58.3 49.0 42.3 28.1 COQ8B "ADCK4, COQ8, FLJ12229" ENSG00000123815 "Coenzyme Q8B" Q96D53 19 40691529-40718207 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027229, HPA027277, HPA027279, HPA028303" Supported Enhanced Mitochondria Mitochondria "HPA027229: AB_10600100, HPA027277: AB_10599857, HPA027279: AB_10601219, HPA028303: AB_2672551" "unprognostic (7.57e-2)" "unprognostic (9.48e-2)" "unprognostic (1.61e-1)" "unprognostic (2.36e-2)" "unprognostic (2.33e-2)" "unprognostic (1.19e-1)" "unprognostic (1.79e-1)" "unprognostic (4.63e-2)" "unprognostic (1.85e-1)" "unprognostic (2.27e-1)" "unprognostic (2.82e-2)" "unprognostic (1.48e-1)" "unprognostic (2.93e-2)" "unprognostic (6.18e-2)" "unprognostic (1.46e-1)" "unprognostic (7.17e-2)" "unprognostic (2.65e-2)" 13.6 17.8 21.1 13.1 16.4 11.5 10.0 24.1 19.2 13.6 13.6 18.6 14.8 17.9 15.0 13.2 16.6 26.5 16.7 14.7 15.7 10.7 11.8 15.6 12.1 12.2 15.5 12.1 16.3 19.4 12.6 32.7 7.9 13.2 15.1 5.7 12.3 16.8 17.6 10.3 12.9 18.6 16.2 15.6 12.1 17.5 12.5 16.7 16.8 15.5 6.9 13.2 14.8 11.8 12.9 15.0 17.7 15.6 9.7 13.1 10.5 8.2 33.7 6.9 13.3 6.2 6.0 6.4 7.7 8.3 5.8 6.2 10.5 15.0 11.0 14.9 4.4 7.1 4.8 8.6 2.1 13.2 10.0 10.6 20.5 5.8 10.7 3.6 16.5 7.9 9.2 4.2 5.1 6.5 5.6 6.0 4.0 5.0 4.7 4.4 5.3 3.5 7.9 9.7 8.3 10.1 13.9 12.4 10.1 10.3 15.8 16.7 14.2 13.8 6.1 5.0 17.0 3.6 4.5 6.7 5.4 5.6 18.9 4.2 6.9 15.8 15.6 14.6 11.6 15.4 13.1 12.9 9.0 12.4 15.0 11.7 8.9 9.1 17.7 9.7 13.7 8.7 8.8 10.5 21.1 16.4 24.1 19.2 15.7 10.7 15.5 12.1 13.2 16.7 COX20 "FAM36A, FLJ43269" ENSG00000203667 "COX20, cytochrome c oxidase assembly factor" Q5RI15 1 244835322-244845057 "Disease related genes, Predicted membrane proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043617, HPA045490" Approved Enhanced Mitochondria Mitochondria "HPA043617: AB_10965694, HPA045490: AB_10962869" "unprognostic (5.84e-3)" "unprognostic (1.20e-1)" "unprognostic (7.33e-2)" "unprognostic (2.86e-1)" "unprognostic (3.62e-1)" "unprognostic (3.70e-2)" "unprognostic (1.07e-1)" "unprognostic (1.62e-1)" "unprognostic (1.03e-1)" "prognostic favourable (3.13e-4)" "unprognostic (1.99e-1)" "unprognostic (6.38e-2)" "unprognostic (3.44e-2)" "unprognostic (2.54e-2)" "unprognostic (3.70e-2)" "unprognostic (3.10e-1)" "unprognostic (7.02e-3)" 13.1 37.9 30.2 17.5 28.9 12.5 14.9 22.0 25.8 11.8 20.5 11.8 9.3 18.2 17.5 16.9 20.6 11.4 16.2 35.4 22.8 27.7 36.7 23.6 11.1 13.4 32.1 18.3 26.7 15.1 14.3 15.1 15.0 19.2 20.2 11.8 27.9 11.3 15.5 33.3 8.1 19.4 42.5 22.0 10.1 17.9 21.1 17.0 10.4 17.5 20.2 10.7 23.0 16.5 18.2 16.3 11.6 18.4 12.2 22.5 10.5 36.2 9.1 9.2 28.7 6.3 4.8 21.6 15.3 10.2 8.7 7.9 25.9 25.4 5.5 19.4 10.3 9.5 4.8 12.3 11.9 15.4 3.3 10.6 13.4 23.8 8.4 26.1 16.4 4.3 5.9 12.9 9.0 10.0 21.9 23.0 18.0 9.0 14.0 11.6 24.3 18.9 10.3 11.4 33.6 16.3 8.6 5.4 14.7 19.1 10.1 19.8 18.7 7.5 19.4 19.5 25.7 17.0 32.8 36.5 50.1 11.7 24.9 29.1 18.6 5.7 8.8 11.6 15.4 18.4 15.1 18.2 18.3 16.8 15.0 16.0 11.0 16.9 1.7 12.2 17.8 16.3 22.5 10.5 30.2 28.9 22.0 25.8 22.8 27.7 32.1 18.3 19.2 17.0 COX5B ENSG00000135940 "Cytochrome c oxidase subunit 5B" P10606 2 97646040-97648383 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 336.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034517 Supported Enhanced Mitochondria 2200000 Mitochondria "HPA034517: AB_10603561" "unprognostic (4.61e-2)" "unprognostic (4.33e-2)" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" "unprognostic (1.39e-1)" "unprognostic (1.92e-2)" "unprognostic (2.48e-1)" "unprognostic (1.01e-1)" "unprognostic (1.86e-1)" "unprognostic (2.72e-2)" "unprognostic (1.79e-2)" "unprognostic (4.20e-2)" "unprognostic (4.02e-2)" "unprognostic (3.32e-1)" "unprognostic (1.01e-1)" "unprognostic (1.34e-1)" "prognostic favourable (2.73e-4)" 39.8 25.3 54.5 20.8 46.1 27.6 23.9 22.6 46.4 19.5 58.6 16.0 27.6 44.5 13.1 22.3 31.9 19.4 24.0 160.6 39.9 36.0 44.8 52.5 13.8 16.1 48.1 32.5 17.7 24.6 19.9 17.5 18.1 39.0 21.5 31.5 14.3 36.5 29.2 336.2 18.9 38.6 19.9 30.8 17.9 40.4 13.4 23.0 14.2 25.8 65.4 15.3 19.4 16.7 85.1 111.2 115.8 122.5 48.1 83.6 145.2 19.5 22.9 14.1 23.4 16.7 15.2 61.0 25.2 14.1 16.7 18.7 63.1 20.5 33.0 54.2 16.1 29.9 16.3 25.3 7.6 25.7 69.2 44.4 25.3 75.3 32.1 42.2 32.6 28.1 22.4 16.1 12.6 14.3 32.6 14.6 12.9 48.4 26.6 61.1 27.8 120.1 26.1 24.3 49.4 22.5 30.1 28.1 30.0 24.5 29.6 47.3 15.7 44.1 26.0 15.3 26.1 24.5 16.2 38.1 36.0 25.2 27.8 36.2 15.8 96.9 122.5 99.8 54.7 114.1 52.6 85.1 66.3 57.1 111.2 68.8 64.5 57.5 115.8 48.1 95.9 75.8 83.6 145.2 54.5 46.1 22.6 46.4 39.9 36.0 48.1 32.5 39.0 23.0 COX6C ENSG00000164919 "Cytochrome c oxidase subunit 6C" P09669 8 99873200-99894062 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 232.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014295, CAB016244" Enhanced Enhanced Mitochondria 53000 Mitochondria "CAB016244: AB_2085703, HPA014295: " "unprognostic (4.91e-2)" "unprognostic (2.90e-2)" "unprognostic (6.90e-2)" "unprognostic (3.37e-2)" "unprognostic (1.58e-2)" "unprognostic (1.26e-1)" "unprognostic (1.63e-1)" "unprognostic (2.07e-2)" "unprognostic (1.29e-1)" "unprognostic (3.51e-1)" "unprognostic (3.70e-1)" "unprognostic (8.86e-2)" "unprognostic (3.47e-3)" "unprognostic (1.10e-1)" "unprognostic (5.31e-2)" "unprognostic (1.07e-1)" "unprognostic (6.99e-3)" 20.5 43.1 66.1 21.6 56.2 44.4 23.3 28.5 63.8 18.7 46.0 14.3 29.4 113.7 38.8 64.1 31.6 27.4 23.5 113.0 54.8 46.9 38.7 66.8 18.2 23.2 58.8 36.7 32.7 26.5 12.1 24.0 30.7 38.8 23.3 38.1 20.6 32.4 30.1 232.1 31.2 55.8 38.7 40.4 23.7 35.1 29.6 23.5 17.9 19.5 80.6 17.8 31.0 21.3 45.9 62.3 55.7 50.6 37.2 73.5 48.0 16.7 6.7 7.9 32.2 18.0 13.1 13.2 5.5 5.2 3.8 4.3 6.8 35.9 40.7 41.6 8.5 22.3 4.5 45.6 6.3 7.3 11.4 84.4 8.1 19.8 11.7 38.9 26.1 12.1 60.7 3.1 7.0 5.6 5.9 73.1 6.3 16.0 40.4 35.8 15.1 15.6 46.9 2.6 39.8 57.2 89.2 24.5 14.9 3.8 83.6 40.8 58.9 24.9 4.8 28.6 37.2 30.2 7.8 18.2 14.6 24.1 40.2 15.8 25.3 55.7 29.3 22.1 40.1 42.3 41.8 45.9 61.0 42.5 43.8 41.7 73.5 65.7 3.5 37.2 50.6 62.3 56.9 48.0 66.1 56.2 28.5 63.8 54.8 46.9 58.8 36.7 38.8 23.5 COX7A2L "COX7AR, COX7RP, EB1, SIG81" ENSG00000115944 "Cytochrome c oxidase subunit 7A2 like" O14548 2 42333546-42425088 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059124, CAB073545" Enhanced Nucleoli,Mitochondria Mitochondria Nucleoli "CAB073545: , HPA059124: " "unprognostic (3.90e-1)" "unprognostic (1.02e-1)" "unprognostic (1.18e-1)" "unprognostic (5.45e-2)" "unprognostic (4.60e-2)" "unprognostic (1.27e-2)" "prognostic unfavourable (4.13e-5)" "unprognostic (1.17e-1)" "unprognostic (3.12e-1)" "unprognostic (1.66e-2)" "unprognostic (2.43e-1)" "unprognostic (7.07e-3)" "unprognostic (1.54e-2)" "unprognostic (2.76e-1)" "unprognostic (5.53e-2)" "unprognostic (6.19e-2)" "unprognostic (1.02e-1)" 25.1 73.3 47.3 24.4 63.3 47.7 45.4 35.2 58.2 33.4 33.8 21.0 28.8 31.7 30.2 37.9 20.9 31.2 27.1 49.8 40.4 45.3 50.9 48.9 24.0 28.1 42.6 35.6 49.8 49.3 24.9 42.7 24.0 34.9 29.5 36.2 32.3 37.0 30.3 24.4 21.5 32.1 28.4 33.1 23.1 29.4 24.8 20.5 28.0 35.8 35.8 30.9 24.5 31.1 45.1 59.7 57.2 48.7 40.5 53.7 100.9 37.5 24.1 26.8 29.0 46.0 65.6 32.0 31.2 45.6 28.5 36.4 26.4 27.2 33.3 31.3 35.7 16.9 31.9 33.0 41.8 51.2 24.5 22.5 17.3 46.8 54.2 33.8 25.1 64.3 66.6 27.9 67.4 40.1 32.8 57.2 44.1 30.6 40.3 56.3 26.2 25.1 22.0 46.5 28.3 40.8 30.5 31.8 36.4 13.1 32.9 89.4 23.6 39.5 30.2 25.9 33.9 31.3 30.4 47.0 52.5 25.0 36.6 36.8 21.9 57.2 48.7 27.2 39.0 42.0 50.0 45.1 47.9 45.3 53.1 37.6 53.7 46.1 21.6 40.5 46.3 59.7 52.8 100.9 47.3 63.3 35.2 58.2 40.4 45.3 42.6 35.6 34.9 20.5 CPOX "CPO, CPX, HCP" ENSG00000080819 "Coproporphyrinogen oxidase" P36551 3 98521132-98593723 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Heme biosynthesis, Porphyrin biosynthesis" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.9" "Cell line enhanced" "Detected in all" "HEL: 56.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015736, HPA054448" Enhanced Mitochondria 140000 Mitochondria "HPA015736: AB_1847194, HPA054448: " "unprognostic (2.14e-1)" "unprognostic (1.04e-1)" "unprognostic (4.07e-2)" "unprognostic (6.09e-2)" "unprognostic (2.71e-1)" "unprognostic (2.34e-2)" "unprognostic (8.58e-3)" "unprognostic (7.14e-2)" "unprognostic (2.53e-2)" "unprognostic (2.01e-1)" "unprognostic (1.10e-2)" "unprognostic (1.86e-2)" "prognostic unfavourable (1.04e-5)" "unprognostic (1.62e-1)" "unprognostic (2.67e-2)" "unprognostic (2.15e-2)" "unprognostic (2.57e-1)" 6.6 8.9 12.6 9.0 29.9 30.2 6.6 10.1 21.1 7.5 8.2 29.6 5.7 17.7 8.8 6.4 14.1 6.4 7.2 6.9 17.5 11.7 5.6 29.3 6.3 9.1 42.9 16.2 9.5 6.9 9.9 5.5 14.8 23.7 7.4 10.3 3.4 7.2 7.2 8.5 10.8 12.3 7.7 32.8 9.1 7.7 3.9 36.0 7.7 6.2 7.0 9.8 8.5 10.4 1.7 1.7 0.0 2.1 2.1 3.0 0.7 16.3 7.9 7.0 12.4 13.2 9.8 20.3 10.5 7.6 10.9 12.4 13.1 5.1 1.7 11.9 5.5 11.9 8.7 11.4 18.6 5.2 7.6 56.9 4.5 16.9 6.7 12.0 13.5 7.7 9.6 10.3 4.3 10.3 10.9 7.4 10.2 5.0 12.1 10.3 8.3 14.5 8.6 16.0 7.5 9.2 6.8 4.6 4.6 11.1 3.8 31.6 5.9 7.7 8.6 16.2 15.9 9.2 7.7 11.3 8.9 9.1 16.1 13.2 11.8 0.0 2.1 0.0 1.4 1.0 2.5 1.7 2.4 2.9 1.7 1.5 0.8 3.0 0.0 2.1 0.7 1.1 1.1 0.7 12.6 29.9 10.1 21.1 17.5 11.7 42.9 16.2 23.7 36.0 CPT2 "CPT1, CPTASE" ENSG00000157184 "Carnitine palmitoyltransferase 2" P23786 1 53196429-53214197 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028201, HPA028202, HPA028214" Enhanced Supported Nucleoplasm,Nucleoli,Mitochondria "Nucleoplasm, Nucleoli, Mitochondria" "HPA028201: AB_10599177, HPA028202: AB_10599942, HPA028214: AB_10601958" "unprognostic (2.43e-1)" "unprognostic (2.27e-1)" "prognostic favourable (5.27e-4)" "unprognostic (6.48e-2)" "unprognostic (1.88e-1)" "unprognostic (9.34e-2)" "unprognostic (6.48e-2)" "unprognostic (1.75e-2)" "unprognostic (2.86e-1)" "unprognostic (1.67e-1)" "unprognostic (3.00e-2)" "unprognostic (8.97e-2)" "prognostic favourable (1.46e-12)" "unprognostic (4.00e-2)" "unprognostic (2.06e-1)" "unprognostic (1.79e-2)" "unprognostic (2.95e-2)" 7.5 15.5 5.3 6.8 6.1 2.3 6.5 4.0 7.2 5.1 15.4 9.4 10.7 16.6 5.1 7.6 10.5 5.4 11.3 21.4 4.3 4.5 19.8 69.0 6.9 8.3 5.7 3.7 5.3 15.9 10.7 11.5 18.1 6.4 6.0 15.6 13.8 11.8 12.2 13.6 6.0 18.9 5.5 5.2 10.3 10.1 11.2 4.7 9.7 8.3 7.2 10.3 8.0 4.9 5.9 12.4 10.0 13.1 4.8 8.0 6.5 7.8 3.3 7.7 7.5 6.6 3.9 8.8 4.9 5.0 7.1 6.6 1.6 6.7 13.5 7.5 2.3 7.9 14.3 11.3 6.0 7.4 8.4 7.7 4.5 1.3 9.8 7.3 7.4 8.4 9.7 5.1 4.4 4.8 9.8 4.8 4.4 4.6 5.7 6.0 14.4 8.8 6.6 7.3 14.3 8.8 7.4 11.5 7.7 9.8 12.5 18.5 14.5 15.6 4.7 4.0 3.2 7.0 4.0 14.9 9.1 8.3 5.1 8.4 5.8 4.1 8.4 10.0 5.1 12.6 6.2 4.5 4.9 5.9 12.4 5.9 8.0 5.5 5.1 4.8 13.1 6.4 7.0 6.5 5.3 6.1 4.0 7.2 4.3 4.5 5.7 3.7 6.4 4.7 CS ENSG00000062485 "Citrate synthase" O75390 12 56271699-56300392 "Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Tricarboxylic acid cycle" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 125.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA038460, HPA038461, CAB075750, CAB075751, CAB075752, CAB075753, CAB075754" Enhanced Enhanced Mitochondria 4400000 Mitochondria "CAB075750: , CAB075751: , CAB075752: , CAB075753: , CAB075754: , HPA038460: AB_2676023, HPA038461: AB_2676024" "unprognostic (7.67e-3)" "unprognostic (3.80e-1)" "unprognostic (2.59e-2)" "unprognostic (2.50e-2)" "unprognostic (2.70e-2)" "unprognostic (1.25e-1)" "unprognostic (6.09e-3)" "unprognostic (3.34e-2)" "unprognostic (2.43e-1)" "unprognostic (5.58e-2)" "unprognostic (2.56e-1)" "unprognostic (1.97e-2)" "prognostic favourable (1.17e-4)" "unprognostic (1.20e-1)" "unprognostic (2.09e-1)" "unprognostic (1.30e-2)" "unprognostic (2.02e-1)" 37.1 35.5 11.9 16.3 20.4 19.3 55.6 28.5 43.8 17.2 27.4 14.1 11.3 25.3 19.9 10.8 31.7 16.5 14.0 79.2 11.2 14.5 26.7 12.3 17.3 30.8 12.3 14.2 16.9 20.7 28.1 14.3 11.9 24.8 16.2 32.7 19.8 23.1 17.5 125.9 22.8 27.0 21.2 15.0 18.4 21.4 7.9 11.1 20.7 17.9 48.2 26.1 22.9 19.1 19.5 37.1 59.6 27.8 15.9 19.7 18.2 35.4 38.4 31.3 40.7 41.7 38.8 20.4 29.6 29.1 52.1 36.5 54.1 34.9 69.4 29.1 37.3 38.5 86.6 44.5 49.9 24.1 44.0 47.7 27.9 39.0 23.4 58.3 34.3 42.7 42.6 40.9 49.6 58.6 49.3 41.7 45.5 28.5 48.2 18.0 24.9 55.5 47.0 36.8 52.4 32.3 36.1 41.2 27.0 38.3 45.6 30.0 63.5 34.0 38.8 26.3 36.9 37.1 31.2 27.5 41.9 45.2 24.3 42.9 24.7 14.5 22.0 59.6 15.2 27.8 19.7 19.5 18.3 14.3 37.1 16.7 19.4 15.4 9.8 15.9 27.0 20.5 19.3 18.2 11.9 20.4 28.5 43.8 11.2 14.5 12.3 14.2 24.8 11.1 CYCS "CYC, HCS" ENSG00000172115 "Cytochrome c, somatic" P99999 7 25120091-25125361 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Electron transport, Respiratory chain, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 109.6;skeletal muscle: 103.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB004222, CAB005126, CAB018597" Enhanced Supported Mitochondria 190000000 Mitochondria "CAB004222: AB_627385, CAB005126: AB_2090472, CAB018597: AB_627383" "unprognostic (3.06e-2)" "unprognostic (3.39e-1)" "unprognostic (3.32e-2)" "unprognostic (4.11e-3)" "unprognostic (1.15e-1)" "prognostic unfavourable (2.81e-4)" "unprognostic (4.44e-2)" "unprognostic (7.04e-3)" "unprognostic (5.67e-2)" "unprognostic (6.22e-2)" "unprognostic (2.41e-1)" "unprognostic (1.52e-1)" "prognostic favourable (1.30e-5)" "unprognostic (1.18e-1)" "unprognostic (4.94e-2)" "unprognostic (8.75e-3)" "unprognostic (7.04e-2)" 20.3 29.3 29.8 20.0 44.8 17.1 14.7 25.1 41.1 12.1 62.1 13.3 9.6 35.4 11.4 10.7 26.6 11.0 13.1 109.6 30.2 26.4 39.8 37.0 13.4 13.8 30.7 34.7 12.2 9.3 24.8 18.6 10.3 29.9 13.7 58.5 13.5 14.9 15.7 103.7 11.3 30.2 21.8 28.0 15.6 24.3 23.5 18.1 17.3 18.3 41.2 20.0 15.9 14.3 35.5 38.0 17.1 38.3 25.2 31.0 25.2 43.0 24.1 26.1 36.3 15.0 11.6 26.9 41.5 17.1 31.1 36.2 39.9 29.5 49.6 20.4 18.1 51.2 53.0 39.1 55.0 14.7 23.8 41.3 28.6 28.3 23.6 94.3 36.8 15.4 35.0 31.1 67.5 27.8 75.6 52.6 33.0 19.9 51.5 36.7 48.9 45.7 36.3 31.4 47.4 48.4 42.3 53.0 25.2 21.6 92.4 33.4 47.9 56.5 20.1 28.6 52.1 44.1 76.6 54.4 63.0 110.8 38.1 68.7 79.2 17.1 20.0 14.0 25.3 38.3 31.0 35.5 23.4 26.8 38.0 26.0 22.4 26.8 3.0 25.2 33.6 27.8 29.5 25.2 29.8 44.8 25.1 41.1 30.2 26.4 30.7 34.7 29.9 18.1 CYP24A1 "CP24, CYP24, P450-CC24" ENSG00000019186 "Cytochrome P450 family 24 subfamily A member 1" Q07973 20 54153449-54173973 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 38.8;lymphoid tissue: 25.8;urinary bladder: 31.2" "Group enriched" "Detected in some" 16 "A549: 92.9;Hep G2: 27.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.1;memory CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 20 "T-cells: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA022261, HPA063771" Enhanced Supported "Nucleoplasm,Plasma membrane,Mitochondria" "Nucleoplasm, Mitochondria" "Plasma membrane" "HPA022261: AB_1847427, HPA063771: " "unprognostic (1.19e-7)" "unprognostic (1.73e-1)" "unprognostic (2.24e-2)" "unprognostic (7.69e-3)" "unprognostic (3.30e-1)" "unprognostic (2.30e-2)" "unprognostic (1.11e-2)" "unprognostic (2.12e-1)" "unprognostic (2.09e-2)" "unprognostic (5.37e-3)" "unprognostic (1.23e-1)" "unprognostic (6.05e-2)" "unprognostic (5.98e-2)" "unprognostic (1.36e-1)" "unprognostic (4.38e-2)" "unprognostic (2.12e-1)" 0.1 0.1 0.4 0.2 0.7 0.0 2.5 0.1 0.4 2.5 0.1 0.0 0.3 0.0 11.2 0.4 4.4 0.3 0.0 0.1 0.4 0.8 38.8 0.3 1.6 0.1 0.2 0.0 0.1 0.1 0.0 0.7 7.0 0.3 7.0 0.0 0.1 0.3 1.5 0.1 1.0 0.1 0.6 0.2 0.1 0.1 0.3 0.0 0.4 1.4 5.9 25.8 31.2 14.4 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.1 92.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.8 0.0 0.7 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 1.5 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.7 0.1 0.4 0.4 0.8 0.2 0.0 0.3 0.0 DAP3 "bMRP-10, DAP-3, DKFZp686G12159, MGC126058, MGC126059, MRP-S29, MRPS29" ENSG00000132676 "Death associated protein 3" P51398 1 155687960-155739010 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" Apoptosis "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023687 Approved Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA023687: AB_1847472" "unprognostic (2.60e-1)" "unprognostic (2.13e-2)" "unprognostic (2.35e-1)" "unprognostic (2.37e-1)" "unprognostic (1.90e-1)" "unprognostic (1.20e-3)" "prognostic unfavourable (1.20e-4)" "unprognostic (1.80e-1)" "unprognostic (5.63e-2)" "unprognostic (2.33e-1)" "unprognostic (2.87e-2)" "unprognostic (3.16e-1)" "prognostic unfavourable (4.14e-6)" "unprognostic (1.56e-1)" "unprognostic (1.85e-1)" "unprognostic (2.48e-1)" "unprognostic (1.00e-1)" 27.8 36.5 22.9 26.3 25.9 28.9 34.2 19.5 23.6 23.5 33.4 19.5 22.8 29.4 28.7 28.1 31.3 21.8 23.2 56.3 27.0 26.4 32.8 52.2 23.9 49.0 24.9 23.0 23.3 38.5 20.7 27.1 20.5 23.0 27.9 32.1 24.5 28.0 27.1 64.0 30.9 26.5 36.0 23.2 30.8 30.3 31.6 21.1 44.4 27.6 28.4 38.0 38.0 24.1 39.0 41.1 15.9 35.2 34.0 56.5 39.6 32.3 21.0 17.2 27.2 25.4 32.1 42.3 27.3 28.9 28.1 24.6 38.7 39.8 46.2 55.7 22.2 33.1 25.5 23.8 30.7 28.9 18.6 28.1 18.8 35.1 34.8 38.4 25.1 26.9 34.2 35.8 47.4 27.6 60.7 32.9 29.2 43.0 33.7 45.0 30.4 34.4 27.9 21.6 49.0 33.4 31.0 20.0 35.5 26.2 77.4 47.1 48.0 63.3 23.6 23.9 25.2 29.5 45.8 36.0 53.7 53.2 23.8 34.5 30.7 13.9 30.1 15.9 31.3 35.2 51.4 39.0 45.1 38.0 41.1 32.2 56.5 48.4 13.0 34.0 31.9 26.8 45.0 39.6 22.9 25.9 19.5 23.6 27.0 26.4 24.9 23.0 23.0 21.1 DEPTOR "DEP.6, DEPDC6, FLJ12428" ENSG00000155792 "DEP domain containing MTOR interacting protein" Q8TB45 8 119873717-120050913 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 67.6;skeletal muscle: 65.0" "Cell line enhanced" "Detected in many" "Daudi: 29.8;RPMI-8226: 53.0;RPTEC TERT1: 43.9;U-698: 15.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 11 "myeloid DC: 17.1" "Lineage enriched" "Detected in many" 11 "dendritic cells: 17.1" "Low region specificity" "Detected in all" "CAB020841, HPA023938, HPA023945, HPA024011" Enhanced Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "CAB020841: , HPA023938: AB_1847606, HPA023945: AB_1847607, HPA024011: AB_1847608" "unprognostic (3.41e-1)" "unprognostic (1.95e-1)" "unprognostic (1.53e-2)" "unprognostic (1.15e-2)" "unprognostic (3.19e-1)" "unprognostic (2.57e-1)" "unprognostic (1.08e-1)" "unprognostic (4.13e-3)" "unprognostic (2.43e-1)" "unprognostic (2.49e-2)" "unprognostic (3.24e-2)" "unprognostic (6.02e-2)" "unprognostic (7.29e-2)" "unprognostic (5.66e-2)" "unprognostic (1.02e-1)" "unprognostic (4.16e-2)" "unprognostic (2.84e-2)" 8.1 30.2 6.4 5.2 11.0 1.1 9.7 5.1 9.2 18.9 12.7 17.8 5.7 7.8 16.0 5.7 7.2 12.7 6.1 4.3 7.3 6.3 22.7 7.5 2.7 8.5 9.5 6.1 12.5 5.6 13.3 13.6 4.4 7.5 6.4 4.8 0.7 67.6 7.9 65.0 4.3 7.4 7.7 8.2 5.3 20.0 2.1 11.5 0.7 45.0 20.7 2.7 4.8 5.7 0.1 17.1 0.3 1.5 0.3 0.8 0.8 0.0 1.0 0.1 0.3 6.3 1.9 0.1 0.0 0.1 0.1 0.1 0.7 0.1 29.8 0.7 0.3 0.1 1.6 0.0 0.1 0.6 0.8 4.0 0.2 0.1 3.8 0.8 6.9 1.7 2.8 0.2 0.1 0.0 0.0 4.9 0.1 2.0 0.0 0.7 0.4 1.0 0.1 1.4 53.0 43.9 1.2 0.9 0.2 0.5 3.2 0.9 2.8 0.1 0.0 0.1 0.2 6.3 0.1 13.2 3.1 15.6 1.9 1.1 0.2 0.0 0.8 0.0 0.2 1.5 0.7 0.1 0.3 0.6 17.1 0.1 0.8 0.5 0.3 0.3 0.1 0.8 0.3 0.8 6.4 11.0 5.1 9.2 7.3 6.3 9.5 6.1 7.5 11.5 DHODH ENSG00000102967 "Dihydroorotate dehydrogenase (quinone)" Q02127 16 72008588-72027664 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Pyrimidine biosynthesis" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 72.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010123, HPA011942" Approved Enhanced Nucleoplasm,Mitochondria,Cytosol Mitochondria "Nucleoplasm, Cytosol" "HPA010123: AB_1847648, HPA011942: AB_1847649" "unprognostic (4.88e-2)" "unprognostic (1.10e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-2)" "unprognostic (1.41e-3)" "unprognostic (2.10e-1)" "unprognostic (4.27e-2)" "unprognostic (1.31e-2)" "unprognostic (1.26e-1)" "unprognostic (2.68e-1)" "unprognostic (2.14e-1)" "unprognostic (6.40e-2)" "unprognostic (9.26e-3)" "unprognostic (1.98e-1)" "unprognostic (1.97e-1)" "unprognostic (1.14e-1)" "unprognostic (1.81e-1)" 5.9 4.2 4.7 8.8 5.1 2.9 5.0 2.7 5.0 5.9 4.4 6.1 1.4 3.4 6.6 2.3 5.1 5.2 2.3 11.5 4.3 3.0 6.6 72.4 3.4 5.5 4.8 2.7 6.2 9.9 7.1 4.0 2.6 5.2 3.9 4.8 5.9 6.0 4.4 11.7 4.0 3.0 7.5 4.0 3.5 3.4 4.3 5.4 4.0 3.6 7.1 5.1 3.5 3.3 11.2 13.4 3.9 8.1 9.3 12.9 6.8 7.3 15.4 4.5 7.4 2.4 3.2 8.5 6.3 2.5 9.6 7.4 12.1 6.8 16.6 8.6 3.4 7.8 8.8 6.8 11.3 3.7 8.3 9.1 7.5 11.8 6.8 12.6 6.7 3.1 7.0 11.6 12.2 6.9 13.9 3.0 5.8 19.6 11.9 12.1 10.1 6.0 15.1 5.9 17.5 5.8 4.9 5.3 6.3 8.5 9.1 4.1 8.1 6.4 3.0 8.8 5.5 8.3 9.2 5.8 10.8 28.1 4.6 13.8 8.0 3.9 8.1 0.9 9.3 7.7 12.7 11.2 8.9 9.0 13.3 10.6 12.4 12.9 2.1 9.3 5.6 13.4 7.1 6.8 4.7 5.1 2.7 5.0 4.3 3.0 4.8 2.7 5.2 5.4 DIABLO "DFNA64, DIABLO-S, FLJ10537, FLJ25049, SMAC" ENSG00000184047 "Diablo IAP-binding mitochondrial protein" Q9NR28 12 122207663-122226568 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA001825, CAB003857, CAB016688" Supported Enhanced Mitochondria 21000 Mitochondria "CAB003857: AB_365498, CAB016688: AB_1615783, HPA001825: AB_1857247" "unprognostic (3.67e-2)" "unprognostic (1.90e-1)" "unprognostic (1.11e-1)" "unprognostic (3.10e-3)" "unprognostic (1.64e-1)" "unprognostic (2.38e-3)" "unprognostic (1.40e-3)" "unprognostic (5.06e-2)" "unprognostic (1.48e-1)" "unprognostic (1.03e-1)" "unprognostic (1.33e-2)" "unprognostic (4.05e-2)" "prognostic unfavourable (5.35e-4)" "unprognostic (6.68e-2)" "unprognostic (2.36e-1)" "unprognostic (2.00e-1)" "unprognostic (1.40e-1)" 17.2 29.7 21.9 15.5 24.0 26.7 24.8 21.9 30.1 20.4 25.9 29.0 14.3 20.6 22.2 36.6 23.5 21.8 19.2 20.3 21.2 26.8 31.7 37.2 15.8 20.9 28.3 23.6 22.4 32.6 22.9 30.6 28.5 27.0 21.1 24.2 22.4 22.2 20.2 25.8 18.2 21.3 21.8 29.2 18.5 19.8 62.7 21.8 23.2 26.9 23.0 22.8 20.5 17.9 32.8 35.0 27.5 29.1 29.9 32.1 26.8 19.0 37.8 26.7 18.1 19.2 18.8 20.5 19.8 19.5 23.3 21.0 32.6 10.0 23.3 18.7 17.9 19.0 29.0 23.7 27.7 20.1 22.7 25.5 15.6 29.9 27.4 27.4 10.6 26.0 16.9 27.5 41.3 26.9 29.2 9.9 22.6 28.4 22.4 40.3 21.5 35.5 20.4 26.6 25.6 26.3 29.7 25.3 25.8 26.5 10.6 21.5 35.8 19.3 18.3 18.0 22.2 20.4 17.8 21.6 36.1 33.4 23.0 21.1 23.6 23.6 28.9 27.5 30.4 29.1 29.1 32.8 28.4 28.4 35.0 26.0 27.9 28.2 12.7 29.9 26.5 26.8 32.1 26.8 21.9 24.0 21.9 30.1 21.2 26.8 28.3 23.6 27.0 21.8 DLAT "DLTA, PDC-E2" ENSG00000150768 "Dihydrolipoamide S-acetyltransferase" P10515 11 112024814-112064390 "Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 55.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003782, HPA040786, HPA062766" Supported Enhanced Mitochondria Mitochondria "CAB003782: , HPA040786: AB_2677136, HPA062766: AB_2684864" "unprognostic (4.57e-3)" "unprognostic (1.75e-1)" "prognostic favourable (6.19e-6)" "unprognostic (7.68e-2)" "unprognostic (2.41e-1)" "unprognostic (1.70e-2)" "prognostic unfavourable (7.49e-5)" "unprognostic (8.68e-2)" "unprognostic (5.36e-2)" "unprognostic (2.93e-1)" "unprognostic (2.23e-3)" "unprognostic (6.25e-2)" "prognostic favourable (1.95e-14)" "unprognostic (5.82e-2)" "unprognostic (4.12e-2)" "unprognostic (2.17e-1)" "unprognostic (6.15e-2)" 14.1 10.7 10.6 8.8 11.9 4.8 10.9 10.5 14.2 6.7 13.3 6.3 7.8 12.4 6.3 8.1 12.2 7.2 6.4 55.4 10.4 13.5 19.1 12.0 6.6 8.7 11.2 9.7 7.9 6.0 15.8 7.8 8.3 13.0 8.3 13.5 7.6 10.4 9.9 41.0 7.2 13.0 6.6 7.3 6.9 8.1 7.3 4.2 12.7 10.7 22.1 8.8 7.5 6.7 9.2 9.1 7.9 8.9 7.2 10.3 8.0 6.0 6.1 8.1 10.8 11.4 8.5 9.7 8.3 4.8 9.2 10.4 19.3 17.8 24.8 16.3 7.6 13.0 16.9 8.9 10.5 8.9 10.5 15.7 6.5 11.9 8.2 19.9 9.0 10.3 9.8 9.2 9.3 8.4 25.7 11.9 10.8 4.7 9.0 23.9 9.5 11.8 14.0 11.0 27.9 16.9 6.4 15.6 9.5 10.0 28.3 6.3 21.0 12.4 5.6 9.2 10.0 9.2 10.6 3.9 6.2 37.6 2.6 21.8 7.2 7.9 6.6 4.7 8.3 8.9 9.5 9.2 8.2 8.9 9.1 7.5 10.3 8.3 0.5 7.2 8.9 7.4 8.8 8.0 10.6 11.9 10.5 14.2 10.4 13.5 11.2 9.7 13.0 4.2 DNAJA3 "hTid-1, TID1" ENSG00000103423 "DnaJ heat shock protein family (Hsp40) member A3" Q96EY1 16 4425805-4456775 "Predicted intracellular proteins" Apoptosis Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016095, HPA040875, HPA044229" Approved Enhanced Vesicles,Mitochondria Mitochondria Vesicles "CAB016095: AB_668801, HPA040875: , HPA044229: " "unprognostic (5.65e-2)" "unprognostic (1.34e-1)" "unprognostic (2.86e-3)" "unprognostic (2.91e-2)" "unprognostic (4.17e-1)" "unprognostic (5.18e-2)" "unprognostic (1.60e-1)" "unprognostic (1.38e-1)" "unprognostic (2.06e-1)" "unprognostic (3.16e-3)" "unprognostic (1.55e-1)" "unprognostic (3.27e-2)" "prognostic favourable (1.79e-4)" "unprognostic (4.17e-2)" "unprognostic (1.57e-1)" "unprognostic (1.34e-1)" "unprognostic (1.92e-1)" 10.8 26.6 10.7 11.3 15.5 6.2 13.0 15.3 20.8 10.0 14.0 13.9 11.1 17.3 11.3 8.7 15.6 12.6 12.5 28.8 13.9 12.6 19.0 44.8 9.1 13.4 13.0 13.0 13.2 18.1 21.6 12.1 13.7 14.2 11.5 13.4 10.6 14.4 13.4 46.7 12.8 13.2 11.4 12.6 11.4 12.8 15.1 11.1 13.6 16.1 16.2 13.3 13.4 11.2 10.4 6.5 2.2 7.0 7.8 11.9 7.9 8.9 17.9 6.3 11.8 7.9 6.9 11.7 11.8 8.9 16.5 13.6 14.9 12.6 17.6 11.0 7.6 13.6 20.4 14.0 9.6 12.1 17.6 9.0 15.5 14.3 19.5 15.6 8.6 8.4 16.8 14.5 24.3 7.9 23.1 14.6 9.3 20.4 14.6 11.3 13.7 16.6 18.2 10.0 32.9 12.3 9.6 15.5 6.7 12.9 29.6 19.5 16.9 13.1 7.4 12.3 8.4 29.6 14.7 15.1 20.2 24.0 6.6 15.1 14.4 0.7 4.6 2.2 9.5 7.0 11.0 10.4 9.1 8.9 6.5 8.9 11.9 9.2 0.5 7.8 5.2 4.6 7.4 7.9 10.7 15.5 15.3 20.8 13.9 12.6 13.0 13.0 14.2 11.1 ECH1 HPXEL ENSG00000104823 "Enoyl-CoA hydratase 1" Q13011 19 38815422-38832005 "Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002907, HPA005835" Supported Supported Enhanced Mitochondria 5700000 Mitochondria "HPA002907: AB_1847964, HPA005835: AB_1847965" "unprognostic (1.91e-1)" "unprognostic (3.03e-2)" "unprognostic (3.64e-2)" "unprognostic (6.43e-2)" "unprognostic (5.73e-3)" "unprognostic (6.90e-2)" "unprognostic (1.28e-1)" "unprognostic (1.79e-1)" "unprognostic (2.43e-1)" "unprognostic (5.86e-2)" "unprognostic (2.24e-1)" "unprognostic (3.37e-1)" "unprognostic (7.01e-2)" "prognostic unfavourable (2.23e-4)" "unprognostic (3.54e-1)" "unprognostic (3.52e-1)" "unprognostic (1.74e-2)" 33.0 52.0 17.6 21.7 20.9 14.7 29.6 11.4 19.8 14.8 34.1 19.5 19.8 25.8 16.8 15.4 30.2 18.9 30.6 130.6 18.6 15.5 40.0 105.8 16.9 19.6 22.2 17.2 16.0 36.5 11.5 11.3 32.8 17.5 20.9 27.1 20.8 27.4 15.2 130.9 18.7 24.4 27.0 13.3 28.1 24.8 26.2 20.6 15.9 24.5 43.5 21.5 21.3 19.3 68.7 60.7 49.9 61.1 61.4 72.6 83.3 12.8 56.5 8.8 14.5 34.2 17.8 12.8 6.3 11.1 5.6 5.7 36.2 25.5 20.1 24.9 15.0 6.1 14.6 15.1 4.4 69.6 8.1 24.3 17.2 29.2 34.8 25.8 24.7 23.6 39.2 7.3 12.7 13.2 11.5 33.6 12.3 24.1 17.9 14.9 5.8 13.7 20.4 26.4 40.0 35.3 29.3 11.0 14.1 33.2 16.5 17.5 22.2 58.0 11.1 9.9 8.5 9.7 5.9 25.5 29.5 19.2 15.0 33.3 18.9 49.1 61.1 49.9 51.9 46.8 48.9 68.7 50.9 51.2 60.7 62.2 45.7 51.4 8.1 61.4 38.3 41.4 72.6 83.3 17.6 20.9 11.4 19.8 18.6 15.5 22.2 17.2 17.5 20.6 ECHS1 SCEH ENSG00000127884 "Enoyl-CoA hydratase, short chain 1" P30084 10 133362480-133373689 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Lyase "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 148.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003783, HPA021995, HPA022476" Enhanced Enhanced Mitochondria 1500000 Mitochondria "CAB003783: , HPA021995: AB_1847974, HPA022476: AB_1847975" "unprognostic (3.68e-1)" "unprognostic (2.46e-3)" "unprognostic (9.57e-2)" "unprognostic (4.70e-2)" "unprognostic (1.59e-1)" "unprognostic (3.14e-1)" "unprognostic (2.51e-3)" "unprognostic (2.30e-1)" "unprognostic (1.82e-2)" "unprognostic (2.28e-2)" "unprognostic (1.60e-1)" "unprognostic (1.27e-1)" "prognostic favourable (8.57e-5)" "unprognostic (2.84e-2)" "unprognostic (1.19e-2)" "unprognostic (3.04e-2)" "unprognostic (2.50e-2)" 36.5 18.7 16.6 9.1 16.6 5.0 15.2 8.2 18.3 8.8 21.8 13.0 34.7 22.8 9.5 14.1 16.5 12.2 17.4 29.8 14.6 11.5 62.1 148.2 6.3 7.8 14.8 10.3 11.6 16.3 9.2 11.0 12.8 11.1 13.9 14.0 11.0 40.2 38.4 35.7 8.8 32.1 9.9 11.9 7.3 11.0 10.2 10.2 3.9 16.2 17.5 13.0 11.2 7.8 39.4 53.7 18.3 45.7 33.5 32.1 44.5 28.7 36.1 19.7 49.1 28.6 18.4 18.0 21.2 28.0 29.6 25.1 79.2 28.0 21.7 18.4 23.8 27.0 25.5 21.5 21.4 16.6 44.8 21.6 21.8 56.3 24.0 28.0 15.4 20.5 18.6 19.6 25.1 26.2 19.5 19.1 28.8 68.2 13.9 54.7 13.7 43.4 24.0 23.9 11.6 36.5 36.9 12.7 20.2 21.9 36.4 27.5 28.3 27.0 21.0 13.4 19.4 27.7 27.9 14.4 8.8 24.6 31.7 15.3 11.0 17.0 41.7 18.3 24.9 45.7 32.1 39.4 28.1 27.1 53.7 32.2 28.9 27.9 4.4 33.5 34.3 23.2 26.0 44.5 16.6 16.6 8.2 18.3 14.6 11.5 14.8 10.3 11.1 10.2 ECI1 DCI ENSG00000167969 "Enoyl-CoA delta isomerase 1" P42126 16 2239395-2252300 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 90.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041746, HPA043227" Enhanced Enhanced Mitochondria 11000000 Mitochondria "HPA041746: AB_10960693, HPA043227: AB_10960273" "unprognostic (4.99e-2)" "prognostic favourable (3.04e-5)" "unprognostic (3.75e-1)" "unprognostic (2.92e-3)" "unprognostic (8.90e-2)" "unprognostic (2.85e-2)" "prognostic favourable (1.07e-4)" "unprognostic (1.98e-1)" "unprognostic (2.17e-1)" "unprognostic (5.14e-3)" "unprognostic (6.32e-2)" "unprognostic (2.66e-2)" "prognostic favourable (8.99e-8)" "unprognostic (2.61e-2)" "unprognostic (3.31e-1)" "unprognostic (1.97e-1)" "unprognostic (6.08e-3)" 15.7 12.5 12.5 9.8 10.8 9.1 16.8 12.8 11.3 10.9 27.6 9.7 20.3 30.9 10.6 16.7 15.5 13.4 17.3 56.4 10.1 10.3 36.5 57.4 10.3 10.7 12.4 8.8 10.8 30.4 11.1 11.9 10.6 13.0 13.4 8.4 16.3 40.9 19.1 90.3 10.4 31.2 14.1 10.1 8.0 17.2 8.4 9.6 10.4 38.7 25.4 10.5 14.4 11.5 7.6 6.5 3.9 7.1 5.8 6.7 1.7 7.3 17.5 6.7 27.6 2.6 3.6 25.3 7.4 5.1 6.1 9.0 30.9 22.5 10.6 18.6 4.6 18.1 7.9 7.0 0.8 18.4 40.4 3.2 16.4 38.1 23.6 9.5 1.5 6.8 16.7 5.0 11.0 6.1 17.6 22.6 2.0 30.2 0.9 14.3 15.6 17.8 33.4 7.3 51.1 11.6 8.3 23.2 14.7 17.9 33.9 22.4 21.8 17.0 5.0 4.8 18.0 5.1 8.2 25.0 14.7 17.3 6.3 8.9 6.7 3.2 6.8 2.7 3.8 7.1 6.0 7.6 5.5 2.9 5.5 7.4 6.7 5.6 3.9 5.8 4.2 6.5 6.7 1.7 12.5 10.8 12.8 11.3 10.1 10.3 12.4 8.8 13.0 9.6 ECI2 "ACBD2, DRS1, HCA88, PECI" ENSG00000198721 "Enoyl-CoA delta isomerase 2" O75521 6 4115689-4135597 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 102.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022130, HPA031626" Enhanced Enhanced Peroxisomes,Mitochondria "Peroxisomes, Mitochondria" "HPA022130: AB_1855176, HPA031626: AB_2673965" "unprognostic (2.36e-1)" "unprognostic (1.76e-2)" "unprognostic (1.71e-2)" "unprognostic (1.04e-2)" "unprognostic (1.00e-2)" "prognostic unfavourable (2.85e-4)" "unprognostic (1.17e-3)" "unprognostic (4.97e-2)" "unprognostic (9.49e-2)" "unprognostic (3.95e-3)" "unprognostic (3.17e-2)" "unprognostic (5.75e-2)" "prognostic favourable (2.04e-6)" "unprognostic (1.40e-1)" "unprognostic (1.23e-1)" "unprognostic (8.45e-2)" "unprognostic (1.34e-1)" 17.9 29.2 13.2 7.3 17.4 4.5 17.0 8.9 9.5 15.7 18.0 10.7 14.9 16.2 15.2 26.2 10.6 12.7 12.4 32.1 10.3 11.1 56.8 102.3 7.4 8.9 13.3 7.2 19.0 59.2 8.9 17.2 11.1 10.3 14.6 14.0 13.3 9.0 10.5 45.7 5.6 22.7 10.3 11.9 10.1 23.2 11.9 9.3 13.3 17.7 26.6 7.5 12.6 8.9 20.6 25.1 7.0 16.2 25.5 27.7 16.7 17.8 9.7 16.3 35.4 20.5 30.5 2.0 25.3 26.0 27.7 24.8 7.3 2.7 0.7 31.9 27.5 9.4 18.5 14.7 40.3 6.7 21.2 9.4 13.8 39.3 11.9 8.5 4.7 21.0 9.1 23.5 13.2 57.6 30.8 6.9 26.2 7.1 24.0 21.2 11.0 34.9 23.3 20.2 0.3 14.9 3.6 0.3 7.6 1.5 10.6 22.4 24.5 4.0 58.1 20.9 11.5 18.4 15.0 10.6 18.8 1.8 10.7 7.5 16.1 6.9 15.5 7.0 18.9 11.5 25.9 19.9 22.3 26.4 25.1 20.6 27.7 27.1 0.4 25.5 16.2 19.2 23.6 16.7 13.2 17.4 8.9 9.5 10.3 11.1 13.3 7.2 10.3 9.3 EFEMP1 "DHRD, FBLN3, FBNL, MTLV, S1-5" ENSG00000115380 "EGF containing fibulin extracellular matrix protein 1" Q12805 2 55865967-55924139 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HSkMC: 64.8;HUVEC TERT2: 263.9;TIME: 233.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB016368, HPA049806, HPA070841, HPA071588" Supported Supported Mitochondria "Secreted to extracellular matrix" 1800000000 Mitochondria "CAB016368: AB_2277777, HPA049806: , HPA070841: , HPA071588: " "unprognostic (8.21e-2)" "unprognostic (7.68e-2)" "unprognostic (9.01e-3)" "prognostic unfavourable (4.72e-4)" "unprognostic (3.43e-2)" "unprognostic (1.73e-2)" "unprognostic (4.86e-2)" "unprognostic (1.38e-1)" "unprognostic (3.46e-1)" "unprognostic (9.07e-2)" "unprognostic (1.55e-2)" "unprognostic (1.50e-1)" "prognostic unfavourable (3.89e-8)" "unprognostic (3.15e-3)" "unprognostic (4.94e-2)" "unprognostic (3.09e-1)" "prognostic unfavourable (6.68e-5)" 63.1 14.1 13.6 14.1 35.1 0.1 45.5 8.0 12.8 14.8 20.4 22.0 16.6 6.2 20.1 31.9 22.0 38.6 37.1 55.4 8.2 9.7 16.3 3.5 38.5 24.5 12.5 15.5 52.9 10.9 3.3 6.6 84.5 25.8 47.5 22.9 116.9 26.8 40.5 15.6 13.8 12.0 29.9 8.6 10.1 12.6 9.3 13.5 0.9 57.4 18.1 7.3 45.5 41.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 0.2 0.4 0.0 20.1 13.0 0.0 12.5 13.4 1.5 1.1 0.0 1.2 0.0 8.1 15.1 21.0 0.0 15.0 0.5 0.0 0.0 0.0 5.3 0.0 55.1 0.0 0.0 64.8 6.9 1.5 17.3 263.9 0.0 0.0 5.6 2.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.4 0.1 0.0 17.4 6.5 0.0 20.2 0.0 233.7 0.1 7.0 25.9 8.0 0.7 0.0 0.0 4.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 35.1 8.0 8.8 8.2 9.7 12.5 15.5 25.8 13.5 EIF4E2 "4EHP, EIF4EL3, IF4e" ENSG00000135930 "Eukaryotic translation initiation factor 4E family member 2" O60573 2 232550052-232583644 "Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019253, HPA077074" Enhanced Mitochondria,Cytosol Mitochondria Cytosol "HPA019253: AB_1848092, HPA077074: " "unprognostic (3.44e-2)" "unprognostic (2.70e-1)" "unprognostic (1.30e-1)" "unprognostic (3.83e-2)" "unprognostic (1.63e-2)" "unprognostic (2.79e-1)" "prognostic unfavourable (2.38e-4)" "unprognostic (1.42e-1)" "unprognostic (5.62e-3)" "unprognostic (1.42e-2)" "unprognostic (1.31e-1)" "unprognostic (1.21e-2)" "unprognostic (1.36e-2)" "unprognostic (7.74e-2)" "unprognostic (3.34e-3)" "unprognostic (1.88e-1)" "unprognostic (9.38e-2)" 19.0 22.9 27.9 24.0 24.4 25.4 19.4 27.1 38.1 17.6 30.7 18.4 17.0 24.4 26.2 18.2 32.1 18.5 20.0 21.3 25.8 14.8 29.8 43.2 20.4 21.0 18.6 27.2 22.0 26.2 16.3 25.0 26.8 26.3 19.9 35.7 16.1 27.3 15.9 77.6 23.8 25.2 25.3 27.0 25.4 26.7 25.2 21.5 18.1 19.1 24.8 27.1 20.0 21.2 13.5 38.9 49.6 46.8 14.1 24.1 29.7 27.6 22.9 28.1 20.7 20.6 28.2 43.3 37.2 20.2 25.6 26.3 25.2 26.1 27.1 10.6 36.2 23.5 31.6 32.3 32.3 24.2 26.0 37.0 24.7 33.5 25.1 51.6 35.0 24.2 24.3 26.9 19.5 41.6 34.7 9.2 28.9 44.5 21.0 43.9 44.7 19.1 18.2 62.4 17.7 51.4 32.9 27.3 37.4 19.8 23.0 23.7 21.9 36.3 38.0 24.0 31.7 25.1 27.4 17.3 16.3 35.6 26.9 28.5 20.8 49.6 45.1 40.7 14.8 46.8 11.8 13.5 15.1 15.4 38.9 12.2 12.9 13.1 29.5 14.1 41.7 15.2 24.1 29.7 27.9 24.4 27.1 38.1 25.8 14.8 18.6 27.2 26.3 21.5 ERAL1 HERA-B ENSG00000132591 "Era like 12S mitochondrial rRNA chaperone 1" O75616 17 28854938-28861067 "Disease related genes, Predicted intracellular proteins" "Ribosome biogenesis" "RNA-binding, rRNA-binding" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021425, HPA024423" Supported Enhanced Mitochondria,Cytosol Mitochondria Cytosol "HPA021425: AB_1848228, HPA024423: AB_1848229" "unprognostic (1.03e-1)" "unprognostic (9.16e-2)" "unprognostic (5.36e-2)" "unprognostic (1.77e-2)" "unprognostic (3.55e-1)" "unprognostic (8.37e-3)" "prognostic unfavourable (3.59e-4)" "unprognostic (8.20e-2)" "unprognostic (7.04e-2)" "unprognostic (2.70e-1)" "unprognostic (8.57e-3)" "unprognostic (5.76e-1)" "unprognostic (1.08e-1)" "unprognostic (1.18e-1)" "unprognostic (2.49e-1)" "unprognostic (2.62e-1)" "unprognostic (5.79e-2)" 16.2 24.8 24.1 13.3 31.6 12.7 19.4 25.1 47.9 18.4 20.9 27.1 15.8 18.0 21.5 19.2 20.6 22.2 17.2 24.5 23.0 22.0 24.9 33.7 14.8 16.0 21.3 20.2 22.0 18.1 29.3 15.4 24.7 27.6 18.0 23.4 17.3 28.2 21.2 34.1 18.3 19.7 21.8 18.4 17.0 18.2 17.3 15.5 20.4 20.3 21.5 23.8 16.1 14.8 20.1 29.0 11.1 23.1 20.8 18.2 14.9 15.9 31.1 18.2 20.6 20.1 13.8 17.8 12.8 18.3 38.9 32.0 30.3 10.3 20.6 15.6 22.0 17.8 33.3 29.2 32.5 20.3 39.0 16.5 20.7 30.6 25.8 19.6 15.1 18.0 26.0 31.5 29.9 31.7 32.8 13.0 21.6 25.1 20.4 30.4 16.8 14.9 18.9 28.9 26.6 23.5 18.2 19.4 15.6 20.9 51.5 16.5 36.2 23.1 12.7 15.9 17.9 17.5 26.9 10.5 19.0 22.0 17.2 17.2 16.1 11.1 17.9 7.1 17.8 23.1 13.4 20.1 15.2 13.0 29.0 18.6 17.6 18.2 1.4 20.8 15.6 15.0 16.3 14.9 24.1 31.6 25.1 47.9 23.0 22.0 21.3 20.2 27.6 15.5 ETFA "EMA, GA2, MADD" ENSG00000140374 "Electron transfer flavoprotein alpha subunit" P13804 15 76215355-76311472 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport" "Disease mutation, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018990, HPA018993, HPA018996, HPA024089" Enhanced Enhanced Mitochondria 6300000 Mitochondria "HPA018990: AB_1848277, HPA018993: AB_1848275, HPA018996: AB_1848276, HPA024089: AB_1848278" "unprognostic (3.44e-3)" "unprognostic (1.50e-1)" "unprognostic (2.29e-1)" "unprognostic (2.26e-1)" "unprognostic (3.71e-3)" "unprognostic (5.99e-2)" "unprognostic (6.81e-3)" "unprognostic (3.02e-1)" "unprognostic (5.01e-2)" "unprognostic (6.01e-2)" "unprognostic (3.38e-3)" "unprognostic (1.99e-1)" "prognostic favourable (5.04e-8)" "unprognostic (2.87e-1)" "unprognostic (4.90e-2)" "unprognostic (9.22e-2)" "unprognostic (2.90e-2)" 18.8 39.9 12.8 16.4 13.6 10.7 26.1 7.6 13.4 8.6 26.4 7.3 9.6 27.5 10.1 11.1 18.9 7.7 12.6 84.4 13.3 8.5 36.4 78.3 9.8 15.7 11.9 12.9 7.8 28.1 7.6 11.0 24.0 11.8 11.2 26.0 9.4 15.8 10.8 84.0 12.3 29.2 17.3 11.8 11.7 18.5 9.7 10.8 10.8 11.9 37.9 12.8 14.8 11.5 24.6 50.7 25.2 38.8 36.0 29.3 39.4 21.7 35.9 23.8 24.9 26.8 28.6 37.5 26.3 30.5 34.2 30.7 31.7 40.7 36.5 26.5 26.1 55.9 92.3 36.6 39.9 43.8 18.0 39.7 26.1 36.6 21.9 37.9 29.7 21.4 34.7 17.3 28.9 34.5 37.5 38.0 35.0 34.3 7.8 31.7 18.5 10.8 34.3 29.6 48.8 37.6 70.1 24.9 12.6 39.9 91.2 36.1 46.8 40.2 20.2 33.4 22.7 29.2 31.7 18.5 38.0 45.0 24.0 50.5 23.6 11.2 38.8 25.2 22.1 34.5 20.8 24.6 20.8 22.7 50.7 20.2 17.0 21.1 9.9 36.0 28.4 20.3 29.3 39.4 12.8 13.6 7.6 13.4 13.3 8.5 11.9 12.9 11.8 10.8 ETFB ENSG00000105379 "Electron transfer flavoprotein beta subunit" P38117 19 51345169-51366418 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport" "Disease mutation, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 108.6;liver: 106.6" "Cell line enriched" "Detected in all" 4 "Hep G2: 185.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018910, HPA018921, HPA018923" Supported Enhanced Mitochondria 640000 Mitochondria "HPA018910: AB_1848280, HPA018921: AB_1848281, HPA018923: AB_1848282" "unprognostic (1.44e-1)" "prognostic favourable (6.45e-4)" "unprognostic (8.66e-2)" "unprognostic (3.08e-1)" "unprognostic (1.77e-1)" "unprognostic (3.94e-2)" "unprognostic (3.20e-1)" "unprognostic (6.93e-3)" "unprognostic (2.63e-2)" "unprognostic (7.79e-2)" "unprognostic (1.23e-1)" "unprognostic (4.75e-1)" "prognostic favourable (6.45e-5)" "unprognostic (2.19e-1)" "unprognostic (2.54e-1)" "unprognostic (4.83e-1)" "unprognostic (1.99e-1)" 35.8 28.7 26.1 12.0 30.7 14.3 16.7 9.4 19.5 9.1 27.2 17.7 11.3 33.2 9.8 10.1 24.2 13.2 31.5 108.6 22.2 19.2 32.1 106.6 10.2 12.3 27.9 17.1 11.1 23.0 12.8 11.7 10.5 18.1 12.9 10.1 18.4 46.7 10.2 72.9 13.6 30.6 16.6 22.2 10.6 19.1 7.7 15.9 17.7 14.2 47.7 14.6 11.4 9.9 66.0 62.5 27.0 49.3 46.2 50.7 31.9 13.2 34.2 4.7 13.0 15.2 17.8 7.5 9.0 6.9 7.3 7.3 28.7 21.8 13.2 9.2 14.5 11.7 9.4 19.2 2.2 19.7 36.6 10.4 20.9 185.6 16.7 9.9 7.8 27.6 5.7 9.9 10.2 6.2 15.6 14.9 9.4 26.8 10.3 9.4 3.0 42.3 11.5 12.8 24.7 10.0 15.2 10.6 5.1 19.9 5.7 10.3 14.9 9.6 8.7 7.6 8.0 8.2 8.2 22.9 13.9 11.8 39.0 14.8 19.6 26.7 46.9 27.0 26.4 49.3 34.4 63.9 39.6 33.7 53.5 66.0 42.2 35.0 23.6 46.2 36.6 62.5 50.7 31.9 26.1 30.7 9.4 19.5 22.2 19.2 27.9 17.1 18.1 15.9 ETHE1 "HSCO, YF13H12" ENSG00000105755 "ETHE1, persulfide dioxygenase" O95571 19 43506719-43527244 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 80.7" "Cell line enhanced" "Detected in many" "BJ hTERT+: 57.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028360, HPA029028, HPA029029" Enhanced Enhanced Mitochondria 13000 Mitochondria "HPA028360: AB_10599297, HPA029028: AB_10602092, HPA029029: AB_10601998" "unprognostic (8.04e-2)" "unprognostic (3.33e-1)" "unprognostic (1.50e-2)" "unprognostic (2.45e-1)" "unprognostic (8.34e-2)" "unprognostic (1.25e-2)" "unprognostic (2.58e-1)" "prognostic unfavourable (9.58e-4)" "unprognostic (7.75e-2)" "unprognostic (2.28e-1)" "unprognostic (5.47e-2)" "unprognostic (3.24e-1)" "unprognostic (1.01e-1)" "unprognostic (5.27e-2)" "unprognostic (1.75e-1)" "unprognostic (9.72e-3)" "unprognostic (2.73e-2)" 7.7 10.5 5.2 28.3 6.3 13.1 8.8 4.5 6.7 10.9 80.7 4.6 9.6 27.4 7.1 12.2 28.2 7.1 18.4 8.9 4.4 4.1 19.0 21.3 11.4 15.5 5.6 4.9 7.4 12.7 3.0 7.2 16.7 5.1 12.0 72.1 5.6 18.5 6.7 9.4 9.1 40.3 11.8 4.5 11.0 13.2 3.3 4.7 12.0 26.2 23.3 24.4 10.9 13.3 7.9 35.8 7.4 24.3 9.9 20.2 15.1 13.4 17.7 3.6 12.6 19.8 13.5 1.4 20.9 57.0 18.0 18.5 5.3 13.8 0.0 15.7 20.0 11.0 5.2 31.5 4.8 6.7 1.7 3.4 7.7 14.7 9.0 5.0 4.7 13.8 24.8 6.9 19.5 13.3 2.2 22.6 8.8 9.1 5.8 4.6 0.9 8.6 6.6 1.6 3.0 39.1 28.0 0.0 4.5 5.3 19.2 12.5 5.8 8.4 11.2 2.9 12.4 3.5 3.8 6.4 5.0 0.3 12.6 20.8 15.0 7.4 24.3 0.6 17.2 12.7 20.0 7.9 20.2 16.3 35.8 3.4 15.6 14.8 0.7 9.9 8.5 7.1 19.4 15.1 5.2 6.3 4.5 6.7 4.4 4.1 5.6 4.9 5.1 4.7 FAHD1 "C16orf36, DKFZP566J2046" ENSG00000180185 "Fumarylacetoacetate hydrolase domain containing 1" Q6P587 16 1826941-1840207 "Enzymes, Predicted intracellular proteins" "Hydrolase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025530, HPA043226, HPA043534" Enhanced Enhanced Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "CAB025530: , HPA043226: AB_2678370, HPA043534: AB_2678535" "unprognostic (3.71e-1)" "unprognostic (1.25e-2)" "prognostic favourable (8.27e-4)" "unprognostic (1.99e-1)" "unprognostic (6.74e-2)" "unprognostic (1.01e-3)" "unprognostic (2.89e-2)" "unprognostic (4.32e-1)" "unprognostic (1.13e-1)" "unprognostic (5.36e-2)" "unprognostic (1.65e-1)" "unprognostic (1.38e-1)" "prognostic favourable (2.80e-14)" "unprognostic (1.02e-1)" "unprognostic (1.66e-1)" "unprognostic (1.26e-1)" "unprognostic (3.31e-2)" 10.4 17.0 10.4 6.7 9.9 6.5 9.2 8.6 12.7 6.8 21.7 9.3 8.2 26.7 9.8 10.9 14.8 5.8 10.2 15.8 10.9 11.4 46.8 43.6 5.6 5.2 10.1 9.4 7.9 17.4 9.0 11.1 10.4 9.9 8.1 11.1 8.5 9.1 9.8 20.2 12.4 24.8 6.9 8.8 6.3 14.9 6.9 9.5 4.7 12.5 19.0 5.7 9.9 7.9 18.5 23.1 8.6 27.5 19.6 16.0 13.7 8.3 18.8 9.0 15.8 12.0 8.7 5.6 13.7 6.8 9.2 10.1 12.0 8.7 5.3 11.6 8.5 17.2 7.0 11.0 8.3 8.0 16.6 4.8 16.2 27.6 11.7 8.2 9.2 11.4 14.5 8.4 5.6 11.9 4.9 5.6 11.5 38.2 4.4 12.5 5.3 14.1 10.2 12.2 15.0 32.9 10.5 17.6 14.6 17.9 14.4 21.5 21.2 5.6 17.4 15.1 10.8 8.8 7.4 8.1 17.0 6.3 9.6 6.0 6.4 6.5 23.5 8.6 14.4 27.5 13.0 18.5 14.5 15.7 23.1 16.9 16.0 14.9 2.0 19.6 19.1 17.9 14.7 13.7 10.4 9.9 8.6 12.7 10.9 11.4 10.1 9.4 9.9 9.5 FAM162A "C3orf28, E2IG5" ENSG00000114023 "Family with sequence similarity 162 member A" Q96A26 3 122384176-122412334 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035856, HPA058113" Approved Enhanced Mitochondria,Cytosol 29000 "Mitochondria, Cytosol" "HPA035856: AB_10611965, HPA058113: AB_2683609" "unprognostic (1.17e-2)" "unprognostic (1.42e-1)" "unprognostic (5.64e-2)" "unprognostic (1.10e-1)" "unprognostic (3.99e-1)" "unprognostic (7.84e-2)" "unprognostic (1.01e-1)" "unprognostic (1.15e-1)" "unprognostic (5.91e-3)" "unprognostic (8.74e-2)" "unprognostic (1.95e-2)" "unprognostic (7.91e-3)" "unprognostic (4.75e-2)" "unprognostic (2.69e-1)" "unprognostic (1.06e-1)" "unprognostic (4.10e-2)" "prognostic favourable (3.93e-4)" 13.6 32.8 24.9 18.6 49.9 14.1 18.7 10.7 44.8 21.8 57.8 11.5 19.6 22.7 17.0 25.5 58.7 13.8 25.4 54.2 40.2 21.7 35.9 78.1 12.2 16.5 23.6 27.7 30.2 71.5 24.6 16.1 7.3 31.0 27.3 61.3 16.2 17.7 23.1 56.6 29.2 21.2 27.2 24.4 10.9 25.7 16.9 18.8 8.6 17.9 48.6 16.7 34.6 36.0 26.8 29.4 25.3 24.4 16.4 33.1 12.9 30.4 6.5 9.7 18.1 17.9 16.6 5.0 12.5 11.2 11.9 30.5 16.3 14.0 33.2 21.8 4.3 21.4 17.6 30.4 31.9 17.1 13.2 26.9 11.3 29.1 11.8 26.2 9.6 19.2 16.0 11.3 24.0 15.8 18.1 13.3 17.0 11.9 26.7 31.9 14.3 34.7 16.1 13.9 43.2 34.5 74.4 14.6 11.7 9.3 22.2 25.5 13.9 13.0 11.1 11.8 8.5 6.9 12.9 26.5 9.0 33.7 35.1 25.7 5.4 2.6 9.3 25.3 21.7 23.0 32.1 26.8 29.8 27.1 29.4 23.9 32.6 33.1 3.0 16.4 24.4 24.6 27.1 12.9 24.9 49.9 10.7 44.8 40.2 21.7 23.6 27.7 31.0 18.8 FDX1 "ADX, FDX" ENSG00000137714 "Ferredoxin 1" P10109 11 110429883-110464881 "Predicted intracellular proteins" "Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Steroidogenesis, Sterol metabolism, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 113.9;seminal vesicle: 55.6" "Cell line enhanced" "Detected in all" "U-698: 37.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041630, HPA062087" Enhanced Enhanced Mitochondria Mitochondria "HPA041630: AB_10793970, HPA062087: AB_2630366" "unprognostic (1.66e-1)" "unprognostic (1.68e-2)" "unprognostic (5.29e-3)" "unprognostic (4.67e-2)" "unprognostic (2.39e-1)" "unprognostic (4.32e-3)" "unprognostic (1.23e-2)" "unprognostic (2.07e-1)" "unprognostic (2.19e-2)" "unprognostic (4.12e-1)" "unprognostic (3.10e-2)" "unprognostic (5.48e-2)" "prognostic favourable (3.58e-7)" "prognostic favourable (2.53e-4)" "unprognostic (1.10e-1)" "unprognostic (1.94e-1)" "unprognostic (2.80e-1)" 5.5 113.9 3.9 4.7 4.5 3.9 5.6 2.7 4.0 3.2 7.5 5.2 33.7 7.9 3.2 3.9 5.1 3.0 5.6 9.6 3.6 4.3 10.7 22.8 7.8 4.7 4.5 2.5 3.5 8.6 3.5 3.7 48.4 3.1 4.8 4.2 4.2 4.1 55.6 7.3 3.3 12.3 3.6 3.4 3.9 5.0 5.3 2.6 5.2 8.7 5.0 3.5 5.6 5.4 10.7 6.9 3.4 5.8 4.4 8.7 2.9 5.2 3.7 5.7 6.2 5.6 10.0 12.8 4.9 6.0 4.3 7.4 12.6 8.9 12.4 14.4 6.3 6.3 6.6 7.4 5.9 11.8 8.4 6.2 6.5 7.7 9.8 6.5 10.2 17.3 6.1 3.9 9.3 8.8 6.2 18.5 9.2 5.8 9.2 14.6 5.1 7.0 13.7 5.4 11.4 9.4 9.5 7.8 4.0 9.3 10.6 6.2 6.2 4.5 5.2 4.4 5.4 5.3 5.2 4.2 3.2 37.2 3.3 13.4 5.6 1.8 5.7 3.4 5.3 4.2 5.8 10.7 7.3 7.4 6.9 7.5 8.6 6.1 0.7 4.4 5.8 5.3 8.7 2.9 3.9 4.5 2.7 4.0 3.6 4.3 4.5 2.5 3.1 2.6 FDXR ADXR ENSG00000161513 "Ferredoxin reductase" P22570 17 74862497-74873031 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport" Oxidoreductase "Deafness, Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 93.9" "Cell line enhanced" "Detected in many" "BEWO: 29.5;Hep G2: 54.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008597, CAB009818, HPA044393, HPA053673" Enhanced Enhanced Mitochondria Mitochondria "CAB008597: AB_1615557, CAB009818: AB_2102601, HPA044393: AB_2678927, HPA053673: AB_2682225" "unprognostic (2.69e-2)" "unprognostic (1.17e-3)" "unprognostic (7.51e-2)" "prognostic favourable (2.38e-4)" "unprognostic (3.43e-2)" "unprognostic (1.20e-1)" "unprognostic (1.53e-1)" "unprognostic (1.68e-2)" "unprognostic (2.29e-1)" "unprognostic (1.50e-1)" "unprognostic (1.09e-1)" "unprognostic (6.30e-2)" "unprognostic (1.42e-2)" "unprognostic (1.19e-2)" "unprognostic (4.50e-2)" "unprognostic (4.03e-2)" "unprognostic (2.13e-1)" 1.7 93.9 2.6 2.1 3.1 1.3 1.8 8.4 2.7 2.1 4.6 3.2 6.4 2.6 2.6 23.8 8.7 6.6 6.1 1.9 3.4 1.7 2.7 4.1 4.4 1.7 2.9 3.5 7.1 3.9 2.3 1.5 2.6 3.6 3.3 2.1 0.9 5.3 4.2 7.9 5.6 2.5 2.0 4.4 9.7 2.2 32.1 3.0 3.9 2.0 7.7 3.7 3.0 3.0 5.4 7.4 4.8 6.4 10.0 15.2 5.6 3.9 21.1 3.1 3.5 2.3 3.0 29.5 4.7 5.2 2.8 5.7 5.9 3.5 9.4 0.8 2.0 8.1 2.3 5.9 0.8 8.9 4.9 7.1 3.5 54.0 6.4 1.5 25.0 9.9 6.7 2.9 1.0 14.4 11.3 1.5 4.3 16.7 6.1 3.3 1.7 4.6 3.3 5.3 5.0 2.3 6.7 1.7 4.0 3.2 7.1 3.4 15.4 1.5 6.7 1.9 17.6 3.1 2.3 4.4 0.7 2.0 5.3 2.4 6.6 1.8 6.4 4.8 6.2 4.3 5.3 5.4 5.6 7.3 7.4 2.8 4.9 6.1 2.1 10.0 3.2 1.4 15.2 5.6 2.6 3.1 8.4 2.7 3.4 1.7 2.9 3.5 3.6 3.0 FH fumarase ENSG00000091483 "Fumarate hydratase" P07954 1 241497603-241519761 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Tricarboxylic acid cycle" Lyase "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 93.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017785, HPA025770, HPA025948, HPA027341" Enhanced Supported Enhanced Mitochondria 2800000 Mitochondria "CAB017785: , HPA025770: AB_10599603, HPA025948: AB_10602177, HPA027341: AB_10601222" "unprognostic (1.03e-2)" "unprognostic (3.82e-2)" "unprognostic (9.46e-3)" "unprognostic (2.18e-1)" "unprognostic (2.10e-1)" "unprognostic (2.07e-1)" "unprognostic (2.28e-2)" "unprognostic (1.55e-1)" "unprognostic (5.14e-2)" "unprognostic (1.85e-2)" "unprognostic (1.27e-2)" "unprognostic (1.09e-1)" "prognostic favourable (2.76e-7)" "unprognostic (1.05e-1)" "unprognostic (1.05e-1)" "unprognostic (4.41e-2)" "unprognostic (1.24e-2)" 14.3 28.1 15.7 10.4 20.2 9.3 13.3 15.7 24.4 10.5 22.7 9.9 16.7 23.2 13.7 10.7 17.7 10.3 9.5 59.0 22.9 13.9 35.0 93.4 9.9 13.3 15.2 19.4 9.4 13.9 25.2 11.4 14.3 18.4 12.3 24.4 10.2 18.4 20.6 65.1 13.4 21.4 14.7 14.4 11.1 17.5 14.0 11.7 13.8 12.3 45.2 13.4 13.4 11.2 16.0 26.4 4.5 18.8 10.4 13.9 8.9 29.2 24.5 23.3 21.0 22.9 27.0 36.9 36.3 28.5 41.0 25.8 35.1 18.3 18.6 24.1 27.8 41.7 35.6 27.0 35.8 21.2 11.5 17.4 26.0 29.9 20.5 40.7 15.9 19.5 16.8 23.0 26.0 25.2 53.0 24.1 29.8 14.6 35.1 27.2 24.7 52.7 29.0 25.5 83.5 39.5 24.9 30.0 25.9 30.6 36.3 23.2 27.6 27.7 24.7 18.4 23.8 32.5 60.5 21.6 23.1 22.6 20.6 46.8 26.4 4.5 12.8 2.7 9.7 18.8 12.6 16.0 11.4 9.0 26.4 14.1 13.9 12.7 0.7 10.4 15.7 13.2 13.2 8.9 15.7 20.2 15.7 24.4 22.9 13.9 15.2 19.4 18.4 11.7 GADD45GIP1 "CKBBP2, CKbetaBP2, CRIF1, MGC4667, MGC4758, PLINP-1, Plinp1, PRG6" ENSG00000179271 "GADD45G interacting protein 1" Q8TAE8 19 12953119-12957236 "Predicted intracellular proteins, Ribosomal proteins" "Cell cycle, Host-virus interaction" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055205, HPA065048, HPA071910" Supported Enhanced Mitochondria Mitochondria "HPA055205: , HPA065048: , HPA071910: " "unprognostic (5.82e-2)" "unprognostic (2.62e-2)" "unprognostic (4.49e-2)" "unprognostic (2.08e-1)" "unprognostic (8.14e-3)" "unprognostic (2.49e-1)" "unprognostic (1.20e-1)" "unprognostic (1.65e-1)" "unprognostic (9.67e-2)" "unprognostic (7.73e-3)" "unprognostic (1.06e-1)" "unprognostic (7.09e-2)" "unprognostic (1.03e-1)" "unprognostic (1.62e-1)" "unprognostic (1.25e-1)" "unprognostic (1.50e-2)" "unprognostic (1.73e-1)" 23.9 31.8 32.7 22.3 29.1 28.1 19.3 17.2 31.4 16.9 18.9 11.2 17.9 21.1 19.2 20.0 22.3 17.5 25.0 41.9 26.4 27.6 24.3 31.5 15.3 21.0 26.0 23.6 20.7 29.6 10.1 18.5 21.3 17.7 18.7 9.7 13.1 36.2 21.7 85.5 18.4 19.2 19.5 19.3 19.8 20.0 17.2 17.1 14.8 27.0 37.9 14.8 17.5 21.5 34.2 17.7 4.8 14.1 16.1 23.6 10.6 19.8 17.0 7.1 10.0 5.0 6.5 10.0 14.7 7.4 14.7 12.1 23.4 8.1 14.4 24.6 8.8 14.0 8.7 14.4 3.8 9.3 42.7 10.2 22.9 26.2 12.2 16.9 15.6 7.7 11.7 10.2 8.4 8.5 15.4 5.6 9.1 29.3 26.7 35.6 19.7 53.7 19.8 7.2 23.0 11.3 11.8 22.0 20.1 11.0 14.8 16.6 11.6 16.0 13.8 28.6 10.0 24.8 27.0 22.4 15.6 14.9 19.8 21.3 16.4 4.1 14.1 4.8 14.4 13.4 14.5 34.2 22.1 22.8 17.7 28.0 23.6 17.4 0.9 16.1 11.3 16.9 17.5 10.6 32.7 29.1 17.2 29.1 26.4 27.6 26.0 23.6 17.7 17.1 GFER "ALR, ERV1, HERV1, HPO1, HPO2, HSS" ENSG00000127554 "Growth factor, augmenter of liver regeneration" P55789 16 1984207-1987749 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Growth factor, Oxidoreductase" "Cataract, Deafness, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041227, HPA063553" Approved Enhanced Mitochondria,Cytosol "Intracellular and membrane" "Mitochondria, Cytosol" "HPA041227: AB_10795538, HPA063553: " "unprognostic (5.35e-2)" "unprognostic (2.11e-2)" "unprognostic (3.08e-1)" "unprognostic (4.42e-2)" "unprognostic (3.15e-1)" "unprognostic (2.63e-1)" "unprognostic (1.27e-2)" "unprognostic (1.42e-1)" "unprognostic (1.11e-2)" "unprognostic (2.30e-1)" "unprognostic (1.56e-1)" "unprognostic (5.93e-2)" "prognostic favourable (4.06e-4)" "unprognostic (4.93e-2)" "unprognostic (3.64e-1)" "unprognostic (3.56e-1)" "unprognostic (1.09e-2)" 9.7 12.2 9.7 15.2 9.9 10.7 14.8 15.2 12.5 8.1 24.8 10.8 15.2 29.6 10.1 10.2 11.0 10.2 16.1 17.8 9.8 9.7 13.7 33.5 17.1 18.1 10.7 9.7 9.4 43.8 19.2 10.9 18.0 8.0 11.9 18.0 10.5 22.5 12.5 27.5 8.3 33.2 9.2 9.6 15.2 12.8 20.0 7.8 7.7 15.1 15.0 11.4 12.4 17.1 16.1 9.1 9.8 12.7 7.8 17.7 7.7 11.3 18.1 14.9 12.1 6.3 12.6 19.3 13.2 12.9 18.6 15.2 26.0 19.0 6.4 18.0 9.8 17.1 11.3 17.4 11.8 19.7 23.1 8.8 17.8 29.5 11.4 12.7 16.6 8.1 13.5 16.2 14.6 8.7 13.7 21.4 13.5 26.7 14.5 13.8 23.8 18.1 31.8 11.4 20.7 18.9 8.9 13.1 12.5 17.8 38.0 14.1 18.1 13.6 8.1 18.1 20.2 10.1 22.6 36.3 19.6 18.3 6.0 8.7 15.2 3.1 12.6 9.8 9.2 10.5 9.9 16.1 12.6 15.6 9.1 13.4 11.5 7.9 1.1 7.8 12.7 4.0 17.7 7.7 9.7 9.9 15.2 12.5 9.8 9.7 10.7 9.7 8.0 7.8 GRPEL2 "DKFZp451C205, FLJ23713, Mt-GrpE#2" ENSG00000164284 "GrpE like 2, mitochondrial" Q8TAA5 5 149345430-149354583 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 43.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018173, HPA023211" Uncertain Enhanced Mitochondria Mitochondria "HPA018173: AB_1850358, HPA023211: AB_1850360" "unprognostic (3.13e-2)" "unprognostic (1.69e-1)" "prognostic favourable (3.87e-5)" "prognostic unfavourable (2.21e-4)" "unprognostic (3.22e-1)" "unprognostic (2.07e-2)" "prognostic unfavourable (6.16e-8)" "unprognostic (1.34e-1)" "unprognostic (8.16e-2)" "unprognostic (3.43e-2)" "unprognostic (2.21e-2)" "unprognostic (1.04e-1)" "prognostic unfavourable (4.20e-4)" "unprognostic (3.40e-1)" "unprognostic (1.79e-1)" "unprognostic (2.20e-1)" "unprognostic (2.26e-1)" 7.4 5.1 5.4 6.5 6.4 5.3 9.8 10.9 8.9 13.3 4.8 3.7 3.9 6.0 5.4 5.8 43.1 5.1 4.3 6.3 5.5 5.6 7.5 5.7 10.2 8.1 5.1 5.2 7.5 6.8 7.2 6.5 8.5 8.4 5.1 4.8 3.7 7.2 6.7 7.8 5.4 5.8 4.3 4.4 5.9 6.1 4.9 5.1 7.4 7.9 14.4 12.8 6.1 11.5 3.5 3.8 8.2 2.5 3.7 13.5 4.6 9.0 4.9 7.1 25.5 4.5 4.7 14.3 8.0 6.8 7.8 11.0 12.0 6.1 9.4 8.5 4.2 7.0 11.3 11.7 10.0 5.0 9.5 11.9 9.4 6.8 13.6 11.1 6.0 6.9 14.4 9.7 15.2 4.7 10.3 23.2 5.8 6.4 7.2 9.5 9.4 17.9 9.1 9.9 12.4 5.0 8.4 14.7 12.2 8.1 15.0 23.9 13.1 13.3 5.3 8.5 9.4 6.1 11.8 8.6 11.4 9.1 8.6 16.2 7.7 8.2 2.5 3.3 5.1 2.4 6.2 3.5 7.7 5.7 3.8 1.9 10.3 7.7 1.9 3.7 2.5 1.0 13.5 4.6 5.4 6.4 10.9 8.9 5.5 5.6 5.1 5.2 8.4 5.1 GRSF1 ENSG00000132463 "G-rich RNA sequence binding factor 1" Q12849 4 70815782-70839945 "Predicted intracellular proteins" "mRNA processing, tRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 101.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036984, HPA036985" Enhanced Enhanced Mitochondria Mitochondria "HPA036984: AB_2675415, HPA036985: AB_10672785" "unprognostic (1.45e-3)" "unprognostic (1.82e-2)" "prognostic favourable (1.47e-5)" "unprognostic (8.63e-2)" "unprognostic (6.73e-2)" "unprognostic (4.15e-3)" "prognostic unfavourable (8.29e-5)" "unprognostic (1.94e-1)" "unprognostic (1.43e-1)" "unprognostic (1.66e-2)" "unprognostic (7.68e-2)" "unprognostic (8.05e-2)" "prognostic favourable (2.72e-9)" "unprognostic (6.12e-2)" "unprognostic (1.23e-1)" "unprognostic (1.78e-1)" "unprognostic (9.65e-3)" 17.9 33.4 21.3 22.3 19.9 8.8 29.0 19.1 42.5 16.8 22.7 19.7 15.0 18.1 17.2 18.2 21.7 18.9 22.9 33.3 22.9 22.6 23.9 23.6 23.7 24.6 24.8 20.2 17.3 26.9 19.6 13.7 18.3 23.6 17.7 27.1 12.0 32.1 20.9 101.8 18.7 17.2 18.1 24.1 17.3 22.5 13.6 19.1 37.0 19.7 31.1 21.7 21.1 15.4 5.7 20.0 7.6 11.6 14.3 11.7 5.6 31.9 21.8 25.7 26.7 27.3 31.9 36.9 38.8 24.6 29.3 24.1 22.2 32.9 46.2 29.7 39.9 12.2 45.4 30.3 39.3 25.1 14.9 24.3 22.4 30.7 33.7 35.5 14.0 26.8 29.2 29.6 20.6 30.1 27.8 26.9 40.7 34.2 58.3 25.0 27.4 23.1 24.1 40.0 19.6 36.2 40.0 26.8 24.2 18.3 52.2 64.0 22.6 17.4 27.5 27.4 29.0 22.6 24.4 22.4 17.8 29.7 22.7 23.1 26.7 7.6 11.6 5.2 7.6 8.8 9.5 5.7 11.2 11.7 20.0 4.9 11.2 9.5 1.6 14.3 10.5 19.3 9.3 5.6 21.3 19.9 19.1 42.5 22.9 22.6 24.8 20.2 23.6 19.1 GSDMC MLZE ENSG00000147697 "Gasdermin C" Q9BYG8 8 129748196-129786888 "Predicted intracellular proteins, Transporters" Necrosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 25.9;lymphoid tissue: 25.0;skin 1: 14.1;tongue: 19.2" "Cell line enhanced" "Detected in some" "A-431: 8.2;HaCaT: 5.8;hTCEpi: 3.0;HUVEC TERT2: 3.2;TIME: 8.5" "Group enriched" "Detected in many" 6 "cervical cancer: 11.8;head and neck cancer: 19.0;lung cancer: 5.3;urothelial cancer: 4.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.2" "Low lineage specificity" "Detected in single" "HPA023670, HPA024767, HPA026317" Supported Enhanced Mitochondria Mitochondria "HPA023670: AB_1854006, HPA024767: AB_1854007, HPA026317: AB_1854008" "unprognostic (6.33e-3)" "unprognostic (1.49e-1)" "unprognostic (2.61e-3)" "unprognostic (4.23e-2)" "unprognostic (2.11e-2)" "unprognostic (4.22e-3)" "unprognostic (1.43e-2)" "unprognostic (1.15e-1)" "unprognostic (8.28e-2)" "unprognostic (7.51e-2)" "unprognostic (4.92e-3)" "unprognostic (5.71e-2)" "unprognostic (2.93e-3)" "unprognostic (1.87e-2)" "unprognostic (1.88e-1)" "unprognostic (8.66e-2)" "unprognostic (1.90e-1)" 0.0 0.0 0.2 0.3 0.0 0.1 0.1 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.5 0.2 25.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.7 0.1 0.0 3.4 0.0 0.0 14.1 0.0 0.0 0.2 25.0 0.0 0.0 0.0 0.1 0.1 19.2 17.5 1.4 5.9 0.3 0.3 1.2 0.1 0.4 0.3 0.0 8.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 5.8 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.3 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.1 0.0 0.1 8.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.2 0.3 0.1 0.1 0.1 0.2 0.1 0.0 0.3 0.2 0.2 0.9 0.4 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 GTPBP8 HSPC135 ENSG00000163607 "GTP binding protein 8 (putative)" Q8N3Z3 3 112990918-113015060 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034831, HPA058631" Approved Enhanced Mitochondria Mitochondria "HPA034831: AB_10671506, HPA058631: " "unprognostic (1.98e-1)" "unprognostic (1.02e-2)" "unprognostic (4.36e-2)" "unprognostic (1.99e-3)" "unprognostic (4.39e-2)" "unprognostic (2.00e-2)" "unprognostic (7.18e-3)" "unprognostic (1.80e-2)" "unprognostic (1.06e-2)" "unprognostic (2.08e-1)" "unprognostic (1.35e-2)" "unprognostic (1.21e-2)" "prognostic favourable (3.07e-5)" "unprognostic (7.10e-2)" "unprognostic (7.21e-2)" "unprognostic (4.57e-1)" "unprognostic (2.69e-1)" 7.5 9.3 7.4 7.3 7.8 9.5 7.3 8.5 10.1 7.1 11.9 9.2 8.3 8.0 8.3 5.2 12.2 6.4 7.4 20.0 7.6 7.6 12.2 8.2 6.2 13.2 7.6 8.3 10.4 12.1 13.0 12.1 9.3 9.5 8.2 9.3 6.6 9.6 5.2 25.3 6.5 11.8 7.4 11.7 9.3 9.1 22.7 8.9 25.4 13.4 14.3 10.2 9.6 8.0 6.7 12.2 6.7 7.0 11.9 15.8 7.8 19.2 8.8 11.7 13.1 7.1 12.4 9.3 13.3 11.6 13.7 17.1 15.4 8.3 12.6 7.9 7.3 13.2 15.5 12.9 15.8 5.6 10.8 34.5 8.9 8.0 6.8 22.0 8.5 9.8 9.3 7.5 5.4 12.6 12.2 15.0 13.2 7.6 14.0 10.8 24.0 16.7 12.0 10.7 8.0 9.6 12.2 13.5 13.7 10.8 8.5 17.7 9.6 15.0 7.5 10.0 14.8 3.6 12.4 9.8 12.8 17.7 10.0 18.3 11.0 6.7 7.0 4.5 10.4 4.6 9.1 6.7 11.9 10.0 12.2 5.9 15.8 10.3 1.0 11.9 3.9 5.8 8.2 7.8 7.4 7.8 8.5 10.1 7.6 7.6 7.6 8.3 9.5 8.9 HADHA "GBP, LCEH, LCHAD, MTPA" ENSG00000084754 "Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha" P40939 2 26190635-26244726 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Lyase, Multifunctional enzyme, Oxidoreductase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015536, HPA056070" Approved Enhanced Mitochondria 2700000 Mitochondria "HPA015536: AB_1850473, HPA056070: " "unprognostic (2.02e-1)" "unprognostic (1.38e-2)" "unprognostic (2.55e-1)" "unprognostic (3.43e-1)" "unprognostic (2.67e-2)" "unprognostic (3.23e-2)" "unprognostic (1.25e-2)" "unprognostic (2.02e-1)" "unprognostic (5.16e-2)" "unprognostic (3.45e-1)" "unprognostic (3.81e-1)" "unprognostic (1.16e-1)" "prognostic favourable (3.68e-5)" "unprognostic (7.97e-2)" "unprognostic (1.71e-1)" "unprognostic (2.87e-3)" "unprognostic (2.64e-2)" 41.6 35.3 18.1 13.1 19.5 17.0 23.9 17.4 16.9 20.2 44.9 26.5 15.7 48.1 21.1 15.3 30.8 20.5 15.1 80.0 15.6 15.5 41.3 71.7 17.7 19.3 21.6 13.1 27.3 37.5 29.8 23.5 21.3 24.8 21.9 32.2 23.6 21.1 16.6 117.5 23.3 66.4 25.1 27.8 24.0 24.1 18.7 19.0 25.2 25.1 41.3 24.6 26.9 18.8 15.3 28.9 12.4 32.2 13.5 17.6 26.0 23.3 20.8 13.7 22.4 54.5 34.1 11.7 18.3 19.8 18.9 16.4 26.3 22.7 15.4 12.0 32.1 14.9 24.0 35.5 17.1 34.5 29.4 23.1 22.1 43.8 18.8 29.1 17.0 34.8 23.3 26.8 26.9 31.6 31.4 31.3 24.3 28.6 12.7 32.6 11.7 40.2 11.7 29.6 33.1 21.6 28.2 9.7 19.3 21.5 22.4 24.8 11.9 28.2 28.9 11.0 16.3 16.4 13.4 10.3 20.3 27.4 17.1 34.5 13.2 8.1 27.7 12.4 12.3 32.2 14.8 15.3 14.2 15.0 28.9 11.2 16.7 15.3 7.4 13.5 28.0 11.0 17.6 26.0 18.1 19.5 17.4 16.9 15.6 15.5 21.6 13.1 24.8 19.0 HCCS "CCHL, MLS" ENSG00000004961 "Holocytochrome c synthase" P53701 X 11111301-11123078 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Lyase "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002946 Approved Enhanced Mitochondria "Intracellular and membrane" Mitochondria "HPA002946: AB_1079041" "prognostic unfavourable (8.69e-5)" "unprognostic (6.89e-3)" "unprognostic (8.46e-3)" "unprognostic (4.92e-2)" "unprognostic (1.34e-1)" "unprognostic (5.44e-2)" "prognostic unfavourable (1.35e-5)" "unprognostic (9.18e-2)" "unprognostic (2.73e-1)" "unprognostic (2.52e-2)" "unprognostic (2.10e-2)" "unprognostic (1.60e-1)" "prognostic favourable (6.17e-8)" "unprognostic (2.66e-2)" "unprognostic (1.52e-1)" "unprognostic (2.04e-1)" "unprognostic (1.93e-2)" 10.6 14.2 8.8 9.0 12.7 11.8 9.6 11.0 17.7 6.7 15.5 7.4 8.0 17.2 8.5 5.5 15.8 6.9 9.8 36.9 8.4 8.3 15.9 19.0 9.5 10.1 8.2 11.1 10.0 11.4 11.5 10.0 12.8 10.6 7.8 15.2 9.3 12.8 8.0 41.6 13.8 14.4 10.4 6.3 12.3 12.2 10.5 6.0 10.3 10.8 16.4 11.8 11.4 17.3 18.1 28.4 13.3 29.7 8.4 11.1 8.7 23.2 26.8 12.5 12.0 11.8 11.4 13.3 23.5 17.9 29.7 25.5 31.1 17.0 14.5 12.1 18.8 21.6 25.9 22.4 29.0 13.5 20.3 14.5 34.4 15.5 20.9 15.8 17.7 11.1 17.5 28.2 19.3 21.0 26.8 16.8 19.9 31.5 11.4 12.8 22.7 29.0 11.2 25.2 28.4 20.0 18.3 9.1 10.7 23.4 25.5 15.0 19.7 11.4 20.6 19.3 10.4 49.2 20.0 12.4 12.6 19.2 15.5 12.7 18.4 10.1 22.5 13.3 9.9 29.7 9.5 18.1 9.7 8.9 28.4 15.5 8.5 11.1 6.2 8.4 24.8 25.9 10.4 8.7 8.8 12.7 11.0 17.7 8.4 8.3 8.2 11.1 10.6 6.0 HEATR1 "BAP28, FLJ10359, UTP10" ENSG00000119285 "HEAT repeat containing 1" Q9H583 1 236549005-236604504 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046917, HPA062200" Approved Enhanced "Nucleoli fibrillar center,Mitochondria" 120000 "Nucleoli fibrillar center" Mitochondria "HPA046917: , HPA062200: " "unprognostic (2.61e-1)" "unprognostic (1.44e-3)" "unprognostic (6.26e-2)" "unprognostic (1.34e-3)" "unprognostic (7.18e-2)" "unprognostic (4.98e-2)" "prognostic unfavourable (2.05e-4)" "unprognostic (5.82e-2)" "unprognostic (4.15e-2)" "unprognostic (3.80e-1)" "unprognostic (4.67e-3)" "unprognostic (1.10e-1)" "prognostic unfavourable (4.04e-4)" "unprognostic (8.08e-2)" "unprognostic (3.38e-1)" "unprognostic (3.27e-2)" "unprognostic (4.00e-2)" 14.1 11.0 9.2 14.7 11.3 15.2 13.8 15.0 13.9 10.7 10.6 8.6 8.3 7.6 15.9 9.4 14.7 12.5 8.1 9.4 10.0 5.8 9.9 13.2 10.6 16.5 12.9 6.9 15.8 17.2 13.5 12.8 10.5 11.6 11.1 10.8 8.2 12.6 9.5 12.7 14.5 11.6 13.1 6.6 16.1 11.5 20.3 13.2 18.3 12.0 12.8 17.9 12.7 12.8 9.9 5.9 1.8 4.5 6.4 10.0 2.4 14.5 17.5 9.2 13.8 12.9 14.5 20.6 11.7 7.6 13.5 12.1 17.5 12.4 23.9 13.3 10.8 17.7 20.8 12.6 18.4 12.0 24.0 16.9 12.4 14.9 11.6 30.2 11.0 11.8 11.4 20.5 17.7 15.5 38.3 8.1 13.4 7.8 14.3 8.3 36.6 7.2 16.0 13.3 22.4 8.7 14.7 8.6 19.2 14.2 10.2 12.1 12.1 11.4 14.7 13.6 12.9 17.5 29.0 15.4 19.1 28.3 12.2 17.0 20.3 1.8 3.6 1.1 7.3 4.5 6.6 9.9 7.2 7.9 4.3 8.1 10.0 9.4 0.5 6.4 4.3 5.9 5.9 2.4 9.2 11.3 15.0 13.9 10.0 5.8 12.9 6.9 11.6 13.2 HINT2 ENSG00000137133 "Histidine triad nucleotide binding protein 2" Q9BX68 9 35812960-35815354 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020961, HPA059109" Supported Enhanced Mitochondria "Intracellular and membrane" 1100000 Mitochondria "HPA020961: AB_1850715, HPA059109: " "unprognostic (9.64e-3)" "unprognostic (1.53e-2)" "unprognostic (3.02e-1)" "unprognostic (3.01e-2)" "unprognostic (5.51e-2)" "unprognostic (3.97e-2)" "unprognostic (1.07e-1)" "unprognostic (2.38e-2)" "unprognostic (2.61e-1)" "prognostic favourable (1.66e-4)" "unprognostic (3.71e-3)" "unprognostic (2.87e-2)" "prognostic favourable (2.97e-9)" "unprognostic (4.29e-2)" "unprognostic (1.41e-1)" "unprognostic (8.78e-2)" "unprognostic (1.72e-1)" 18.4 27.2 16.0 14.5 15.5 10.3 15.6 9.5 16.5 10.0 16.4 11.0 26.1 15.3 8.9 24.1 12.6 14.4 21.7 33.7 13.3 13.3 34.8 68.7 15.2 14.2 15.3 13.6 6.8 30.8 21.0 14.1 12.8 12.5 10.8 16.4 12.2 20.2 31.0 30.9 10.3 15.8 17.0 12.3 11.3 16.7 10.3 8.2 16.8 14.9 29.8 11.8 10.4 7.5 24.6 62.0 7.8 20.3 15.1 25.5 18.5 9.7 26.8 16.7 16.1 10.7 9.0 11.0 9.2 13.8 15.1 16.7 17.6 10.9 12.7 10.7 8.8 9.8 7.6 14.4 16.0 27.7 13.8 13.9 23.4 15.8 24.8 7.8 14.0 10.0 13.2 14.4 23.5 11.7 8.1 41.5 12.0 20.8 19.5 9.8 7.4 46.2 19.7 11.1 17.5 21.6 7.6 13.3 15.9 12.0 14.9 16.0 16.1 15.1 5.3 8.1 12.8 10.5 11.6 36.1 40.1 18.3 18.0 10.8 12.7 7.8 20.3 1.1 18.5 14.3 16.7 24.6 19.9 18.5 28.6 23.8 15.4 15.9 1.9 15.1 13.0 62.0 25.5 18.5 16.0 15.5 9.5 16.5 13.3 13.3 15.3 13.6 12.5 8.2 HKDC1 "FLJ22761, FLJ37767" ENSG00000156510 "Hexokinase domain containing 1" Q2TB90 10 69220303-69267559 "Enzymes, Predicted intracellular proteins" Glycolysis "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 77.4" "Cell line enhanced" "Detected in some" "A549: 14.7;CACO-2: 20.9;CAPAN-2: 41.4;EFO-21: 12.8;Hep G2: 12.1;RPTEC TERT1: 30.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 8.3;T-reg: 6.6" "Lineage enriched" "Detected in single" 29 "T-cells: 8.3" "Region enhanced" "Detected in some" "cerebral cortex: 12.2" "Low region specificity" "Detected in all" "HPA011956, HPA064198, HPA064230" Approved Enhanced Mitochondria Mitochondria "HPA011956: AB_1850758, HPA064198: , HPA064230: " "unprognostic (1.29e-2)" "unprognostic (2.26e-2)" "unprognostic (1.86e-1)" "unprognostic (8.47e-2)" "unprognostic (1.55e-1)" "unprognostic (3.05e-1)" "unprognostic (6.31e-3)" "unprognostic (5.03e-2)" "unprognostic (1.08e-1)" "unprognostic (1.19e-1)" "unprognostic (1.23e-3)" "unprognostic (3.11e-1)" "unprognostic (1.04e-3)" "unprognostic (1.35e-1)" "unprognostic (2.24e-1)" "unprognostic (2.10e-3)" "unprognostic (2.19e-1)" 0.2 0.0 0.9 1.2 1.6 0.0 0.2 0.8 1.4 0.5 29.8 0.5 0.2 29.9 0.5 1.0 0.3 2.5 11.2 0.2 0.5 0.6 15.6 4.6 1.3 0.3 0.3 0.2 1.0 4.7 0.0 0.5 0.2 0.4 0.2 2.3 12.0 0.2 0.2 0.2 0.0 77.4 0.2 0.2 0.2 0.4 0.6 0.2 0.2 5.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.2 8.3 1.6 0.4 14.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 20.9 41.4 0.0 12.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 12.1 1.0 0.0 0.0 0.0 0.1 0.1 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 30.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.1 0.2 0.0 0.0 0.0 3.1 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.7 0.0 4.4 1.4 0.0 0.0 8.3 3.2 0.0 0.2 0.0 0.0 6.6 1.6 0.9 1.6 0.8 0.4 0.5 0.6 0.3 0.2 0.4 0.2 HSDL2 "C9orf99, SDR13C1" ENSG00000119471 "Hydroxysteroid dehydrogenase like 2" Q6YN16 9 112379937-112472410 "Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 70.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Lineage enriched" "Detected in all" 5 "granulocytes: 23.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042890, HPA050453" Enhanced Enhanced Mitochondria Mitochondria "HPA042890: AB_2678216, HPA050453: AB_2681131" "unprognostic (3.17e-3)" "unprognostic (1.62e-2)" "unprognostic (1.90e-3)" "prognostic favourable (9.23e-6)" "unprognostic (3.94e-2)" "unprognostic (1.43e-2)" "unprognostic (1.17e-1)" "unprognostic (5.15e-2)" "unprognostic (7.58e-2)" "unprognostic (6.48e-2)" "unprognostic (1.57e-1)" "unprognostic (1.82e-1)" "prognostic favourable (9.29e-7)" "unprognostic (1.44e-1)" "unprognostic (2.33e-1)" "unprognostic (1.35e-2)" "unprognostic (7.35e-2)" 31.0 26.3 18.3 5.8 17.7 4.1 13.8 5.7 12.1 10.1 14.1 11.9 6.2 15.2 11.0 5.0 14.4 8.8 7.6 52.1 16.1 13.7 29.3 70.5 11.4 7.8 17.9 10.8 21.3 11.4 7.9 7.7 9.9 12.4 12.2 11.0 10.2 7.3 6.9 54.1 12.5 18.3 13.3 12.9 10.1 9.9 5.9 14.5 5.7 13.2 27.7 6.9 14.2 10.7 3.6 4.6 23.3 5.0 2.6 4.1 2.4 15.2 13.7 10.3 5.2 17.9 17.8 11.9 10.5 6.5 7.5 6.3 26.3 17.2 9.8 5.8 15.3 17.6 11.1 14.7 9.3 41.2 7.3 10.2 22.2 25.7 11.2 5.7 6.6 18.9 10.7 11.2 8.1 8.7 14.1 6.6 20.4 10.1 14.2 5.3 6.0 17.8 9.2 31.2 14.4 15.9 13.9 7.4 5.3 26.3 17.5 8.8 24.7 7.0 9.8 10.8 10.1 30.2 10.2 7.8 19.2 4.6 13.4 8.5 6.3 21.9 4.0 15.2 2.3 3.9 3.5 3.3 2.5 2.6 4.5 3.6 3.0 3.1 23.3 2.6 5.0 4.6 4.1 2.4 18.3 17.7 5.7 12.1 16.1 13.7 17.9 10.8 12.4 14.5 HSPD1 "GroEL, HSP60, SPG13" ENSG00000144381 "Heat shock protein family D (Hsp60) member 1" P10809 2 197486581-197516737 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction" "Chaperone, Isomerase" "Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 162.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA001523, CAB002775, HPA050025, CAB072816" Supported Enhanced Mitochondria 53000000 Mitochondria "CAB002775: , CAB072816: , HPA001523: AB_1079028, HPA050025: AB_2680995" "unprognostic (2.79e-2)" "unprognostic (1.72e-2)" "unprognostic (5.21e-2)" "prognostic unfavourable (1.61e-4)" "unprognostic (2.59e-1)" "unprognostic (3.57e-3)" "prognostic unfavourable (2.25e-4)" "unprognostic (3.51e-2)" "unprognostic (9.91e-2)" "unprognostic (8.63e-3)" "unprognostic (3.47e-2)" "unprognostic (7.83e-3)" "unprognostic (5.64e-3)" "unprognostic (1.73e-2)" "unprognostic (1.52e-1)" "unprognostic (2.61e-2)" "unprognostic (4.10e-2)" 28.5 125.2 28.7 23.4 31.8 21.0 55.9 18.2 24.3 17.4 30.3 17.8 23.3 28.9 17.5 18.5 27.2 25.3 16.3 24.0 24.2 27.8 67.1 147.5 22.4 25.3 35.5 16.1 30.2 50.6 32.5 25.9 27.1 33.6 25.9 37.2 11.9 17.6 21.0 36.4 13.7 32.0 23.6 32.4 22.7 25.2 10.9 35.8 22.7 38.7 29.4 30.3 33.3 162.6 25.6 30.3 6.2 29.3 23.1 33.5 22.2 40.4 49.8 41.8 37.5 28.7 30.0 60.8 42.2 22.3 50.8 37.3 167.0 24.4 123.1 55.1 22.0 41.4 163.6 46.5 72.1 30.2 65.6 87.4 80.6 193.3 27.0 96.8 27.5 33.9 54.0 45.0 79.4 39.8 107.6 48.3 37.3 51.8 60.1 98.0 82.6 104.2 72.3 51.6 88.9 53.4 42.3 54.8 31.0 42.3 45.8 54.1 31.7 57.5 17.7 31.6 43.8 40.6 66.6 27.1 59.6 102.2 37.1 58.5 33.9 4.5 19.7 5.3 15.5 29.3 28.8 25.6 25.0 21.8 30.3 21.0 33.5 29.0 6.2 23.1 25.8 20.2 19.7 22.2 28.7 31.8 18.2 24.3 24.2 27.8 35.5 16.1 33.6 35.8 IARS2 FLJ10326 ENSG00000067704 "Isoleucyl-tRNA synthetase 2, mitochondrial" Q9NSE4 1 220094102-220148041 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Cataract, Deafness, Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024212, HPA024594, HPA024596" Enhanced Enhanced Mitochondria 26000 Mitochondria "HPA024212: AB_1851363, HPA024594: AB_1851368, HPA024596: AB_1851370" "unprognostic (2.15e-2)" "prognostic unfavourable (1.04e-4)" "unprognostic (2.42e-3)" "unprognostic (3.22e-2)" "unprognostic (2.04e-1)" "unprognostic (1.55e-1)" "unprognostic (1.91e-1)" "unprognostic (7.81e-2)" "unprognostic (1.78e-1)" "unprognostic (1.91e-1)" "prognostic unfavourable (9.24e-5)" "unprognostic (9.48e-2)" "unprognostic (2.10e-2)" "unprognostic (3.01e-1)" "unprognostic (2.16e-1)" "unprognostic (8.87e-2)" "unprognostic (6.27e-3)" 25.9 39.3 18.0 17.9 16.9 6.7 31.9 15.1 20.8 16.9 26.2 14.8 24.3 18.9 21.5 16.8 23.8 18.8 16.5 40.0 17.5 12.6 29.5 37.3 16.8 25.9 15.6 16.0 20.5 20.5 42.5 15.3 26.2 17.4 18.5 24.9 15.0 22.4 22.3 57.8 22.2 23.4 17.7 15.7 16.1 18.5 15.7 13.7 19.5 17.8 25.9 20.1 24.9 18.7 16.8 20.0 17.2 19.0 18.5 22.6 16.8 37.7 35.4 20.4 20.0 30.8 31.1 49.1 23.0 24.8 25.5 20.7 34.0 39.5 34.9 31.2 28.5 36.7 28.2 28.7 29.5 24.1 34.0 17.3 29.0 38.2 19.1 27.5 18.8 22.4 29.3 27.5 28.5 24.7 42.7 20.3 33.3 20.9 21.6 19.8 26.4 23.5 19.2 40.6 55.8 36.7 25.4 11.0 30.9 34.8 54.1 35.8 62.6 31.1 25.3 25.1 21.0 33.7 38.5 17.4 26.7 25.4 26.6 21.6 27.8 17.2 16.7 15.1 16.8 19.0 22.6 16.8 18.4 22.0 20.0 13.6 20.8 19.0 3.3 18.5 14.5 7.3 19.7 16.8 18.0 16.9 15.1 20.8 17.5 12.6 15.6 16.0 17.4 13.7 IDH3A ENSG00000166411 "Isocitrate dehydrogenase 3 (NAD(+)) alpha" P50213 15 78131498-78171949 "Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 47.2" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041465, HPA062971" Supported Enhanced Mitochondria 2000000 Mitochondria "HPA041465: AB_10794377, HPA062971: AB_2684913" "unprognostic (2.33e-1)" "unprognostic (1.21e-1)" "unprognostic (5.76e-3)" "unprognostic (2.26e-1)" "unprognostic (1.02e-1)" "unprognostic (4.01e-1)" "unprognostic (2.29e-1)" "unprognostic (6.47e-2)" "unprognostic (1.69e-2)" "unprognostic (2.30e-1)" "unprognostic (3.05e-1)" "unprognostic (1.42e-1)" "prognostic favourable (6.49e-8)" "unprognostic (1.40e-1)" "unprognostic (3.08e-2)" "unprognostic (4.49e-2)" "unprognostic (3.39e-2)" 14.6 18.1 18.0 13.0 25.3 6.5 7.7 16.1 29.5 9.9 17.6 11.9 6.1 24.5 11.2 5.9 12.0 8.4 6.5 41.5 16.6 16.8 15.2 10.4 8.8 11.0 20.6 18.1 8.0 9.2 18.5 12.4 8.4 29.0 10.1 18.8 10.4 11.2 11.9 47.7 11.1 23.8 11.9 18.1 10.1 8.9 11.5 13.8 16.2 8.1 26.5 16.4 11.1 10.3 10.1 47.2 6.1 17.0 5.5 6.0 7.4 15.9 21.9 4.0 13.9 10.0 10.2 8.7 19.0 9.3 15.5 11.8 15.5 9.7 34.0 14.1 11.1 24.1 36.9 14.7 14.4 14.9 12.2 13.1 23.7 7.0 8.5 25.4 18.8 7.7 9.1 15.1 15.9 9.7 16.8 14.0 9.8 15.2 18.6 6.8 4.9 8.2 10.8 17.0 10.6 12.9 21.7 15.9 6.1 21.8 31.2 17.6 12.4 13.8 10.0 18.3 17.0 24.1 30.6 16.0 35.6 18.1 12.9 24.3 14.3 4.2 9.4 2.7 5.3 17.0 5.7 9.2 5.2 4.8 14.2 10.1 5.6 6.0 6.1 5.5 16.6 47.2 5.6 7.4 18.0 25.3 16.1 29.5 16.6 16.8 20.6 18.1 29.0 13.8 IDH3B RP46 ENSG00000101365 "Isocitrate dehydrogenase 3 (NAD(+)) beta" O43837 20 2658395-2664219 "Citric acid cycle related proteins, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049387, HPA054180" Supported Enhanced Mitochondria Mitochondria "HPA049387: AB_2680740, HPA054180: AB_2682407" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (2.12e-1)" "unprognostic (2.43e-2)" "unprognostic (3.24e-2)" "unprognostic (6.83e-2)" "prognostic unfavourable (1.59e-4)" "unprognostic (2.76e-2)" "unprognostic (2.99e-1)" "unprognostic (5.69e-2)" "unprognostic (4.75e-3)" "unprognostic (1.39e-2)" "prognostic favourable (6.78e-8)" "unprognostic (8.89e-2)" "unprognostic (4.02e-2)" "unprognostic (2.79e-1)" "unprognostic (1.16e-1)" 19.5 20.0 19.4 15.5 31.7 20.6 18.5 32.1 30.5 16.4 23.9 16.9 14.5 30.5 19.2 16.7 20.7 17.9 19.2 57.3 19.8 20.0 29.7 25.2 15.1 17.6 24.0 29.4 20.2 15.2 27.6 12.2 17.0 31.2 15.4 25.6 16.2 19.3 19.5 75.5 20.9 24.9 21.5 17.1 19.2 19.9 19.6 16.0 19.7 19.1 37.7 22.5 16.7 17.4 34.7 49.4 25.8 44.7 29.5 38.6 33.9 26.1 35.5 16.2 14.1 18.0 14.2 18.8 14.1 18.0 33.3 26.6 45.7 27.6 29.6 12.9 19.3 37.0 29.9 45.7 30.6 8.1 23.5 35.9 13.8 47.3 17.6 39.0 7.8 18.8 17.6 31.1 16.4 19.6 45.3 16.6 20.2 14.4 33.9 44.8 31.5 33.7 27.8 29.6 33.2 19.1 24.6 29.3 21.2 17.3 57.7 29.7 28.9 17.4 17.4 26.0 16.4 8.8 32.3 22.6 51.6 31.2 12.2 40.4 24.6 22.2 41.7 25.8 33.9 44.7 25.6 34.7 29.4 30.7 49.4 30.6 34.4 29.8 11.9 29.5 38.3 22.9 38.6 33.9 19.4 31.7 32.1 30.5 19.8 20.0 24.0 29.4 31.2 16.0 IMMT "HMP, Mic60, MINOS2, P87, P89" ENSG00000132305 "Inner membrane mitochondrial protein" Q16891 2 86143932-86195770 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022439, HPA036164, HPA036165" Supported Enhanced Mitochondria 240000 Mitochondria "CAB022439: , HPA036164: AB_2674979, HPA036165: AB_2674980" "unprognostic (3.83e-3)" "unprognostic (1.56e-1)" "unprognostic (1.95e-2)" "prognostic unfavourable (1.06e-4)" "unprognostic (1.40e-1)" "unprognostic (2.45e-2)" "prognostic unfavourable (2.03e-4)" "unprognostic (5.66e-2)" "unprognostic (1.53e-1)" "unprognostic (8.10e-2)" "unprognostic (7.35e-2)" "unprognostic (2.21e-1)" "prognostic favourable (3.51e-6)" "unprognostic (2.06e-3)" "unprognostic (6.35e-2)" "unprognostic (1.20e-1)" "unprognostic (2.82e-1)" 20.0 36.9 15.6 17.0 23.5 15.3 15.4 17.5 27.1 13.6 24.8 16.0 15.4 25.1 16.5 13.6 19.1 13.9 12.3 67.3 15.1 18.0 37.5 35.1 14.3 17.7 18.4 18.8 13.3 23.1 31.4 17.6 21.6 32.2 12.8 26.3 17.3 16.7 21.2 78.6 15.4 25.6 17.9 12.1 20.0 22.0 28.3 15.0 29.1 16.2 38.3 19.9 18.0 14.1 10.9 21.5 7.6 21.6 13.2 16.1 14.4 34.0 33.7 30.5 14.0 29.8 27.5 31.2 24.5 25.7 33.2 30.2 48.4 27.1 52.3 24.6 25.9 25.4 39.1 35.4 40.7 21.1 31.9 41.3 21.3 57.2 30.3 39.8 28.4 31.4 25.8 31.2 37.4 37.4 40.2 29.8 32.0 29.3 39.6 41.6 36.4 26.9 26.5 65.4 47.0 37.8 38.7 37.2 27.6 25.1 38.2 37.4 21.7 28.3 28.0 23.9 26.3 34.5 30.4 23.7 29.9 35.9 27.2 47.6 28.9 7.5 18.6 7.6 16.1 21.6 14.6 10.9 14.4 13.3 21.5 8.8 13.1 15.5 2.5 13.2 19.9 11.1 14.9 14.4 15.6 23.5 17.5 27.1 15.1 18.0 18.4 18.8 32.2 15.0 L2HGDH "C14orf160, FLJ12618" ENSG00000087299 "L-2-hydroxyglutarate dehydrogenase" Q9H9P8 14 50237563-50312548 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 10.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065409, HPA069708" Approved Enhanced Mitochondria Mitochondria "HPA065409: , HPA069708: " "unprognostic (1.74e-1)" "unprognostic (1.15e-2)" "unprognostic (1.13e-2)" "unprognostic (1.23e-3)" "unprognostic (1.04e-2)" "unprognostic (4.33e-2)" "unprognostic (8.84e-2)" "unprognostic (1.58e-2)" "unprognostic (4.17e-2)" "unprognostic (9.91e-2)" "unprognostic (2.84e-1)" "unprognostic (1.97e-1)" "prognostic favourable (9.75e-10)" "unprognostic (1.24e-2)" "unprognostic (5.88e-2)" "unprognostic (1.45e-1)" "unprognostic (1.02e-2)" 5.4 5.1 6.9 3.6 8.4 3.5 5.1 12.7 10.9 3.5 5.6 4.9 4.8 6.2 3.4 4.3 9.0 4.4 3.2 7.7 6.1 4.7 25.5 16.0 2.5 3.3 7.7 4.7 4.2 5.4 7.1 5.8 2.6 5.7 4.6 6.8 7.7 5.0 5.6 17.7 7.0 5.0 4.7 5.3 2.3 5.6 6.0 6.0 3.7 6.5 6.2 5.2 4.6 4.4 1.4 1.5 10.5 0.6 2.4 3.3 0.8 13.8 9.8 4.0 3.9 2.0 1.3 11.4 4.6 2.6 7.3 8.7 15.6 6.4 10.9 5.4 1.8 10.2 12.1 4.8 8.2 8.7 6.9 23.7 6.7 2.1 1.9 8.3 8.2 1.2 3.1 4.8 4.2 3.1 8.3 6.9 1.9 16.7 9.4 3.8 5.9 10.4 8.9 13.2 8.5 6.8 16.3 8.3 5.9 13.6 10.4 5.9 13.6 2.3 2.9 4.6 13.1 5.3 6.1 6.3 14.3 15.4 2.6 4.2 5.2 10.5 0.6 1.4 1.5 0.3 3.3 1.4 1.7 1.6 0.9 1.2 2.1 2.6 0.9 2.4 0.3 1.5 2.4 0.8 6.9 8.4 12.7 10.9 6.1 4.7 7.7 4.7 5.7 6.0 LONP1 "hLON, LonHS, PIM1, PRSS15" ENSG00000196365 "Lon peptidase 1, mitochondrial" P36776 19 5691834-5720572 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA-binding, Hydrolase, Protease, Serine protease" "Cataract, Deafness, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 78.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002034, HPA002192" Supported Enhanced Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA002034: AB_2756304, HPA002192: AB_1079695" "unprognostic (6.52e-2)" "unprognostic (1.12e-1)" "unprognostic (2.43e-1)" "unprognostic (2.43e-2)" "unprognostic (2.84e-1)" "unprognostic (2.38e-1)" "unprognostic (1.66e-3)" "unprognostic (5.56e-2)" "unprognostic (2.71e-1)" "unprognostic (7.57e-2)" "unprognostic (4.04e-2)" "unprognostic (1.26e-1)" "unprognostic (1.76e-2)" "unprognostic (1.09e-2)" "unprognostic (1.24e-1)" "unprognostic (1.11e-1)" "unprognostic (2.11e-1)" 15.8 78.3 16.4 12.8 19.8 12.5 13.9 16.1 22.8 11.3 13.6 15.8 13.3 13.7 10.5 13.8 12.7 12.7 15.7 27.3 15.4 15.3 19.9 49.6 10.3 14.5 17.7 14.9 15.5 17.7 17.6 16.8 16.6 16.2 11.7 8.5 12.7 18.5 14.7 38.0 14.7 13.9 11.5 12.7 15.5 13.5 9.8 13.3 13.8 21.2 15.3 11.8 14.7 12.5 6.7 6.5 6.0 6.2 4.0 7.2 3.0 23.0 23.9 7.9 25.3 9.4 6.7 24.7 14.7 11.7 15.9 19.5 20.4 8.3 29.0 20.6 15.4 9.8 20.4 17.8 7.7 17.1 16.8 16.0 20.9 26.7 43.7 36.4 16.8 12.6 25.6 15.1 29.9 12.7 42.3 57.8 7.3 15.3 18.0 21.7 28.3 31.6 19.0 11.4 31.2 8.8 13.7 21.1 21.1 12.9 18.9 51.6 11.1 45.7 9.0 8.1 8.9 22.5 21.4 60.9 37.5 25.7 36.5 39.9 14.6 6.0 4.1 0.8 6.4 6.2 4.1 6.0 5.6 6.1 4.3 6.7 7.2 4.8 0.5 4.0 2.4 6.5 4.0 3.0 16.4 19.8 16.1 22.8 15.4 15.3 17.7 14.9 16.2 13.3 LRPPRC "GP130, LRP130, LSFC" ENSG00000138095 "Leucine rich pentatricopeptide repeat containing" P42704 2 43886508-43996005 "Disease related genes, Predicted intracellular proteins" "mRNA transport, Transcription, Transcription regulation, Transport" "DNA-binding, RNA-binding" "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033786, HPA036408, HPA036409" Enhanced Enhanced Mitochondria 16000 Mitochondria "CAB033786: AB_2137450, HPA036408: AB_10670438, HPA036409: AB_2675108" "unprognostic (1.49e-1)" "unprognostic (1.30e-1)" "unprognostic (1.61e-3)" "prognostic unfavourable (1.72e-5)" "unprognostic (1.68e-1)" "unprognostic (8.34e-3)" "prognostic unfavourable (2.31e-7)" "unprognostic (1.02e-1)" "unprognostic (1.25e-1)" "unprognostic (1.11e-1)" "unprognostic (2.44e-3)" "unprognostic (7.68e-2)" "prognostic favourable (6.65e-6)" "unprognostic (9.07e-2)" "unprognostic (1.92e-1)" "unprognostic (1.12e-1)" "unprognostic (5.00e-2)" 20.6 25.5 20.2 27.7 24.8 26.7 37.2 34.3 51.8 16.4 31.7 15.1 15.9 21.8 21.5 19.2 22.5 18.6 15.2 36.6 24.3 21.9 41.7 31.6 26.3 38.0 21.9 22.9 23.6 28.0 33.3 19.7 17.6 29.2 18.9 32.5 13.6 17.8 22.8 63.2 22.4 19.1 32.6 17.9 18.0 20.7 20.7 16.0 25.4 20.5 30.5 19.9 20.4 17.8 15.8 15.5 5.5 11.7 13.2 18.1 12.4 30.1 24.7 15.6 19.8 15.4 20.5 26.8 20.1 14.6 21.9 17.0 39.6 16.0 43.3 19.4 12.4 25.6 29.1 21.5 29.4 26.1 18.4 39.2 19.5 52.4 22.7 56.3 17.8 20.3 18.9 20.3 32.9 17.6 57.7 17.6 19.3 16.7 29.5 65.2 26.0 17.6 33.1 34.9 35.2 24.0 27.7 27.6 26.8 22.7 30.5 36.5 22.4 34.2 15.1 15.8 21.7 16.7 21.4 17.9 20.2 37.8 15.2 35.0 13.6 5.5 10.7 1.8 9.5 10.8 18.0 15.2 12.8 12.6 15.5 15.8 18.1 15.4 0.8 13.2 11.7 6.2 10.5 12.4 20.2 24.8 34.3 51.8 24.3 21.9 21.9 22.9 29.2 16.0 MALSU1 "C7orf30, mtRsfA" ENSG00000156928 "Mitochondrial assembly of ribosomal large subunit 1" Q96EH3 7 23298739-23311729 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "AN3-CA: 27.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020487, HPA052210" Approved Enhanced Mitochondria "Intracellular and membrane" Mitochondria "HPA020487: AB_1845757, HPA052210: " "unprognostic (3.62e-1)" "unprognostic (3.68e-1)" "unprognostic (1.43e-1)" "unprognostic (4.66e-3)" "unprognostic (5.24e-3)" "prognostic unfavourable (9.71e-4)" "unprognostic (1.08e-1)" "unprognostic (1.51e-2)" "unprognostic (9.79e-2)" "unprognostic (1.83e-3)" "unprognostic (3.15e-2)" "unprognostic (7.15e-2)" "unprognostic (2.37e-2)" "unprognostic (1.25e-1)" "unprognostic (1.43e-2)" "unprognostic (4.51e-2)" "unprognostic (1.68e-1)" 7.9 11.3 9.5 6.9 9.4 7.6 11.0 8.6 11.1 7.9 8.4 8.3 5.8 5.1 9.2 10.2 12.3 10.1 7.6 29.8 8.8 9.1 12.5 21.2 8.2 10.2 8.9 7.2 10.3 10.1 8.0 7.8 12.6 12.7 7.9 7.8 17.2 10.6 10.3 20.1 6.7 7.0 8.9 8.1 6.9 7.5 13.7 5.6 8.5 14.8 14.9 8.0 9.2 7.5 6.1 4.8 3.5 5.4 4.2 7.3 5.1 5.0 6.3 4.6 27.2 4.6 3.2 4.7 3.9 2.8 3.6 3.3 10.6 4.2 5.1 4.2 2.4 5.2 4.5 2.4 4.4 2.5 8.2 3.0 8.6 16.3 3.0 6.6 1.8 2.7 3.8 3.0 3.4 3.3 9.0 1.3 4.5 3.5 4.6 20.8 8.5 17.0 3.9 3.9 6.7 3.5 4.5 4.2 5.1 3.2 5.1 8.0 2.6 3.9 5.7 2.9 2.6 5.5 6.8 2.0 5.0 8.8 11.0 8.2 9.0 3.4 5.4 3.5 4.4 4.0 5.0 6.1 6.1 4.9 4.7 5.7 7.3 4.9 3.4 4.2 3.3 4.8 5.7 5.1 9.5 9.4 8.6 11.1 8.8 9.1 8.9 7.2 12.7 5.6 MAOA ENSG00000189221 "Monoamine oxidase A" P21397 X 43654907-43746824 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" "Catecholamine metabolism, Neurotransmitter degradation" Oxidoreductase "Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 39.5;HHSteC: 74.2;HSkMC: 18.6;hTCEpi: 20.9;RT4: 30.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.0;MAIT T-cell: 1.3" "Group enriched" "Detected in many" 10 "monocytes: 1.0;T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009437, HPA054807, HPA059299" Enhanced Enhanced Mitochondria,Cytosol Mitochondria Cytosol "CAB009437: AB_2137260, HPA054807: , HPA059299: " "unprognostic (9.54e-3)" "unprognostic (1.63e-1)" "unprognostic (7.99e-2)" "unprognostic (3.07e-1)" "unprognostic (6.75e-2)" "unprognostic (3.32e-1)" "unprognostic (9.51e-2)" "unprognostic (6.89e-3)" "unprognostic (2.21e-1)" "unprognostic (4.29e-2)" "unprognostic (3.94e-1)" "unprognostic (3.54e-1)" "unprognostic (1.45e-3)" "unprognostic (1.16e-2)" "unprognostic (1.47e-1)" "unprognostic (4.04e-2)" "unprognostic (2.98e-3)" 72.3 11.0 8.2 10.2 7.8 0.3 35.2 3.3 6.1 12.4 85.7 2.8 10.7 53.6 12.5 6.2 36.6 12.0 14.7 37.8 6.7 8.3 77.8 45.9 34.4 5.2 11.1 6.1 14.2 24.4 9.6 1.5 79.8 8.7 26.2 39.9 6.2 49.1 12.9 12.5 11.2 90.1 23.6 3.4 2.1 19.3 5.5 4.7 0.0 68.6 9.7 3.9 35.3 35.1 0.0 0.0 0.1 1.0 0.0 1.3 0.1 0.0 0.8 0.1 2.3 39.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.0 1.4 5.3 0.0 0.0 0.5 1.6 0.1 4.2 74.2 0.0 4.0 18.6 20.9 0.0 10.9 4.7 0.0 0.1 1.3 0.6 0.0 0.1 0.3 1.2 0.0 0.0 0.1 5.3 30.6 0.7 1.8 0.0 0.0 0.0 0.1 0.0 2.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.3 0.0 0.1 0.3 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.1 8.2 7.8 3.3 6.1 6.7 8.3 11.1 6.1 8.7 4.7 MAVS "Cardif, IPS-1, KIAA1271, VISA" ENSG00000088888 "Mitochondrial antiviral signaling protein" Q7Z434 20 3846799-3876123 "Predicted membrane proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009187, HPA049850, HPA053524" Enhanced Enhanced Mitochondria 230000 Mitochondria "CAB009187: , HPA049850: AB_2680912, HPA053524: AB_2682177" "unprognostic (1.30e-2)" "unprognostic (4.51e-2)" "unprognostic (2.17e-1)" "unprognostic (6.67e-2)" "unprognostic (1.42e-1)" "unprognostic (1.75e-1)" "unprognostic (1.18e-3)" "unprognostic (2.23e-2)" "unprognostic (2.30e-2)" "unprognostic (5.95e-2)" "prognostic favourable (3.81e-4)" "unprognostic (1.92e-1)" "prognostic favourable (4.13e-5)" "unprognostic (4.97e-2)" "unprognostic (3.03e-1)" "unprognostic (3.12e-2)" "unprognostic (7.39e-2)" 15.9 13.9 13.0 15.5 17.7 10.8 25.5 17.7 15.7 12.3 18.5 17.2 15.1 17.2 14.9 10.6 17.3 13.8 12.2 15.4 12.3 8.0 13.3 13.9 18.1 17.4 19.9 9.0 18.9 22.5 23.4 13.7 12.0 13.8 13.1 18.6 13.6 15.3 22.4 39.4 22.1 17.0 17.1 13.7 12.7 15.8 5.9 17.1 15.1 14.6 14.0 14.3 18.2 21.6 5.1 5.6 6.4 6.9 5.9 4.8 4.6 17.2 20.1 8.2 10.2 22.6 15.5 6.4 10.5 13.4 11.2 8.2 15.7 11.2 7.5 6.4 14.7 21.8 9.8 15.7 11.5 4.6 4.7 14.4 7.4 24.9 12.5 9.0 6.1 15.6 13.4 18.9 11.3 11.3 16.2 5.8 10.9 15.6 13.6 7.7 5.2 11.1 10.3 11.4 7.5 11.9 17.4 6.2 6.4 11.9 23.3 10.0 12.4 8.4 17.0 15.3 5.7 18.0 12.1 11.9 14.2 5.3 6.1 11.1 7.7 4.4 6.9 6.1 4.8 5.1 3.6 3.8 3.8 3.7 4.4 5.1 4.4 4.4 6.4 5.9 5.5 5.6 3.0 4.6 13.0 17.7 17.7 15.7 12.3 8.0 19.9 9.0 13.8 17.1 MCCC2 MCCB ENSG00000131844 "Methylcrotonoyl-CoA carboxylase 2" Q9HCC0 5 71587288-71658704 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Ligase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 74.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038300, HPA038301, HPA061546" Enhanced Enhanced Mitochondria Mitochondria "HPA038300: AB_2675941, HPA038301: AB_10670661, HPA061546: AB_2684557" "unprognostic (2.39e-1)" "unprognostic (6.89e-3)" "prognostic favourable (3.62e-4)" "unprognostic (1.79e-2)" "unprognostic (1.89e-2)" "unprognostic (8.07e-2)" "prognostic favourable (1.70e-4)" "unprognostic (1.01e-1)" "unprognostic (3.37e-1)" "unprognostic (5.39e-2)" "unprognostic (2.90e-1)" "unprognostic (2.38e-1)" "prognostic favourable (6.43e-8)" "unprognostic (1.27e-1)" "unprognostic (1.29e-1)" "unprognostic (5.15e-2)" "unprognostic (3.47e-2)" 12.4 29.4 9.2 11.8 13.6 2.7 30.5 7.9 10.0 11.2 15.3 12.2 15.1 13.0 9.7 20.0 14.5 9.1 12.3 74.3 7.6 8.1 35.6 61.9 8.4 11.6 7.8 8.0 9.6 18.9 14.1 10.3 15.1 13.4 24.6 18.1 12.8 20.6 29.4 17.6 10.8 14.1 7.8 17.0 11.0 13.6 6.9 6.9 9.4 22.2 13.3 14.3 15.7 8.5 8.8 16.7 1.7 11.5 12.9 10.2 6.7 11.8 16.3 7.0 26.9 7.5 7.8 12.0 5.6 9.5 11.7 8.5 28.7 15.1 27.5 20.9 8.2 9.8 12.2 18.9 14.7 14.5 15.6 14.9 8.5 31.5 13.2 7.4 14.2 9.9 9.9 10.7 8.5 10.3 18.8 10.3 8.1 32.3 0.1 13.5 9.2 9.2 14.4 20.2 40.4 30.4 21.4 11.1 12.3 24.7 36.7 12.0 30.4 18.8 7.5 4.8 7.4 8.6 15.2 7.4 13.7 17.0 7.8 20.6 11.8 1.7 7.4 1.6 6.1 11.5 7.9 8.8 7.9 6.9 16.7 8.6 8.0 8.7 1.2 12.9 6.8 7.4 10.2 6.7 9.2 13.6 7.9 10.0 7.6 8.1 7.8 8.0 13.4 6.9 MCL1 "BCL2L3, Mcl-1" ENSG00000143384 "MCL1, BCL2 family apoptosis regulator" Q07820 1 150574551-150579738 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 12 "U-698: 328.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 42.1" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002781, HPA008455, HPA031125, CAB068195" Approved Enhanced Mitochondria Mitochondria "CAB002781: , CAB068195: , HPA008455: AB_1079334, HPA031125: AB_10602026" "unprognostic (3.82e-2)" "unprognostic (8.79e-2)" "unprognostic (9.15e-2)" "unprognostic (2.05e-2)" "unprognostic (1.34e-1)" "unprognostic (3.91e-2)" "unprognostic (3.16e-2)" "unprognostic (2.43e-2)" "unprognostic (1.29e-1)" "unprognostic (8.60e-2)" "unprognostic (1.57e-2)" "unprognostic (1.65e-2)" "prognostic unfavourable (7.16e-4)" "unprognostic (3.22e-2)" "unprognostic (1.94e-1)" "unprognostic (4.87e-2)" "unprognostic (4.46e-2)" 67.7 37.1 19.0 59.3 21.6 134.5 46.3 15.3 18.9 35.9 38.5 19.0 23.9 21.2 36.1 27.6 56.5 57.2 73.3 32.5 20.4 14.9 30.5 76.7 61.8 52.4 28.2 11.4 32.1 41.9 20.3 27.7 59.4 26.7 34.0 30.7 31.0 36.0 24.5 39.8 45.7 50.2 38.9 26.4 51.1 44.3 19.8 23.0 32.3 45.4 53.3 57.4 40.6 59.4 5.0 6.2 42.1 8.0 3.8 11.1 3.9 9.8 5.0 9.4 5.6 19.1 20.2 12.9 12.1 12.4 12.7 10.3 6.3 8.1 12.5 7.1 8.6 13.2 7.1 14.4 12.8 10.3 4.9 5.1 8.1 7.2 15.1 8.6 11.6 11.0 16.6 12.4 24.2 13.9 11.4 18.2 16.6 10.8 4.2 6.6 17.4 8.9 6.5 7.6 6.5 14.0 7.1 7.3 9.9 8.6 11.7 15.5 7.4 13.3 17.1 8.1 8.5 5.1 15.1 23.3 27.3 328.0 13.9 6.8 10.6 7.6 8.0 18.8 6.1 6.5 7.2 5.0 8.0 6.7 6.2 4.6 9.6 7.2 42.1 3.8 5.8 3.7 11.1 3.9 19.0 21.6 15.3 18.9 20.4 14.9 28.2 11.4 26.7 23.0 MDH2 ENSG00000146701 "Malate dehydrogenase 2" P40926 7 76048051-76067508 "Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" Oxidoreductase "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 175.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019714, HPA019716, HPA019848, HPA026720" Enhanced Enhanced Mitochondria 47000000 Mitochondria "HPA019714: AB_1853678, HPA019716: AB_1853680, HPA019848: AB_1853683, HPA026720: AB_1853685" "unprognostic (3.20e-2)" "unprognostic (2.85e-1)" "unprognostic (1.11e-1)" "unprognostic (1.43e-2)" "unprognostic (5.55e-3)" "unprognostic (8.94e-2)" "unprognostic (6.45e-2)" "unprognostic (3.77e-2)" "unprognostic (3.60e-1)" "unprognostic (2.02e-2)" "unprognostic (1.40e-1)" "unprognostic (9.70e-2)" "prognostic favourable (1.49e-5)" "unprognostic (8.57e-2)" "unprognostic (9.64e-2)" "unprognostic (5.68e-2)" "unprognostic (2.66e-1)" 18.1 39.1 17.4 15.4 20.6 18.3 22.2 15.3 34.4 14.9 27.0 13.5 16.9 32.5 16.6 13.5 31.8 19.4 17.6 103.1 17.1 18.8 29.1 101.9 13.8 26.6 17.4 21.9 17.3 35.5 16.8 16.9 17.5 20.5 17.9 24.3 15.0 26.8 21.5 175.8 24.6 26.7 21.9 12.8 21.1 22.3 17.6 9.5 22.4 20.1 76.2 23.8 19.9 17.8 37.1 52.8 22.1 45.3 30.1 45.6 44.7 28.6 47.0 17.0 42.6 19.5 21.4 29.3 19.3 24.9 27.6 25.0 41.3 34.5 43.4 8.7 25.4 29.3 43.7 28.8 19.8 30.9 63.2 24.1 25.3 38.1 24.0 37.4 24.9 27.0 25.7 26.8 40.1 25.7 75.8 25.4 25.5 64.9 32.4 66.1 37.9 59.3 26.5 21.0 62.4 25.8 37.9 42.7 38.9 19.3 96.8 39.7 55.0 42.3 19.8 27.8 26.3 30.0 38.3 28.5 23.5 48.0 24.1 48.0 42.1 22.1 38.9 18.2 32.7 43.5 34.2 37.1 36.9 35.3 52.8 32.1 36.0 33.1 10.2 30.1 45.3 47.1 45.6 44.7 17.4 20.6 15.3 34.4 17.1 18.8 17.4 21.9 20.5 9.5 MIPEP MIP ENSG00000027001 "Mitochondrial intermediate peptidase" Q99797 13 23730189-23889419 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030676, HPA031669, HPA031670" Approved Enhanced Mitochondria Mitochondria "HPA030676: AB_10598907, HPA031669: AB_10600986, HPA031670: AB_10602198" "unprognostic (2.05e-1)" "unprognostic (3.17e-2)" "unprognostic (3.75e-3)" "unprognostic (3.72e-2)" "unprognostic (1.24e-1)" "unprognostic (1.23e-1)" "unprognostic (2.41e-1)" "unprognostic (2.21e-1)" "unprognostic (4.69e-2)" "unprognostic (1.12e-1)" "unprognostic (7.54e-2)" "unprognostic (4.76e-1)" "prognostic favourable (7.66e-12)" "unprognostic (1.62e-2)" "unprognostic (4.95e-2)" "unprognostic (2.79e-1)" "unprognostic (6.90e-3)" 7.3 14.9 6.2 7.1 12.2 4.4 11.0 4.7 10.3 8.1 12.2 12.9 12.1 8.4 9.6 20.4 14.4 17.1 11.7 16.9 8.8 5.3 24.7 12.0 8.2 8.4 5.1 8.0 8.5 14.7 8.1 15.4 5.3 9.1 10.9 13.1 9.1 12.9 10.1 16.2 22.0 8.9 11.5 4.4 6.5 9.8 13.9 4.9 8.9 10.9 15.7 11.1 11.2 8.6 9.2 6.5 1.2 10.6 9.7 10.0 3.9 8.9 10.1 5.0 11.7 11.5 15.5 10.7 6.5 10.1 9.8 8.2 13.4 17.8 10.5 6.6 5.2 22.6 11.5 13.6 12.2 6.1 7.3 4.6 4.8 11.5 9.4 10.7 2.5 7.6 17.1 10.1 9.0 12.2 8.8 1.7 15.2 6.6 7.6 6.0 6.9 10.2 8.5 13.5 9.1 21.8 6.0 11.8 3.9 6.9 11.4 13.6 11.7 6.0 6.7 6.0 5.0 9.8 6.9 1.7 2.4 5.6 10.3 5.5 7.4 0.0 3.0 1.2 7.9 3.7 10.0 9.2 7.7 7.1 6.5 7.7 7.4 7.3 0.0 9.7 10.6 5.6 5.1 3.9 6.2 12.2 4.7 10.3 8.8 5.3 5.1 8.0 9.1 4.9 MPC1 "BRP44L, CGI-129, dJ68L15.3, SLC54A1" ENSG00000060762 "Mitochondrial pyruvate carrier 1" Q9Y5U8 6 166364919-166383013 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 149.8;liver: 129.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045119, HPA055790" Enhanced Enhanced Mitochondria Mitochondria "HPA045119: AB_10960421, HPA055790: " "unprognostic (3.30e-2)" "prognostic favourable (1.45e-4)" "unprognostic (5.24e-3)" "unprognostic (1.68e-1)" "unprognostic (3.17e-2)" "unprognostic (2.85e-2)" "unprognostic (7.61e-2)" "prognostic favourable (1.29e-4)" "unprognostic (3.27e-1)" "unprognostic (1.19e-1)" "unprognostic (1.11e-3)" "unprognostic (5.64e-2)" "prognostic favourable (4.79e-11)" "unprognostic (4.13e-2)" "unprognostic (1.03e-1)" "unprognostic (7.48e-2)" "unprognostic (8.45e-2)" 13.1 9.4 27.1 7.2 28.5 10.9 12.2 12.3 21.6 12.4 21.1 26.1 8.3 18.8 8.4 10.5 16.0 8.3 9.5 149.8 27.6 21.5 56.1 129.7 10.0 8.7 39.2 18.3 10.5 14.9 12.4 9.4 5.4 23.8 10.3 19.9 11.5 23.0 10.5 63.3 9.2 16.9 11.0 43.3 9.2 19.7 5.0 25.8 9.0 18.6 43.9 9.9 10.6 8.1 12.2 26.5 32.2 43.7 13.9 24.5 17.1 6.5 1.9 8.1 28.1 23.8 13.7 12.1 7.6 12.3 11.9 11.6 10.0 4.6 13.8 13.7 11.7 6.3 12.2 9.5 8.4 9.3 20.9 6.8 10.1 33.1 9.9 26.4 9.0 10.9 13.5 9.7 7.0 9.6 23.8 22.0 7.3 10.4 18.3 48.9 4.2 9.3 10.1 13.6 34.5 22.1 5.2 25.6 22.8 8.7 38.2 8.7 9.0 39.6 6.6 6.9 7.2 24.4 7.7 15.1 10.3 11.5 6.3 32.6 11.0 18.6 23.0 32.2 16.4 35.3 15.4 12.2 19.4 17.6 26.5 9.2 18.2 17.4 20.4 13.9 43.7 15.7 24.5 17.1 27.1 28.5 12.3 21.6 27.6 21.5 39.2 18.3 23.8 25.8 MRPL10 "L10MT, MGC17973, MRP-L10, MRP-L8, MRPL8, RPML8" ENSG00000159111 "Mitochondrial ribosomal protein L10" Q7Z7H8 17 47823272-47831534 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021234, HPA029885" Enhanced Enhanced Mitochondria Mitochondria "HPA021234: AB_1854098, HPA029885: AB_2673233" "unprognostic (6.84e-3)" "unprognostic (1.03e-1)" "unprognostic (8.05e-2)" "unprognostic (9.09e-3)" "unprognostic (1.97e-1)" "unprognostic (4.01e-3)" "prognostic unfavourable (6.67e-4)" "unprognostic (5.21e-2)" "unprognostic (1.03e-1)" "unprognostic (8.91e-2)" "unprognostic (1.38e-1)" "unprognostic (6.16e-2)" "unprognostic (1.29e-1)" "unprognostic (2.82e-1)" "unprognostic (1.87e-2)" "unprognostic (1.60e-1)" "unprognostic (6.87e-2)" 20.8 23.2 18.3 23.8 25.2 17.7 34.3 22.2 25.9 19.2 24.7 11.5 24.4 21.2 22.8 26.5 20.3 25.6 28.7 44.0 18.9 18.1 21.6 26.0 29.6 39.6 18.0 19.4 42.9 34.7 17.8 12.3 19.3 16.9 17.6 19.6 16.5 18.2 27.5 43.2 15.5 17.6 37.9 21.4 19.6 23.8 18.6 13.2 19.2 20.4 26.6 21.2 26.0 19.6 17.7 20.4 11.2 18.3 11.6 31.6 17.7 12.6 27.9 11.8 11.9 28.2 26.0 22.0 11.1 18.7 19.2 16.4 53.7 17.4 20.5 26.0 14.3 12.0 16.7 21.7 17.1 19.7 26.6 16.4 15.0 37.6 24.4 14.7 9.2 29.2 18.9 22.7 32.3 18.4 21.9 20.6 14.7 24.8 15.0 18.5 19.4 26.8 12.1 23.1 22.7 20.9 12.4 14.2 22.8 8.5 9.8 23.7 29.0 15.6 11.3 17.3 14.3 11.6 15.6 36.2 27.9 16.5 15.2 11.2 11.5 11.2 17.6 8.2 31.6 18.3 29.8 15.9 21.8 27.9 20.4 17.7 18.6 21.9 7.1 11.6 14.7 12.4 24.3 17.7 18.3 25.2 22.2 25.9 18.9 18.1 18.0 19.4 16.9 13.2 MRPL45 MGC11321 ENSG00000278845 "Mitochondrial ribosomal protein L45" 17 38297023-38323218 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 12.4;Daudi: 29.7;K-562: 18.0;REH: 14.5;U-266/84: 17.2;U-698: 21.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023373, HPA023385" Enhanced Enhanced Mitochondria Mitochondria "HPA023373: AB_1854114, HPA023385: AB_1854115" "unprognostic (8.56e-3)" "unprognostic (4.09e-2)" "unprognostic (1.11e-2)" "unprognostic (3.08e-1)" "unprognostic (9.50e-2)" "unprognostic (2.22e-3)" "unprognostic (1.11e-2)" "unprognostic (1.60e-1)" "unprognostic (7.21e-2)" "unprognostic (1.37e-2)" "unprognostic (3.65e-1)" "unprognostic (1.35e-1)" "unprognostic (6.01e-3)" "unprognostic (3.07e-1)" "unprognostic (1.00e-1)" "unprognostic (2.40e-1)" "unprognostic (8.13e-2)" 3.1 0.6 1.4 2.6 2.4 1.8 4.9 1.8 6.3 9.6 3.6 1.4 0.7 0.3 10.3 1.1 2.1 0.4 5.8 3.7 1.2 5.9 7.0 2.6 9.6 1.7 1.7 3.9 9.1 0.3 2.4 2.5 2.7 7.7 6.9 1.8 3.8 1.1 11.1 2.4 13.2 1.4 1.8 1.2 1.4 1.7 1.3 1.2 2.6 2.8 10.5 0.9 1.5 6.1 9.3 1.6 5.9 6.9 8.7 4.3 0.0 0.1 12.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.5 29.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.3 4.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 18.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 14.5 0.0 11.0 0.0 11.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 6.1 0.0 0.0 0.0 8.6 17.2 21.9 0.0 0.0 0.1 0.4 5.7 1.6 4.7 5.9 5.5 6.1 7.0 3.7 9.3 5.2 8.7 5.3 0.1 6.9 1.2 3.3 5.2 4.3 MRPS36 "DC47, MRP-S36" ENSG00000134056 "Mitochondrial ribosomal protein S36" P82909 5 69217760-69230129 "Predicted intracellular proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035802, HPA056795" Supported Enhanced Mitochondria Mitochondria "HPA035802: AB_10600933, HPA056795: " "unprognostic (1.19e-1)" "unprognostic (6.78e-3)" "unprognostic (4.08e-2)" "unprognostic (1.02e-1)" "unprognostic (1.92e-1)" "unprognostic (2.96e-3)" "unprognostic (1.99e-1)" "unprognostic (7.49e-2)" "unprognostic (1.49e-1)" "unprognostic (1.99e-2)" "unprognostic (1.38e-1)" "unprognostic (3.90e-1)" "prognostic favourable (5.02e-6)" "unprognostic (2.06e-1)" "unprognostic (2.49e-1)" "unprognostic (1.37e-2)" "unprognostic (4.84e-3)" 13.6 13.7 16.7 9.1 21.4 12.8 13.8 10.4 24.8 8.0 16.8 4.7 12.6 17.1 9.1 11.7 14.4 8.2 10.9 42.8 17.6 13.5 34.8 26.5 17.0 12.2 16.3 14.3 8.8 21.7 11.7 10.4 9.3 17.7 10.8 17.8 6.4 9.6 9.5 29.8 8.1 20.9 13.9 11.4 8.0 13.9 6.8 10.0 10.8 12.7 22.3 11.5 9.9 9.0 27.9 24.4 24.7 27.5 21.5 34.7 14.9 15.8 15.3 10.8 14.8 19.1 19.4 28.6 14.2 13.7 18.3 22.7 21.2 17.8 17.1 29.7 12.0 16.3 18.0 21.6 18.2 20.0 18.9 11.6 18.1 23.5 22.6 12.3 15.9 20.1 15.5 17.4 8.3 13.5 13.7 12.9 16.1 17.2 18.8 18.9 8.0 17.9 11.2 18.9 26.1 31.5 18.0 15.2 14.8 14.6 21.4 24.6 16.4 18.0 9.7 8.2 14.0 18.1 24.3 13.6 22.2 22.7 14.3 23.2 10.7 24.4 20.4 24.7 21.4 27.5 23.6 27.9 24.5 23.9 24.4 22.4 22.2 23.4 22.0 21.5 24.7 24.1 34.7 14.9 16.7 21.4 10.4 24.8 17.6 13.5 16.3 14.3 17.7 10.0 MRPS9 "MRP-S9, RPMS9, S9mt" ENSG00000135972 "Mitochondrial ribosomal protein S9" P82933 2 105037983-105099960 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043476, HPA048479" Supported Enhanced Mitochondria Mitochondria "HPA043476: AB_2678498, HPA048479: AB_2680412" "unprognostic (8.10e-3)" "unprognostic (4.75e-3)" "unprognostic (3.69e-1)" "unprognostic (3.80e-3)" "unprognostic (5.25e-1)" "unprognostic (1.39e-1)" "prognostic unfavourable (4.43e-4)" "unprognostic (1.88e-1)" "unprognostic (1.16e-2)" "unprognostic (1.77e-1)" "unprognostic (1.13e-1)" "unprognostic (3.78e-1)" "unprognostic (2.62e-3)" "unprognostic (4.62e-2)" "unprognostic (5.28e-2)" "unprognostic (1.20e-1)" "unprognostic (1.12e-1)" 13.9 25.0 14.1 16.9 18.5 13.3 15.4 13.2 20.6 13.7 18.9 15.9 14.3 19.0 17.6 13.2 16.7 16.2 8.9 39.1 14.4 15.3 24.5 23.5 10.0 14.5 18.1 15.7 21.0 17.3 22.0 23.9 8.4 25.2 15.8 22.0 10.9 15.3 16.4 56.8 14.0 17.0 16.6 15.0 14.0 17.4 20.6 16.6 20.7 15.6 28.7 16.8 15.2 12.4 22.1 20.4 7.1 17.2 20.0 22.8 14.5 22.0 9.5 20.1 18.5 10.6 11.0 23.6 14.2 13.6 22.5 20.3 50.8 15.5 23.0 14.1 11.1 20.0 39.4 20.6 24.0 14.2 25.9 22.7 14.1 30.6 17.7 16.8 10.2 13.1 14.0 18.5 15.5 17.2 32.4 12.1 15.3 17.7 22.6 22.1 31.8 21.0 28.9 17.3 32.0 28.2 15.5 17.5 10.5 16.4 24.1 19.1 19.8 17.1 11.2 13.3 26.9 13.2 15.2 11.1 13.1 18.4 11.5 25.8 11.1 7.1 11.6 4.6 19.9 14.6 22.0 22.1 22.0 20.9 20.4 16.5 22.3 21.9 1.3 20.0 17.2 15.2 22.8 14.5 14.1 18.5 13.2 20.6 14.4 15.3 18.1 15.7 25.2 16.6 MTFR1 "CHPPR, FAM54A2, KIAA0009" ENSG00000066855 "Mitochondrial fission regulator 1" Q15390 8 65644734-65771261 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 48.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023152, HPA056120" Uncertain Supported Mitochondria,Cytosol Mitochondria Cytosol "HPA023152: AB_1854176, HPA056120: " "prognostic unfavourable (4.06e-4)" "unprognostic (4.58e-2)" "unprognostic (4.01e-2)" "unprognostic (4.57e-2)" "unprognostic (6.56e-3)" "unprognostic (3.93e-2)" "unprognostic (1.66e-1)" "unprognostic (3.28e-2)" "unprognostic (1.50e-1)" "unprognostic (3.53e-1)" "unprognostic (5.69e-3)" "unprognostic (5.44e-2)" "unprognostic (6.63e-3)" "unprognostic (1.84e-1)" "unprognostic (1.26e-1)" "prognostic unfavourable (5.21e-4)" "unprognostic (8.25e-2)" 10.7 17.7 6.6 5.5 11.7 3.9 9.5 10.1 8.8 9.7 10.7 10.8 14.2 11.1 9.9 11.9 12.3 7.2 6.2 8.7 6.8 5.5 28.4 37.7 7.1 3.9 10.3 5.4 7.9 19.1 8.0 15.0 16.2 9.7 8.1 11.2 14.8 11.0 11.5 11.7 8.3 16.2 8.8 11.3 6.5 13.2 16.8 11.7 5.4 13.0 11.2 9.3 10.5 9.7 1.7 3.1 4.3 2.8 0.8 2.9 1.7 14.4 10.8 8.5 10.0 12.0 11.7 6.9 9.5 8.8 11.9 12.5 9.2 15.1 8.1 3.1 9.2 9.5 19.5 13.0 16.1 2.9 10.5 10.0 8.0 18.4 14.9 2.6 4.9 8.0 14.0 15.2 48.7 14.4 13.6 8.4 13.7 13.0 8.8 6.1 9.1 9.7 4.5 11.8 6.7 14.6 13.1 3.8 5.7 9.6 16.3 12.6 17.9 5.7 10.8 7.2 10.0 17.1 8.2 8.2 5.3 5.9 8.8 10.6 9.5 4.3 2.8 1.2 2.0 2.5 2.9 1.7 2.6 2.2 3.1 1.4 2.6 2.9 0.7 0.8 1.2 1.9 2.5 1.7 6.6 11.7 10.1 8.8 6.8 5.5 10.3 5.4 9.7 11.7 MTIF2 IF-2mt ENSG00000085760 "Mitochondrial translational initiation factor 2" P46199 2 55236595-55269347 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006021, HPA061422" Uncertain Enhanced Mitochondria Mitochondria "HPA006021: AB_2147687, HPA061422: " "unprognostic (2.91e-2)" "unprognostic (9.58e-2)" "unprognostic (1.52e-2)" "unprognostic (1.87e-3)" "unprognostic (8.86e-2)" "unprognostic (5.57e-2)" "unprognostic (9.76e-3)" "unprognostic (1.88e-1)" "unprognostic (6.85e-3)" "unprognostic (3.01e-2)" "unprognostic (6.58e-3)" "unprognostic (1.76e-1)" "unprognostic (3.98e-2)" "unprognostic (2.54e-2)" "unprognostic (1.66e-1)" "unprognostic (9.45e-3)" "unprognostic (1.33e-1)" 13.8 17.8 13.6 12.0 15.8 9.6 15.5 9.4 17.7 12.0 21.1 11.2 17.7 21.0 10.0 15.9 17.5 10.6 11.2 24.5 13.5 12.1 27.4 32.2 10.6 17.5 15.5 11.8 10.4 24.6 20.2 20.2 12.5 22.6 12.2 25.1 9.7 16.3 14.3 31.5 12.3 26.9 15.0 16.9 16.3 16.3 9.0 14.6 16.1 20.6 27.1 15.2 14.5 11.6 9.6 13.9 9.4 12.8 17.2 12.7 6.9 15.2 14.8 8.8 15.0 10.9 15.0 20.1 14.1 11.3 13.6 11.9 17.6 14.8 25.2 26.7 12.9 13.7 20.8 20.2 22.5 27.9 16.1 23.2 11.6 32.4 20.9 36.5 13.8 16.4 21.0 18.8 39.4 10.9 41.0 14.4 14.1 12.7 11.2 24.6 18.7 18.3 11.9 28.2 24.3 13.2 13.5 15.8 10.1 12.5 20.7 25.4 11.0 12.2 10.7 14.2 16.4 16.9 23.0 27.1 24.2 6.9 15.1 27.3 11.2 5.4 11.0 9.4 10.1 12.8 12.6 8.3 10.3 9.4 13.9 9.6 12.5 12.7 4.2 17.2 10.7 6.8 11.7 6.9 13.6 15.8 9.4 17.7 13.5 12.1 15.5 11.8 22.6 14.6 NDUFAF2 "B17.2L, mimitin, MMTN, NDUFA12L" ENSG00000164182 "NADH:ubiquinone oxidoreductase complex assembly factor 2" Q8N183 5 60945129-61153037 "Disease related genes, Predicted intracellular proteins" Chaperone "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048082, HPA054776" Supported Enhanced Mitochondria Mitochondria "HPA048082: AB_2680254, HPA054776: AB_2682598" "unprognostic (7.28e-2)" "unprognostic (6.83e-2)" "unprognostic (1.37e-1)" "unprognostic (2.46e-3)" "unprognostic (2.41e-2)" "unprognostic (2.74e-2)" "prognostic unfavourable (2.56e-4)" "unprognostic (1.06e-1)" "unprognostic (4.76e-2)" "unprognostic (8.40e-3)" "unprognostic (1.28e-1)" "unprognostic (2.71e-1)" "prognostic unfavourable (2.49e-4)" "unprognostic (1.79e-2)" "unprognostic (6.10e-2)" "unprognostic (2.37e-1)" "unprognostic (4.66e-2)" 25.5 25.9 22.5 16.7 24.9 11.4 27.1 13.6 24.4 16.9 20.5 11.7 8.2 16.0 16.3 12.2 19.3 12.6 15.0 33.6 19.9 21.2 19.1 27.2 11.9 13.4 20.5 14.2 23.5 41.2 14.2 25.3 9.8 18.5 19.0 18.2 13.2 16.0 16.8 56.3 12.9 13.3 23.9 18.3 10.0 17.2 20.1 12.6 4.9 17.7 16.0 12.3 26.9 19.5 15.9 20.9 1.5 13.1 17.3 20.3 9.1 31.0 16.4 11.3 36.5 22.1 31.3 21.4 36.4 19.4 23.1 28.4 27.3 22.5 39.1 37.7 24.7 12.9 19.4 31.8 28.7 20.7 27.8 13.5 29.3 25.5 33.3 19.5 8.0 16.9 34.4 21.0 63.9 20.6 22.2 20.9 24.1 24.6 17.3 28.8 9.4 39.0 19.1 31.2 53.0 22.0 13.4 23.9 10.7 22.7 19.7 35.3 23.5 13.8 19.1 16.7 25.4 35.8 40.2 15.3 22.0 43.0 22.1 35.1 19.3 0.0 13.1 1.5 12.5 11.9 14.3 15.9 15.9 14.6 20.9 11.0 13.9 14.3 0.6 17.3 9.1 7.5 20.3 9.1 22.5 24.9 13.6 24.4 19.9 21.2 20.5 14.2 18.5 12.6 NDUFB6 "B17, CI" ENSG00000165264 "NADH:ubiquinone oxidoreductase subunit B6" O95139 9 32552999-32573184 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044001, HPA053334" Supported Enhanced Mitochondria Mitochondria "HPA044001: AB_10959448, HPA053334: " "unprognostic (4.09e-1)" "prognostic favourable (3.18e-4)" "unprognostic (1.81e-2)" "unprognostic (1.53e-2)" "unprognostic (1.50e-1)" "unprognostic (1.49e-1)" "unprognostic (1.14e-1)" "unprognostic (6.10e-2)" "unprognostic (1.18e-1)" "unprognostic (1.35e-3)" "unprognostic (1.22e-1)" "unprognostic (1.49e-1)" "prognostic favourable (7.47e-10)" "unprognostic (2.70e-1)" "unprognostic (1.82e-1)" "unprognostic (1.26e-1)" "unprognostic (1.83e-1)" 21.9 26.8 33.9 17.7 31.8 16.0 18.7 22.6 28.3 13.7 21.9 15.5 17.3 26.5 16.8 17.4 18.6 15.4 15.9 58.6 27.6 27.9 32.8 36.6 13.9 15.4 28.4 27.2 14.1 19.5 15.4 17.8 15.5 22.9 15.1 18.2 14.6 22.7 16.1 87.2 14.6 25.5 16.4 25.9 13.5 20.0 28.9 17.1 19.2 22.2 34.4 14.5 14.1 13.5 26.0 38.8 77.4 27.3 22.2 27.5 26.5 29.8 18.4 20.5 23.4 13.9 13.0 13.1 20.0 16.4 18.5 20.5 18.0 13.5 22.3 20.9 13.8 17.0 19.3 22.1 14.0 30.6 30.9 53.0 28.2 18.5 13.6 26.4 13.7 13.4 10.8 16.7 12.7 16.7 16.9 25.2 20.7 17.3 35.5 62.4 21.6 40.9 24.5 17.2 20.6 20.7 11.3 20.6 23.3 23.2 26.7 13.5 25.2 20.5 14.8 20.3 30.7 22.3 29.4 11.2 21.0 36.2 33.9 18.6 9.5 25.0 25.8 33.3 21.0 23.1 20.2 26.0 22.4 21.6 27.6 21.8 23.0 24.3 77.4 22.2 27.3 38.8 27.5 26.5 33.9 31.8 22.6 28.3 27.6 27.9 28.4 27.2 22.9 17.1 NDUFV3 CI-10k ENSG00000160194 "NADH:ubiquinone oxidoreductase subunit V3" P56181 21 42879644-42913304 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 129.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019791, HPA020463, HPA030427, CAB034142" Enhanced Enhanced Mitochondria Mitochondria "CAB034142: AB_2298212, HPA019791: AB_1854357, HPA020463: AB_1854358, HPA030427: AB_10603024" "unprognostic (1.62e-1)" "unprognostic (2.17e-3)" "unprognostic (1.31e-1)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (1.11e-2)" "unprognostic (4.69e-1)" "unprognostic (2.97e-2)" "unprognostic (1.05e-1)" "unprognostic (3.13e-1)" "unprognostic (3.85e-3)" "unprognostic (1.54e-1)" "unprognostic (1.45e-1)" "unprognostic (6.56e-2)" "unprognostic (9.30e-3)" "unprognostic (2.14e-1)" "unprognostic (1.94e-1)" 18.1 14.1 16.9 11.1 17.2 15.8 14.6 11.8 23.2 12.0 15.9 11.9 14.6 15.2 15.1 15.7 15.6 12.7 15.4 54.9 14.2 11.0 15.1 24.3 10.8 12.5 14.0 18.6 16.0 17.7 13.2 13.1 11.6 19.2 13.6 11.4 12.2 19.4 21.8 129.5 15.4 13.5 16.9 16.0 13.3 14.3 20.3 13.3 6.6 11.6 18.5 10.6 13.3 11.8 9.9 22.9 16.0 22.8 10.5 8.8 10.3 9.6 11.3 11.0 18.0 13.6 11.8 13.6 19.2 11.0 11.4 9.6 20.7 11.9 10.7 15.2 7.1 10.5 12.8 16.9 7.5 6.1 15.4 35.2 13.3 16.2 21.3 12.0 18.5 13.3 14.7 11.6 18.4 14.4 27.9 13.9 13.1 18.9 8.0 18.2 14.3 22.4 13.8 8.0 33.4 15.4 12.8 8.0 8.4 19.2 22.8 12.7 19.5 15.9 16.9 10.8 7.5 13.8 13.6 20.8 13.7 12.1 14.1 21.6 16.2 3.7 21.4 16.0 8.0 22.8 8.1 8.1 7.6 6.7 22.9 9.9 8.8 7.7 3.8 10.5 19.6 11.3 8.8 10.3 16.9 17.2 11.8 23.2 14.2 11.0 14.0 18.6 19.2 13.3 NGRN DSC92 ENSG00000182768 "Neugrin, neurite outgrowth associated" Q9NPE2 15 90265659-90278141 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041367, HPA076267" Approved Supported "Nucleoplasm,Cytokinetic bridge,Mitochondria" "Intracellular and membrane" Mitochondria "Nucleoplasm, Cytokinetic bridge" "HPA041367: AB_10796668, HPA076267: " "unprognostic (2.82e-1)" "unprognostic (1.04e-2)" "unprognostic (1.66e-3)" "unprognostic (2.34e-1)" "unprognostic (2.21e-1)" "unprognostic (3.19e-2)" "unprognostic (2.94e-2)" "unprognostic (5.00e-2)" "unprognostic (7.78e-2)" "unprognostic (1.93e-2)" "unprognostic (5.22e-2)" "unprognostic (7.22e-2)" "unprognostic (3.31e-2)" "unprognostic (2.10e-1)" "unprognostic (2.05e-1)" "unprognostic (1.68e-3)" "unprognostic (3.21e-1)" 13.3 21.3 49.2 11.0 43.2 19.4 18.7 27.6 61.5 18.5 15.6 13.8 8.4 9.3 18.9 21.0 13.1 15.2 14.1 19.1 38.9 42.2 11.2 13.3 15.3 11.9 38.9 37.7 19.4 18.9 21.1 17.1 12.3 30.9 15.5 12.1 11.4 14.4 14.5 47.6 17.7 11.3 12.4 25.7 14.0 13.9 13.8 14.0 3.8 23.3 15.4 11.4 12.7 15.4 5.2 2.4 6.0 3.1 4.2 4.8 2.5 2.9 7.2 9.6 15.1 8.4 3.7 1.2 4.1 3.2 3.9 2.9 3.5 1.7 4.6 2.8 4.9 4.8 9.3 2.3 5.7 1.9 8.6 4.4 4.4 5.3 5.4 5.1 3.3 5.0 8.5 3.7 4.7 3.5 5.5 5.7 2.3 3.5 4.8 2.1 4.5 4.3 7.4 5.4 2.2 4.1 12.8 9.6 12.1 8.0 6.3 3.5 2.6 7.3 5.7 9.4 4.0 6.1 7.3 3.7 19.6 4.9 4.1 5.3 7.6 6.0 2.3 3.6 3.2 3.1 4.0 3.5 3.1 2.7 1.2 5.2 3.7 4.4 5.0 4.2 1.9 2.4 4.8 2.5 49.2 43.2 27.6 61.5 38.9 42.2 38.9 37.7 30.9 14.0 OCIAD2 MGC45416 ENSG00000145247 "OCIA domain containing 2" Q56VL3 4 48885019-48906937 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 56.5;U-251 MG: 67.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040979, HPA041090" Enhanced Enhanced Mitochondria Mitochondria "HPA040979: AB_10795497, HPA041090: AB_10796236" "unprognostic (4.29e-1)" "unprognostic (2.69e-1)" "unprognostic (3.76e-2)" "prognostic favourable (7.37e-4)" "unprognostic (3.49e-2)" "unprognostic (1.66e-2)" "unprognostic (9.05e-2)" "unprognostic (1.23e-1)" "unprognostic (2.00e-1)" "prognostic favourable (6.56e-4)" "prognostic unfavourable (6.89e-4)" "unprognostic (1.38e-1)" "prognostic favourable (2.67e-5)" "unprognostic (1.10e-1)" "unprognostic (8.54e-2)" "unprognostic (8.24e-3)" "prognostic favourable (2.34e-4)" 4.0 10.7 24.5 15.7 18.3 4.7 8.1 3.7 14.0 7.2 23.0 1.9 14.0 41.6 8.9 19.5 12.4 7.7 22.3 7.2 19.9 11.7 51.6 43.6 6.6 10.7 9.7 9.9 3.7 13.2 9.4 18.7 2.9 8.8 8.8 17.3 6.6 18.3 12.9 1.8 9.0 37.5 5.2 4.1 5.2 27.9 4.1 5.7 24.9 14.9 5.8 13.3 9.3 8.5 29.7 22.9 32.7 0.6 27.1 60.8 26.1 34.6 18.4 0.2 0.0 0.0 0.0 0.5 9.0 4.1 4.9 4.6 0.0 43.0 6.0 40.3 5.1 11.2 5.1 56.5 5.0 14.1 3.8 0.0 13.6 0.0 4.6 16.9 0.0 2.7 25.8 0.0 11.0 20.2 0.0 3.0 5.2 13.0 28.5 11.5 17.7 25.0 6.4 0.0 10.0 50.2 22.8 40.0 12.1 13.0 4.4 0.9 4.5 4.2 33.6 0.0 37.4 0.2 67.1 8.6 9.8 19.1 28.8 0.0 0.0 32.7 0.6 12.4 20.4 0.2 27.0 29.7 38.4 29.2 3.4 27.0 50.2 33.6 2.1 27.1 0.2 22.9 60.8 26.1 24.5 18.3 3.7 14.0 19.9 11.7 9.7 9.9 8.8 5.7 OGDH E1k ENSG00000105953 "Oxoglutarate dehydrogenase" Q02218 7 44606572-44709066 "Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Glycolysis Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 99.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019514, HPA020347" Supported Enhanced Mitochondria 53000 Mitochondria "HPA019514: AB_1854772, HPA020347: AB_1854773" "unprognostic (1.96e-2)" "unprognostic (1.40e-1)" "unprognostic (4.39e-1)" "unprognostic (5.64e-3)" "unprognostic (3.02e-3)" "unprognostic (1.20e-1)" "unprognostic (3.45e-1)" "unprognostic (7.58e-2)" "unprognostic (1.74e-1)" "unprognostic (1.52e-2)" "unprognostic (3.38e-1)" "unprognostic (3.30e-2)" "prognostic favourable (2.22e-14)" "unprognostic (1.53e-1)" "unprognostic (1.62e-1)" "unprognostic (2.23e-2)" "unprognostic (5.88e-3)" 18.9 20.8 12.3 14.5 18.5 8.7 11.0 14.3 23.7 10.1 19.4 15.9 13.5 29.0 16.2 11.1 19.5 11.1 11.8 73.9 11.3 12.8 28.8 14.8 13.0 11.1 14.2 11.7 9.8 13.0 25.5 11.0 14.5 22.2 12.3 13.3 22.3 23.7 15.9 99.3 15.6 35.5 16.4 10.1 12.1 14.9 11.3 11.0 11.3 17.8 39.8 15.8 13.0 10.8 7.2 13.4 7.5 20.4 11.2 25.7 11.6 10.8 22.8 13.7 20.8 21.2 23.3 13.4 17.0 16.6 19.4 16.9 20.8 22.5 47.8 20.2 24.7 33.8 27.0 25.4 18.9 27.9 7.1 14.5 46.2 10.2 10.8 17.9 16.3 21.6 19.3 27.4 19.7 26.2 16.7 14.3 20.4 15.3 17.7 10.3 12.6 25.8 17.0 9.6 53.7 22.2 32.4 23.4 11.2 24.6 34.1 10.6 20.2 18.0 20.6 14.0 12.6 24.2 19.6 13.0 24.9 26.4 25.3 20.3 25.3 4.8 12.1 7.3 11.7 17.7 12.8 7.2 13.5 11.7 13.4 5.9 5.8 7.0 7.5 11.2 20.4 6.6 25.7 11.6 12.3 18.5 14.3 23.7 11.3 12.8 14.2 11.7 22.2 11.0 OXCT1 "OXCT, SCOT" ENSG00000083720 "3-oxoacid CoA-transferase 1" P55809 5 41730065-41870519 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 108.8" "Cell line enhanced" "Detected in many" "HeLa: 56.1;SiHa: 72.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012047, HPA061425" Enhanced Enhanced Mitochondria "Intracellular and membrane" 1000000 Mitochondria "HPA012047: AB_1854857, HPA061425: AB_2684515" "unprognostic (4.26e-2)" "unprognostic (2.10e-2)" "unprognostic (2.89e-2)" "unprognostic (1.51e-1)" "unprognostic (5.51e-2)" "unprognostic (1.82e-2)" "prognostic unfavourable (1.03e-4)" "unprognostic (7.42e-3)" "unprognostic (1.74e-3)" "unprognostic (1.67e-1)" "unprognostic (2.80e-2)" "unprognostic (3.62e-1)" "prognostic favourable (1.86e-8)" "unprognostic (2.66e-2)" "unprognostic (9.99e-2)" "unprognostic (5.86e-3)" "unprognostic (2.28e-3)" 21.9 8.0 17.3 7.5 30.3 5.8 9.5 26.6 36.8 6.7 9.2 8.3 10.7 4.4 8.6 8.7 13.1 6.9 7.5 108.8 19.3 15.2 25.3 1.2 4.2 9.5 13.1 25.7 7.2 3.0 20.9 8.4 2.8 21.2 12.5 10.4 6.6 8.5 14.7 13.4 10.7 6.5 17.0 8.9 5.2 14.6 6.2 5.3 22.8 13.0 10.7 11.8 8.0 7.5 8.0 4.6 3.3 1.6 7.5 15.6 5.1 7.8 0.3 6.5 7.7 20.1 10.8 0.0 14.1 8.9 11.7 7.1 1.2 5.4 20.4 3.5 10.7 4.6 17.8 12.7 13.8 17.4 2.0 14.3 56.1 2.6 8.8 27.7 4.8 10.1 3.4 11.5 19.4 10.7 2.9 26.3 13.4 1.0 23.1 1.3 1.4 5.6 18.4 18.2 15.4 9.5 0.6 6.5 6.7 72.9 0.0 8.6 0.1 6.0 6.4 9.3 12.2 15.9 11.3 4.3 3.6 0.8 14.1 20.4 7.1 1.0 1.0 3.3 9.1 1.1 10.9 8.0 9.2 9.8 4.6 6.1 10.8 8.9 0.3 7.5 1.6 1.8 15.6 5.1 17.3 30.3 26.6 36.8 19.3 15.2 13.1 25.7 21.2 5.3 PC PCB ENSG00000173599 "Pyruvate carboxylase" P11498 11 66848233-66958376 "Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Gluconeogenesis, Lipid biosynthesis, Lipid metabolism" "Ligase, Multifunctional enzyme" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 41.1;liver: 76.0" "Cell line enhanced" "Detected in many" "HeLa: 27.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 2.6;monocytes: 3.8;T-cells: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033742, HPA043922, HPA058765" Enhanced Enhanced Mitochondria 96000 Mitochondria "CAB033742: AB_2283532, HPA043922: AB_2678732, HPA058765: AB_2683812" "unprognostic (2.10e-1)" "unprognostic (1.51e-1)" "unprognostic (1.36e-2)" "unprognostic (8.24e-3)" "unprognostic (3.67e-1)" "unprognostic (3.18e-2)" "unprognostic (2.97e-1)" "unprognostic (3.00e-1)" "unprognostic (3.63e-1)" "prognostic unfavourable (7.86e-5)" "unprognostic (1.54e-1)" "unprognostic (1.17e-1)" "prognostic favourable (8.22e-5)" "unprognostic (8.58e-3)" "unprognostic (5.67e-2)" "unprognostic (9.15e-3)" "unprognostic (1.05e-1)" 41.1 10.7 11.1 2.8 14.6 3.1 12.9 13.1 14.9 2.4 3.8 10.7 21.4 5.6 2.1 2.4 5.0 2.7 2.9 4.0 11.3 8.9 18.7 76.0 2.1 1.6 15.5 11.5 4.4 4.3 19.4 4.0 4.1 10.9 5.4 3.1 3.4 24.2 24.4 5.7 2.8 6.7 1.8 9.4 1.5 3.3 6.1 13.1 0.6 4.2 2.5 2.5 2.2 2.1 0.6 2.6 0.0 3.8 0.3 2.9 2.0 2.9 8.9 3.3 8.1 13.7 5.4 3.5 1.8 7.8 3.5 3.4 4.4 3.2 0.0 3.7 2.9 3.8 3.7 20.6 1.0 1.7 5.2 4.4 27.7 17.0 10.7 0.0 5.7 20.6 5.3 2.8 6.4 2.9 8.4 0.0 1.2 19.0 5.0 2.4 6.3 7.4 3.7 6.9 1.8 3.2 0.9 7.2 10.2 17.3 9.2 7.0 7.5 1.2 3.2 3.9 3.6 4.6 2.0 1.9 2.2 0.0 4.0 2.8 3.3 0.0 3.8 0.0 1.2 0.9 1.4 0.2 0.5 1.9 2.6 0.6 2.9 1.6 0.0 0.3 0.5 1.0 1.5 2.0 11.1 14.6 13.1 13.6 11.3 8.9 15.5 11.5 10.9 13.1 PCK2 "PEPCK, PEPCK2" ENSG00000100889 "Phosphoenolpyruvate carboxykinase 2, mitochondrial" Q16822 14 24094053-24110598 "Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Gluconeogenesis "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "intestine: 156.3;liver: 115.1" "Cell line enhanced" "Detected in many" "HHSteC: 34.9;hTCEpi: 33.9;SK-MEL-30: 32.1" "Cancer enhanced" "Detected in all" "liver cancer: 91.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018734, HPA051162, HPA053502" Enhanced Enhanced Mitochondria 3300000 Mitochondria "CAB018734: AB_2160168, HPA051162: AB_2681368, HPA053502: AB_2682171" "unprognostic (3.38e-2)" "unprognostic (1.13e-1)" "unprognostic (1.50e-2)" "unprognostic (4.07e-1)" "unprognostic (3.11e-1)" "unprognostic (2.10e-1)" "prognostic favourable (2.81e-4)" "unprognostic (3.91e-2)" "unprognostic (1.04e-1)" "unprognostic (2.18e-2)" "unprognostic (1.26e-1)" "unprognostic (3.67e-2)" "unprognostic (1.33e-2)" "unprognostic (2.81e-1)" "unprognostic (3.71e-1)" "unprognostic (2.82e-2)" "unprognostic (1.17e-1)" 8.2 2.5 1.0 4.9 1.9 1.0 4.3 1.3 1.3 1.3 69.7 1.4 6.9 51.8 1.3 8.5 4.5 1.2 4.2 2.6 1.5 1.0 26.4 115.1 6.0 4.4 1.7 1.2 1.8 8.5 3.4 1.7 1.2 1.8 2.0 5.4 1.9 11.5 4.9 1.0 2.7 156.3 1.1 1.7 6.7 3.3 3.9 1.3 1.3 5.8 1.9 4.6 2.8 1.9 8.8 10.8 2.4 15.1 1.5 6.5 3.9 5.4 3.1 0.9 5.8 3.6 3.7 14.8 6.8 8.2 5.7 9.3 5.1 6.3 13.9 0.8 10.5 8.0 6.0 8.8 4.7 7.1 0.2 2.5 1.7 27.2 34.9 4.8 11.0 4.3 33.9 3.6 8.8 4.6 7.1 25.8 2.2 23.7 1.2 2.4 1.0 4.1 2.8 3.4 7.9 1.7 8.5 3.7 5.9 5.2 6.8 32.1 9.1 7.5 0.8 1.2 6.6 1.8 1.9 17.7 5.5 3.4 3.5 7.7 3.0 0.1 8.2 2.4 3.1 15.1 3.4 8.8 3.5 3.5 10.8 6.1 2.2 2.0 1.0 1.5 14.4 1.9 6.5 3.9 1.0 1.9 1.3 1.3 1.5 1.0 1.7 1.2 1.8 1.3 PHB2 "Bap37, BCAP37, p22, REA" ENSG00000215021 "Prohibitin 2" Q99623 12 6965327-6970825 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB014889, CAB026335, HPA039874" Supported Enhanced Mitochondria 780000 Mitochondria "CAB014889: , CAB026335: AB_2283865, HPA039874: AB_2616448" "unprognostic (4.64e-3)" "unprognostic (4.32e-2)" "unprognostic (9.65e-2)" "prognostic unfavourable (3.80e-4)" "unprognostic (3.07e-3)" "unprognostic (1.67e-1)" "unprognostic (2.53e-1)" "unprognostic (1.62e-1)" "unprognostic (1.98e-1)" "unprognostic (7.18e-2)" "unprognostic (1.46e-1)" "unprognostic (2.85e-1)" "unprognostic (1.04e-1)" "unprognostic (5.65e-2)" "unprognostic (1.07e-1)" "unprognostic (8.17e-2)" "unprognostic (5.61e-2)" 36.2 46.2 20.0 41.5 21.3 33.5 37.1 21.6 29.7 42.7 48.6 19.8 42.8 40.0 46.3 36.2 55.6 37.7 29.1 44.3 17.9 17.2 36.0 72.8 24.0 64.9 18.8 18.8 68.9 92.3 28.0 22.1 27.4 17.2 48.6 39.5 25.8 62.7 29.1 72.9 39.5 46.3 56.0 17.5 36.6 37.5 20.5 19.0 57.2 50.4 77.4 45.7 46.4 39.9 36.4 47.6 20.9 35.9 38.1 41.6 34.4 36.5 35.3 29.6 40.1 24.0 42.0 66.2 25.9 33.4 45.9 36.4 55.7 38.5 76.1 11.4 25.0 29.9 54.1 45.7 37.2 42.2 45.2 40.0 22.9 52.3 40.4 64.4 29.4 43.3 31.2 29.0 63.4 45.0 35.6 17.5 32.3 36.3 59.1 58.9 113.3 31.5 41.5 47.6 47.3 36.7 41.1 15.3 53.0 20.9 59.7 66.9 9.4 51.6 27.1 19.8 32.4 15.6 54.6 17.6 21.3 78.3 26.7 33.6 28.1 20.9 30.0 14.6 30.8 35.9 37.3 36.4 35.3 35.8 47.6 34.8 32.0 31.8 12.4 38.1 30.4 44.4 41.6 34.4 20.0 21.3 21.6 29.7 17.9 17.2 18.8 18.8 17.2 19.0 PMPCA "Alpha-MPP, INPP5E, KIAA0123" ENSG00000165688 "Peptidase, mitochondrial processing alpha subunit" Q10713 9 136410570-136423761 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Disease mutation, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021648, HPA063735" Supported Enhanced Mitochondria 6500 Mitochondria "HPA021648: AB_1855491, HPA063735: AB_2685108" "unprognostic (9.80e-2)" "unprognostic (1.96e-2)" "unprognostic (4.03e-1)" "unprognostic (1.69e-2)" "unprognostic (4.01e-2)" "unprognostic (8.19e-2)" "unprognostic (6.09e-2)" "unprognostic (1.19e-2)" "unprognostic (1.97e-1)" "unprognostic (3.32e-2)" "prognostic favourable (8.00e-5)" "unprognostic (9.47e-3)" "prognostic favourable (2.14e-6)" "unprognostic (4.27e-3)" "unprognostic (1.57e-2)" "unprognostic (2.40e-1)" "unprognostic (3.54e-2)" 15.2 27.3 19.8 14.6 23.8 20.1 13.2 20.3 24.3 12.3 15.1 13.0 10.4 18.6 14.2 14.1 16.5 13.6 14.9 37.0 15.6 14.8 17.0 48.3 12.3 18.4 15.2 21.9 15.5 18.2 14.7 19.5 15.6 16.8 15.2 11.9 12.8 20.3 17.1 56.7 17.5 17.0 13.8 14.1 18.9 16.3 23.2 12.5 14.0 15.0 19.8 15.3 13.1 13.4 25.5 30.1 17.0 25.1 32.1 30.8 28.2 14.3 26.9 12.9 26.0 9.8 14.3 19.8 15.0 12.1 21.0 15.3 30.7 17.2 20.1 15.8 15.2 33.6 23.8 22.0 9.3 28.9 28.8 16.2 34.7 37.1 17.3 21.0 14.1 21.0 15.2 16.3 8.4 17.7 41.0 13.3 13.0 39.8 19.8 27.1 26.3 25.5 24.7 18.3 44.5 14.4 10.3 26.5 17.4 20.2 28.8 17.5 39.2 28.7 14.6 15.0 16.1 12.3 19.0 8.2 10.9 21.7 19.7 18.4 13.4 15.4 25.1 17.0 27.2 24.4 26.4 25.5 25.7 29.3 30.1 23.7 30.8 26.9 5.9 32.1 23.2 15.3 24.3 28.2 19.8 23.8 20.3 24.3 15.6 14.8 15.2 21.9 16.8 12.5 PMPCB "MPPB, MPPP52" ENSG00000105819 "Peptidase, mitochondrial processing beta subunit" O75439 7 103297422-103329511 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040674, HPA074168" Approved Enhanced Mitochondria 57000 Mitochondria "HPA040674: AB_10961998, HPA074168: " "prognostic favourable (2.79e-4)" "unprognostic (3.11e-1)" "unprognostic (7.18e-3)" "unprognostic (3.03e-1)" "unprognostic (3.65e-2)" "unprognostic (1.72e-1)" "unprognostic (1.06e-1)" "unprognostic (7.67e-2)" "unprognostic (7.74e-2)" "unprognostic (1.21e-1)" "unprognostic (1.38e-1)" "unprognostic (1.42e-3)" "prognostic favourable (2.95e-8)" "unprognostic (2.59e-2)" "unprognostic (9.79e-2)" "unprognostic (2.40e-1)" "unprognostic (4.39e-2)" 29.1 41.8 31.8 23.0 34.3 41.5 31.6 41.1 38.4 29.0 26.9 21.6 28.2 35.1 32.0 25.9 27.9 26.9 23.5 41.4 27.7 20.1 45.9 47.2 21.9 31.3 32.6 35.0 36.8 40.6 41.1 33.9 24.8 34.2 31.6 31.5 20.8 30.6 31.0 31.5 31.6 31.0 25.7 27.8 27.9 33.6 31.3 35.9 37.2 33.2 24.2 30.0 30.7 27.9 19.5 18.4 9.7 16.1 12.9 21.9 15.7 12.1 17.6 20.8 27.9 12.6 25.6 15.7 11.3 19.5 22.9 27.3 18.8 14.0 31.3 18.2 19.3 15.8 24.9 18.2 21.9 10.9 29.7 10.8 30.2 25.0 15.4 14.8 12.8 23.4 17.0 17.9 17.3 12.1 20.9 31.8 20.9 28.3 24.6 35.0 25.4 22.1 17.2 14.5 31.8 21.5 21.8 26.1 31.9 15.3 45.2 22.3 18.5 19.9 10.0 20.3 24.3 36.0 21.0 24.4 31.2 24.0 15.0 24.0 15.9 9.7 14.1 9.3 14.7 16.1 16.1 19.5 17.1 14.7 18.4 14.3 21.5 17.4 4.4 12.9 13.6 9.4 21.9 15.7 31.8 34.3 41.1 38.4 27.7 20.1 32.6 35.0 34.2 35.9 PNKD "BRP17, DKFZp564N1362, DYT8, FKSG19, FPD1, KIAA1184, KIPP1184, MGC31943, MR-1, PDC, PKND1, TAHCCP2" ENSG00000127838 "Paroxysmal nonkinesigenic dyskinesia" Q8N490 2 218270392-218346793 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010134, HPA017068" Approved Enhanced Mitochondria 31000 Mitochondria "HPA010134: AB_1079645, HPA017068: AB_1855495" "unprognostic (3.15e-3)" "unprognostic (1.80e-2)" "unprognostic (5.86e-3)" "unprognostic (1.89e-2)" "unprognostic (1.90e-1)" "unprognostic (1.60e-1)" "unprognostic (3.81e-2)" "unprognostic (1.54e-1)" "unprognostic (1.37e-1)" "unprognostic (7.51e-2)" "unprognostic (3.29e-1)" "unprognostic (7.67e-2)" "prognostic unfavourable (5.13e-5)" "unprognostic (7.98e-2)" "unprognostic (2.17e-1)" "unprognostic (9.61e-2)" "unprognostic (1.44e-3)" 21.8 28.3 33.2 15.9 41.0 13.4 16.4 26.6 51.1 29.8 27.5 14.3 28.9 18.1 14.6 37.0 13.3 28.3 30.4 37.3 31.0 26.5 42.4 107.0 23.4 34.2 33.2 23.6 18.1 18.8 22.3 15.6 28.1 26.8 34.8 25.1 15.9 27.3 27.1 33.8 12.9 15.9 16.6 25.7 18.0 29.5 23.3 20.6 11.6 29.7 15.3 16.3 19.0 13.4 64.0 32.7 44.9 35.4 38.4 43.3 38.9 15.2 20.0 14.7 23.0 22.1 18.7 27.1 9.6 20.8 22.8 25.7 32.8 15.1 17.9 19.3 16.0 15.8 28.2 18.0 16.1 37.1 35.2 26.0 36.6 48.4 24.2 16.8 11.6 25.4 17.8 15.6 4.5 24.6 19.1 23.3 20.2 43.7 21.8 40.1 14.6 20.5 21.5 14.8 14.9 26.2 23.2 14.2 12.0 6.9 46.9 27.3 15.6 16.3 15.2 9.5 16.3 11.2 13.0 9.7 9.9 19.2 24.2 27.7 11.4 33.7 35.4 44.9 32.1 34.1 30.4 64.0 35.1 38.3 32.7 52.0 38.8 37.3 9.8 38.4 31.0 30.4 43.3 38.9 33.2 41.0 26.6 51.1 31.0 26.5 33.2 23.6 26.8 20.6 PNPT1 "DFNB70, old-35, OLD35, PNPase" ENSG00000138035 "Polyribonucleotide nucleotidyltransferase 1" Q8TCS8 2 55634265-55693910 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, Transport" "Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, RNA-binding, Transferase" "Deafness, Disease mutation, Non-syndromic deafness, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033424, HPA034602, HPA034603" Supported Enhanced Mitochondria Mitochondria "CAB033424: AB_2299801, HPA034602: AB_2674243, HPA034603: AB_10603130" "unprognostic (9.09e-2)" "unprognostic (7.40e-2)" "unprognostic (2.30e-1)" "prognostic unfavourable (5.57e-4)" "unprognostic (3.40e-2)" "unprognostic (1.03e-2)" "prognostic unfavourable (1.95e-7)" "unprognostic (1.88e-1)" "unprognostic (5.93e-3)" "unprognostic (5.23e-2)" "prognostic unfavourable (5.44e-5)" "unprognostic (2.19e-2)" "unprognostic (2.11e-2)" "unprognostic (6.92e-2)" "unprognostic (1.94e-1)" "unprognostic (2.41e-1)" "unprognostic (1.21e-1)" 11.1 11.7 13.3 6.5 21.7 11.7 10.8 13.3 18.8 5.7 8.2 12.8 5.4 5.7 8.3 8.8 9.5 7.9 5.8 11.0 12.4 10.9 9.8 11.4 9.1 7.1 24.1 7.4 6.9 9.1 7.4 14.3 5.1 15.2 7.7 10.1 4.2 9.0 6.3 23.5 10.1 7.0 7.9 17.6 10.4 7.6 13.5 22.5 9.6 10.0 7.8 5.9 5.3 7.4 9.8 7.4 6.1 6.5 3.8 8.6 4.7 6.7 3.6 5.0 2.3 3.6 6.3 6.7 10.0 6.1 15.9 10.7 10.5 3.2 14.1 4.2 4.7 5.4 6.4 7.8 7.4 5.0 14.2 8.1 4.6 5.3 9.5 18.3 5.5 7.0 5.4 6.6 5.7 4.9 8.5 3.2 6.3 3.8 11.2 12.8 12.1 6.1 11.1 8.4 12.4 6.7 4.2 12.2 7.3 3.6 11.1 12.2 3.0 8.1 5.1 3.8 3.2 3.3 10.2 14.3 1.1 3.0 7.2 16.0 6.4 4.2 6.5 6.1 8.1 5.7 4.8 5.4 3.7 8.6 2.8 9.8 6.9 7.9 6.1 3.8 5.1 7.4 2.4 4.7 13.3 21.7 13.3 18.8 12.4 10.9 24.1 7.4 15.2 22.5 PPCS FLJ11838 ENSG00000127125 "Phosphopantothenoylcysteine synthetase" Q9HAB8 1 42456117-42473385 "Enzymes, Predicted intracellular proteins" Ligase "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031361, HPA031363" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" 16000 "Nucleoli fibrillar center, Mitochondria" Nucleoplasm "HPA031361: AB_10602150, HPA031363: AB_2673844" "unprognostic (1.49e-1)" "unprognostic (6.71e-2)" "unprognostic (8.15e-2)" "unprognostic (1.55e-1)" "unprognostic (3.84e-3)" "unprognostic (1.68e-2)" "prognostic unfavourable (5.96e-5)" "unprognostic (2.71e-1)" "unprognostic (7.79e-3)" "unprognostic (9.13e-3)" "unprognostic (3.24e-2)" "unprognostic (2.44e-1)" "unprognostic (2.41e-2)" "unprognostic (6.45e-2)" "unprognostic (2.32e-1)" "unprognostic (2.80e-1)" "unprognostic (4.30e-2)" 23.4 36.3 18.9 20.5 21.9 10.7 30.7 12.0 26.0 23.2 32.0 12.4 27.3 25.5 18.2 34.4 31.6 14.5 30.9 22.1 17.8 16.4 41.4 43.9 26.5 28.1 19.3 14.9 19.6 47.0 22.8 16.1 37.6 17.2 27.2 27.3 19.6 36.6 35.0 19.6 21.9 41.0 27.6 18.9 24.4 27.2 13.5 13.4 22.6 31.3 26.0 20.5 24.0 19.4 41.9 44.4 76.1 55.7 42.0 41.0 52.0 22.5 9.4 5.5 8.5 17.1 17.8 20.5 11.4 13.1 15.4 13.7 7.9 27.6 6.8 22.5 14.4 13.3 3.6 17.3 13.0 17.9 10.9 11.4 10.4 9.4 23.5 11.7 20.2 15.7 31.4 10.8 20.0 14.3 4.6 4.9 15.7 13.5 5.7 11.5 6.3 14.6 6.5 5.6 12.1 33.7 21.3 6.5 7.1 14.0 34.2 35.4 16.1 51.8 8.9 8.5 11.3 12.9 13.0 16.2 10.1 4.9 3.5 13.5 17.3 58.1 55.7 76.1 30.7 55.1 35.7 41.9 37.0 33.0 44.4 39.9 41.0 34.9 41.2 42.0 51.8 33.2 36.4 52.0 18.9 21.9 12.0 26.0 17.8 16.4 19.3 14.9 17.2 13.4 PRDX5 "ACR1, AOEB166, B166, MGC117264, MGC142283, MGC142285, PLP, PMP20, PRDX6, PRXV, SBBI10" ENSG00000126432 "Peroxiredoxin 5" P30044 11 64318088-64321811 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Antioxidant, Oxidoreductase, Peroxidase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008661, HPA037915, HPA037916" Enhanced Enhanced Mitochondria 19000000 Mitochondria "CAB008661: AB_1620988, HPA037915: AB_2675735, HPA037916: AB_2675736" "unprognostic (2.75e-1)" "unprognostic (4.08e-1)" "unprognostic (1.33e-1)" "unprognostic (1.46e-1)" "unprognostic (9.43e-2)" "unprognostic (6.71e-3)" "unprognostic (1.08e-3)" "unprognostic (3.11e-1)" "unprognostic (9.30e-2)" "unprognostic (1.07e-3)" "unprognostic (1.57e-2)" "unprognostic (2.20e-1)" "prognostic favourable (1.24e-5)" "unprognostic (8.19e-2)" "unprognostic (2.30e-1)" "unprognostic (9.63e-2)" "unprognostic (5.03e-2)" 28.7 69.7 70.3 38.6 60.3 57.0 35.5 69.3 73.9 47.2 79.3 31.9 49.0 49.5 26.6 54.8 69.6 94.9 44.8 102.4 56.7 74.2 57.3 54.2 50.3 25.0 68.6 70.2 42.2 72.0 36.0 53.7 49.1 71.4 30.7 71.2 33.9 77.5 62.6 104.7 27.0 51.2 30.9 44.1 27.3 64.5 35.0 29.3 25.1 82.0 64.8 33.5 34.4 50.4 55.2 69.2 115.0 66.9 48.4 40.5 75.3 26.0 53.2 32.3 53.3 34.8 52.3 37.3 32.7 52.4 24.0 30.0 38.7 53.6 38.3 57.2 52.2 59.7 30.1 69.4 15.3 53.1 23.7 38.6 83.8 44.1 71.4 14.6 32.9 53.0 90.7 40.3 40.9 36.5 21.7 91.0 33.8 66.2 25.5 63.5 48.9 68.2 24.6 33.1 135.2 90.0 51.8 27.4 52.0 27.3 60.7 93.2 44.4 33.3 35.1 34.4 32.0 39.7 14.4 46.6 55.4 45.0 41.6 29.5 26.8 79.8 66.9 85.4 37.7 59.6 32.7 53.8 35.0 30.8 52.4 55.2 34.8 35.0 115.0 48.4 52.5 69.2 40.5 75.3 70.3 60.3 69.3 73.9 56.7 74.2 68.6 70.2 71.4 29.3 PTCD3 "DKFZp666K071, FLJ20758" ENSG00000132300 "Pentatricopeptide repeat domain 3" Q96EY7 2 86106182-86142157 "Predicted intracellular proteins, Ribosomal proteins" "Translation regulation" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041154, HPA041382" Supported Supported Mitochondria Mitochondria "HPA041154: AB_10795488, HPA041382: AB_10795695" "unprognostic (1.16e-2)" "unprognostic (4.47e-2)" "unprognostic (1.37e-2)" "unprognostic (9.30e-3)" "unprognostic (2.40e-2)" "unprognostic (2.54e-1)" "unprognostic (4.92e-3)" "unprognostic (2.06e-2)" "unprognostic (4.78e-2)" "unprognostic (3.78e-1)" "unprognostic (7.42e-3)" "unprognostic (5.49e-3)" "unprognostic (1.26e-1)" "prognostic favourable (6.77e-4)" "unprognostic (3.69e-1)" "unprognostic (7.79e-2)" "prognostic favourable (6.86e-4)" 13.9 18.6 18.5 12.2 23.2 18.0 14.5 24.5 22.7 13.0 17.5 19.7 11.3 14.3 15.2 15.5 12.7 13.6 9.6 35.0 17.7 16.6 18.0 21.9 11.7 15.4 20.2 19.0 20.2 13.8 17.9 22.7 13.2 21.4 13.0 19.7 11.4 11.1 12.9 45.4 14.2 14.2 13.4 17.9 15.8 14.8 22.8 20.5 20.4 14.9 13.1 15.3 12.4 13.0 13.4 9.4 6.3 11.1 11.9 14.7 7.5 7.6 18.5 11.0 9.2 8.2 8.6 13.2 17.0 6.8 9.0 9.1 34.4 7.4 19.3 6.0 8.9 14.2 22.2 8.7 11.6 8.6 19.5 15.3 11.5 28.4 8.6 12.4 11.6 10.2 6.4 6.8 12.3 7.8 15.9 7.3 7.9 7.1 10.2 14.8 10.0 11.9 13.8 15.5 14.6 12.3 15.5 12.0 7.4 7.4 12.4 14.5 6.6 7.6 5.5 7.2 7.7 7.3 9.3 17.4 22.3 15.6 7.0 14.2 5.5 3.4 8.6 6.3 11.6 5.9 13.6 13.4 10.5 12.2 9.4 13.4 14.7 10.7 0.3 11.9 11.1 9.4 11.8 7.5 18.5 23.2 24.5 22.7 17.7 16.6 20.2 19.0 21.4 20.5 RMDN3 "FAM82A2, FAM82C, FLJ10579, PTPIP51, RMD3" ENSG00000137824 "Regulator of microtubule dynamics 3" Q96TC7 15 40735884-40755851 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009975, HPA074840" Supported Enhanced "Cytokinetic bridge,Mitochondria" Mitochondria "Cytokinetic bridge" "HPA009975: AB_1078811, HPA074840: " "unprognostic (2.54e-2)" "unprognostic (3.53e-1)" "unprognostic (2.35e-2)" "unprognostic (3.97e-3)" "unprognostic (1.50e-1)" "unprognostic (2.50e-3)" "unprognostic (2.78e-2)" "unprognostic (2.54e-2)" "unprognostic (1.73e-1)" "unprognostic (1.68e-1)" "unprognostic (2.78e-2)" "unprognostic (5.94e-3)" "prognostic favourable (6.70e-8)" "unprognostic (1.71e-2)" "unprognostic (1.32e-1)" "unprognostic (5.79e-3)" "unprognostic (2.04e-3)" 22.9 17.3 29.0 12.4 26.4 16.0 15.5 22.6 29.6 15.2 14.6 20.7 9.3 34.4 10.2 10.5 14.9 15.4 14.7 12.1 27.2 21.1 14.7 28.4 27.8 11.1 26.0 29.3 12.0 21.6 17.6 7.3 15.3 18.4 14.1 6.7 10.6 25.3 13.4 12.7 12.9 39.6 9.6 29.4 9.8 14.4 12.2 22.9 7.8 16.1 11.6 8.5 13.6 10.4 7.6 25.5 2.5 9.7 28.1 14.4 10.6 8.4 7.7 9.3 16.0 7.7 7.3 16.3 22.1 8.6 15.7 11.5 27.7 9.5 7.2 29.4 11.4 29.2 10.3 16.4 0.6 19.0 14.7 23.2 22.7 13.6 29.0 15.5 18.5 14.1 14.8 11.1 9.2 10.5 24.2 20.0 5.9 17.1 11.6 10.0 7.4 15.4 18.3 11.2 16.8 11.5 14.3 22.5 8.2 17.5 23.7 8.2 18.6 16.9 16.4 17.1 12.2 22.8 18.4 15.3 17.8 11.5 12.2 16.6 18.6 1.9 6.2 2.5 14.4 8.2 12.6 7.6 10.5 13.0 6.8 6.7 8.2 8.9 1.0 28.1 9.7 25.5 9.1 10.6 29.0 26.4 22.6 26.9 27.2 21.1 26.0 29.3 18.4 22.9 SDHA "FP, SDH2, SDHF" ENSG00000073578 "Succinate dehydrogenase complex flavoprotein subunit A" P31040 5 218241-256700 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport, Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes, Cardiomyopathy, Disease mutation, FDA approved drug targets, Leigh syndrome, Primary mitochondrial disease, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 100.1;skeletal muscle: 114.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034929, HPA041981, HPA064582" Enhanced Supported Nucleoli,Mitochondria 780000 Mitochondria Nucleoli "CAB034929: AB_2183443, HPA041981: AB_2677779, HPA064582: AB_2685293" "prognostic unfavourable (6.00e-4)" "unprognostic (1.93e-1)" "unprognostic (5.97e-2)" "unprognostic (1.36e-1)" "unprognostic (1.89e-1)" "unprognostic (1.62e-1)" "unprognostic (2.80e-1)" "unprognostic (3.14e-2)" "unprognostic (2.88e-1)" "unprognostic (1.67e-2)" "unprognostic (1.97e-1)" "unprognostic (1.24e-1)" "prognostic favourable (9.53e-8)" "unprognostic (1.11e-2)" "unprognostic (2.62e-1)" "unprognostic (3.57e-1)" "unprognostic (1.79e-1)" 17.6 31.4 15.3 11.5 20.3 10.6 12.8 18.8 29.0 10.2 29.4 17.3 10.0 44.3 11.3 12.1 15.3 12.6 14.8 100.1 15.8 14.5 36.5 55.4 10.7 11.7 19.6 19.3 14.5 14.7 23.2 9.5 9.2 29.7 10.7 24.6 14.5 17.3 12.0 114.0 11.5 39.9 16.5 13.2 13.9 21.2 14.6 14.8 15.7 12.5 39.6 12.5 13.2 11.1 28.3 31.9 29.1 29.2 27.1 48.9 32.4 18.4 29.9 12.3 20.1 21.2 15.9 33.4 14.2 18.1 24.5 25.0 32.4 25.1 22.8 45.0 16.2 23.9 21.7 29.0 14.5 48.6 19.9 11.6 82.6 42.0 13.1 14.4 15.1 15.8 18.7 18.3 9.7 26.5 18.6 19.0 11.5 28.2 19.1 39.0 4.2 37.9 24.7 17.9 44.2 52.2 24.5 13.6 7.8 67.0 43.3 17.6 26.3 18.3 19.2 18.2 17.9 10.8 11.7 20.2 8.6 16.8 17.6 20.9 11.5 17.8 24.4 29.1 36.4 29.2 32.1 28.3 34.8 35.1 31.9 24.5 34.5 31.7 5.9 27.1 24.1 20.5 48.9 32.4 15.3 20.3 18.8 29.0 15.8 14.5 19.6 19.3 29.7 14.8 SFXN1 "FLJ12876, SLC56A1" ENSG00000164466 "Sideroflexin 1" Q9H9B4 5 175477062-175529742 "Predicted intracellular proteins, Predicted membrane proteins" "Amino-acid transport, One-carbon metabolism, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 66.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "granulocytes: 34.2;T-cells: 16.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019543, HPA063745" Uncertain Enhanced Mitochondria Mitochondria "HPA019543: AB_1856789, HPA063745: " "unprognostic (4.77e-3)" "unprognostic (5.26e-2)" "unprognostic (1.54e-2)" "unprognostic (3.62e-3)" "unprognostic (2.35e-1)" "unprognostic (1.30e-2)" "unprognostic (3.59e-2)" "unprognostic (8.58e-3)" "unprognostic (2.47e-2)" "unprognostic (1.17e-2)" "unprognostic (2.48e-2)" "unprognostic (1.51e-1)" "unprognostic (1.31e-1)" "unprognostic (7.30e-2)" "unprognostic (4.98e-1)" "unprognostic (1.08e-3)" "unprognostic (4.23e-2)" 5.6 14.0 15.2 12.0 20.9 12.9 8.1 20.7 24.5 6.5 18.8 7.9 5.3 13.2 6.5 6.0 12.6 6.6 7.1 9.4 14.5 18.3 28.3 66.8 5.3 17.0 15.3 17.0 13.6 9.7 7.4 11.8 10.4 15.1 7.6 12.5 5.7 7.7 8.0 11.7 6.3 13.4 8.1 15.0 8.2 10.1 5.0 11.0 13.9 7.7 7.3 17.8 11.3 9.1 4.5 3.0 34.2 2.6 4.8 16.0 5.6 10.0 32.0 16.4 17.7 5.6 12.2 26.4 25.8 10.9 21.8 21.2 40.1 20.4 21.1 20.1 13.5 13.0 31.4 45.0 23.7 51.6 26.3 15.5 28.9 17.5 8.3 30.2 19.6 9.9 8.8 24.1 10.6 16.7 22.2 16.8 15.8 35.3 35.3 2.4 12.9 10.6 29.7 16.8 22.6 8.2 39.7 28.0 17.9 24.9 23.6 12.6 11.4 10.0 16.2 17.3 27.4 12.6 33.6 21.4 25.2 48.2 28.3 27.3 17.9 34.2 2.1 10.4 11.3 2.6 9.4 4.5 16.0 12.6 3.0 3.8 12.7 12.9 0.6 4.8 1.7 1.4 12.7 5.6 15.2 20.9 20.7 24.5 14.5 18.3 15.3 17.0 15.1 11.0 SFXN3 "SFX3, SLC56A3" ENSG00000107819 "Sideroflexin 3" Q9BWM7 10 101031234-101041244 "Predicted membrane proteins" "Amino-acid transport, One-carbon metabolism, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008028, HPA048105" Approved Enhanced Mitochondria 81000 Mitochondria "HPA008028: AB_1079938, HPA048105: " "unprognostic (2.55e-1)" "unprognostic (3.32e-2)" "unprognostic (4.94e-2)" "unprognostic (2.82e-2)" "unprognostic (4.94e-3)" "prognostic unfavourable (3.79e-4)" "unprognostic (3.84e-3)" "unprognostic (8.46e-2)" "unprognostic (1.05e-2)" "unprognostic (9.09e-3)" "unprognostic (1.04e-3)" "unprognostic (1.48e-1)" "prognostic unfavourable (4.94e-4)" "unprognostic (3.56e-1)" "unprognostic (3.05e-2)" "unprognostic (3.70e-2)" "unprognostic (1.71e-1)" 14.4 8.1 11.5 8.7 13.9 4.1 10.7 40.2 22.9 14.5 19.0 15.5 13.6 24.4 13.8 17.7 6.5 14.9 12.9 11.3 12.5 9.8 9.2 3.4 16.4 5.4 18.3 13.7 10.6 7.0 17.1 6.9 16.2 18.4 8.8 8.4 9.1 8.4 13.8 2.7 15.7 44.8 19.9 13.7 8.3 8.2 5.6 16.9 4.3 7.5 5.1 5.5 10.7 11.2 2.2 15.7 8.9 14.8 4.3 9.8 8.3 15.4 6.0 0.6 1.8 16.3 17.3 1.6 9.4 33.5 12.1 9.8 9.9 17.1 0.6 9.1 22.1 11.4 2.8 20.6 5.3 4.3 3.6 1.8 10.0 7.1 11.2 1.4 15.1 11.9 3.0 10.6 10.0 26.5 0.1 0.5 19.6 2.5 0.6 2.2 0.7 14.6 1.5 11.9 4.2 17.8 2.4 3.3 16.2 5.1 0.6 14.0 5.0 11.0 21.7 10.7 8.4 9.4 4.6 2.4 0.9 0.0 26.1 8.4 8.5 8.9 14.8 7.1 9.8 11.1 7.5 2.2 6.7 6.6 15.7 1.0 4.1 5.1 2.8 4.3 6.1 2.5 7.0 8.3 11.5 13.9 40.2 22.9 12.5 9.8 18.3 13.7 18.4 16.9 SHMT2 SHMT ENSG00000182199 "Serine hydroxymethyltransferase 2" P34897 12 57229327-57234935 "Enzymes, Plasma proteins, Predicted intracellular proteins" "One-carbon metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 103.1" "Cell line enhanced" "Detected in all" "RH-30: 208.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020543, HPA020549" Enhanced Enhanced Microtubules,Mitochondria 160000 Mitochondria Microtubules "HPA020543: AB_1856833, HPA020549: AB_1856834" "prognostic unfavourable (8.37e-5)" "unprognostic (1.24e-1)" "unprognostic (1.90e-1)" "unprognostic (2.65e-2)" "unprognostic (1.65e-1)" "unprognostic (4.97e-2)" "unprognostic (1.58e-2)" "unprognostic (9.83e-2)" "unprognostic (1.11e-2)" "unprognostic (2.67e-2)" "unprognostic (4.00e-2)" "unprognostic (3.19e-2)" "prognostic unfavourable (4.84e-8)" "unprognostic (3.05e-1)" "unprognostic (2.30e-1)" "unprognostic (2.72e-1)" "unprognostic (4.74e-2)" 13.0 13.5 5.9 15.0 7.1 12.6 9.5 9.6 9.5 10.5 11.5 6.1 5.0 13.4 10.2 8.5 22.1 8.6 10.3 11.0 6.5 5.4 15.5 103.1 11.8 18.7 8.7 4.6 17.9 38.9 4.5 8.1 16.8 6.5 10.3 9.4 7.1 44.6 5.7 16.5 13.7 11.5 9.9 7.6 23.5 13.4 5.4 6.3 26.1 13.2 19.0 25.6 11.2 13.8 33.6 14.5 6.5 11.7 9.7 48.7 12.3 24.6 11.4 11.6 30.6 9.1 14.0 23.0 13.4 21.8 17.9 16.5 16.4 11.9 45.7 22.2 16.5 15.8 20.9 21.7 9.7 25.5 18.6 18.8 7.0 11.6 67.4 31.1 16.7 17.9 31.6 14.4 48.2 17.8 19.7 43.5 13.6 16.2 24.7 17.0 9.9 18.6 16.7 208.3 42.3 9.0 11.4 24.9 11.9 7.0 16.5 48.4 22.4 38.3 11.2 7.3 14.8 9.4 18.1 58.3 31.9 38.8 15.7 29.0 13.0 6.5 9.8 5.9 6.9 11.7 8.0 33.6 12.1 7.4 14.5 32.4 5.3 5.4 0.5 9.7 7.5 4.8 48.7 12.3 5.9 7.1 9.6 9.5 6.5 5.4 8.7 4.6 6.5 6.3 SLC25A24 "APC1, DKFZp586G0123" ENSG00000085491 "Solute carrier family 25 member 24" Q6NUK1 1 108134036-108200849 "Predicted intracellular proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA028519, HPA063636" Enhanced Enhanced Mitochondria 8900 Mitochondria "HPA028519: AB_10603890, HPA063636: AB_2685068" "unprognostic (1.94e-2)" "unprognostic (7.30e-3)" "prognostic favourable (1.01e-4)" "unprognostic (7.11e-2)" "unprognostic (1.64e-2)" "unprognostic (2.91e-1)" "unprognostic (8.54e-4)" "unprognostic (1.51e-2)" "unprognostic (7.39e-2)" "unprognostic (1.29e-1)" "unprognostic (1.15e-3)" "unprognostic (6.18e-2)" "unprognostic (6.76e-2)" "unprognostic (2.21e-1)" "unprognostic (1.67e-1)" "unprognostic (1.03e-1)" "unprognostic (2.29e-1)" 19.8 10.8 3.0 13.1 3.3 3.8 25.2 2.3 4.5 15.9 26.6 3.9 9.6 13.6 12.4 11.8 11.4 9.0 16.1 12.4 2.8 3.3 15.3 2.9 17.8 10.8 3.0 2.7 13.5 7.2 13.2 7.7 10.4 5.3 12.4 18.2 9.8 11.2 9.7 7.4 6.9 42.4 9.7 4.0 17.0 9.0 5.1 1.5 10.3 13.7 10.8 9.4 10.8 18.2 2.9 4.8 4.4 7.1 1.7 4.3 2.1 23.9 5.3 16.4 5.1 11.3 14.9 8.2 8.4 9.9 15.0 16.5 6.5 8.0 0.0 7.7 15.4 9.4 4.8 13.5 20.3 5.9 2.5 1.5 8.0 3.1 9.3 3.9 3.2 11.1 9.6 8.7 11.2 11.4 4.0 8.1 18.8 15.7 2.2 0.8 9.7 6.2 4.0 21.5 7.2 10.1 12.4 3.1 5.4 11.8 8.5 11.1 8.2 6.8 7.7 8.5 4.3 15.1 9.0 2.2 1.3 0.0 2.9 7.0 5.0 2.8 4.9 4.4 2.3 5.7 2.9 2.9 2.7 2.3 4.8 2.3 1.3 2.3 0.6 1.7 7.1 1.4 4.3 2.1 3.0 3.3 2.3 4.5 2.8 3.3 3.0 2.7 5.3 1.5 SLC25A31 "ANT4, DKFZP434N1235" ENSG00000151475 "Solute carrier family 25 member 31" Q9H0C2 4 127730378-127774299 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 687 "testis: 68.6" "Cell line enhanced" "Detected in single" "hTCEpi: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA015064, HPA016841, HPA046835, HPA071684" Uncertain Enhanced Mitochondria Mitochondria "HPA015064: AB_1847691, HPA016841: AB_1847690, HPA046835: , HPA071684: " "unprognostic (8.15e-2)" "unprognostic (1.62e-1)" "unprognostic (2.70e-1)" "unprognostic (5.32e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SOD2 ENSG00000112096 "Superoxide dismutase 2" 6 159669057-159745186 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 254.9;skeletal muscle: 475.1" "Cell line enhanced" "Detected in all" "BJ hTERT+: 181.9;HSkMC: 80.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 11 "neutrophil: 254.9" "Lineage enriched" "Detected in many" 11 "granulocytes: 254.9" "HPA001814, CAB002013" Supported Enhanced Mitochondria Mitochondria "CAB002013: , HPA001814: AB_1080134" "unprognostic (2.47e-2)" "unprognostic (2.77e-3)" "unprognostic (1.14e-1)" "unprognostic (1.57e-2)" "unprognostic (1.31e-1)" "unprognostic (1.69e-1)" "unprognostic (1.49e-1)" "unprognostic (3.10e-2)" "unprognostic (1.37e-1)" "unprognostic (6.67e-2)" "unprognostic (2.76e-2)" "unprognostic (7.14e-2)" "prognostic unfavourable (1.72e-4)" "unprognostic (8.12e-2)" "unprognostic (4.14e-2)" "unprognostic (5.99e-2)" "unprognostic (1.82e-1)" 77.8 28.6 6.2 82.8 13.8 147.9 32.5 3.6 12.5 13.1 25.6 5.7 3.6 9.1 13.3 16.6 20.3 12.6 19.9 42.4 5.8 6.4 157.4 197.5 33.9 52.7 14.3 2.6 31.8 24.9 6.9 7.0 10.0 16.1 27.1 6.1 6.4 39.9 7.4 475.1 9.0 8.1 27.9 25.5 18.4 13.8 13.6 7.3 3.0 36.8 20.8 11.8 43.4 52.8 2.3 5.8 254.9 22.7 0.9 4.5 15.0 3.6 4.6 4.1 9.4 26.6 44.5 2.1 5.3 181.9 6.5 15.1 9.5 2.1 7.5 16.0 5.9 6.3 4.3 4.6 4.9 7.3 8.9 7.9 7.8 16.2 19.7 7.5 3.4 80.3 7.7 20.6 15.4 3.3 10.8 9.0 6.2 3.9 6.2 4.8 6.9 5.8 8.4 5.6 6.9 12.1 6.0 7.8 3.0 11.2 5.7 2.3 3.5 3.5 3.1 19.1 6.9 10.1 9.2 3.8 9.8 9.0 21.1 5.8 2.4 6.2 19.2 9.4 2.2 14.9 2.4 2.3 3.1 2.2 5.8 1.8 2.6 2.1 254.9 0.9 22.7 0.8 4.5 15.0 6.2 13.8 3.6 12.5 5.8 6.4 14.3 2.6 16.1 7.3 SUCLA2 ENSG00000136143 "Succinate-CoA ligase ADP-forming beta subunit" Q9P2R7 13 47745736-48037968 "Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Tricarboxylic acid cycle" Ligase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 89.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039435, HPA039536, HPA061528" Enhanced Supported Enhanced Mitochondria 6600 Mitochondria "HPA039435: AB_10673144, HPA039536: AB_2676561, HPA061528: AB_2684553" "unprognostic (5.66e-3)" "unprognostic (1.72e-2)" "unprognostic (1.14e-1)" "unprognostic (8.76e-2)" "unprognostic (1.60e-1)" "unprognostic (3.45e-2)" "unprognostic (2.48e-1)" "unprognostic (1.71e-1)" "unprognostic (4.70e-2)" "unprognostic (1.41e-2)" "unprognostic (1.10e-1)" "unprognostic (1.38e-1)" "prognostic favourable (7.59e-14)" "unprognostic (3.53e-1)" "unprognostic (2.19e-1)" "unprognostic (2.29e-1)" "prognostic unfavourable (1.22e-4)" 21.6 18.5 19.2 8.6 22.1 5.2 17.5 29.7 32.4 15.3 15.7 11.7 15.6 24.5 12.7 12.1 14.6 11.3 9.4 42.1 20.0 21.6 34.0 12.9 7.9 11.4 22.6 19.1 14.4 10.8 19.8 14.9 12.2 28.7 16.2 16.5 8.9 13.9 14.8 89.0 10.0 22.7 14.7 18.3 9.7 12.3 8.0 15.4 15.6 16.9 25.6 10.2 11.0 12.6 17.1 29.5 12.4 25.0 23.4 25.2 17.2 17.2 20.0 25.4 15.2 29.1 22.0 15.3 26.4 29.6 27.5 18.7 35.5 19.6 24.2 20.2 25.8 24.0 33.5 25.1 34.9 23.1 28.7 27.2 19.0 23.0 20.3 27.5 15.9 20.7 29.6 18.7 22.1 20.2 18.3 8.8 27.3 11.9 28.3 31.5 26.3 25.6 24.1 23.2 18.7 39.7 16.7 14.1 16.8 22.0 20.4 15.5 18.1 24.4 15.4 15.3 9.9 21.7 18.3 9.1 14.2 28.2 9.5 20.1 22.4 5.7 24.5 12.4 17.6 25.0 21.2 17.1 19.7 21.6 29.5 16.3 25.2 24.9 4.5 23.4 20.0 24.3 21.6 17.2 19.2 22.1 29.7 32.4 20.0 21.6 22.6 19.1 28.7 15.4 TACO1 CCDC44 ENSG00000136463 "Translational activator of cytochrome c oxidase I" Q9BSH4 17 63600872-63608365 "Disease related genes, Predicted intracellular proteins" "Translation regulation" Activator "Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021626, HPA021643, HPA024294" Enhanced Enhanced Mitochondria Mitochondria "HPA021626: AB_1846148, HPA021643: AB_1846149, HPA024294: AB_1846150" "unprognostic (1.26e-1)" "unprognostic (2.92e-2)" "unprognostic (4.55e-3)" "unprognostic (9.82e-2)" "unprognostic (1.30e-1)" "unprognostic (9.30e-3)" "unprognostic (2.83e-1)" "unprognostic (8.09e-2)" "unprognostic (2.09e-1)" "unprognostic (7.38e-2)" "prognostic favourable (3.73e-4)" "unprognostic (1.35e-1)" "unprognostic (4.12e-3)" "unprognostic (5.21e-3)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (1.60e-2)" 8.3 11.3 8.7 6.3 11.1 4.9 6.9 6.4 14.2 5.9 12.1 7.6 6.2 13.0 7.6 7.2 7.5 6.7 10.1 21.2 7.6 8.6 20.7 42.5 7.0 7.3 9.3 7.2 6.0 10.7 8.3 5.7 7.5 9.3 6.4 11.4 8.1 11.4 6.9 37.5 6.1 15.7 6.9 6.5 7.3 8.0 8.1 6.2 8.7 8.7 15.9 8.1 6.3 5.1 8.9 9.9 7.9 8.1 16.6 13.6 7.9 17.0 27.0 8.7 8.9 7.6 10.9 11.6 12.6 11.9 25.4 20.2 17.7 10.2 14.1 9.7 14.4 15.8 19.1 18.4 23.9 7.5 26.5 13.9 13.8 30.9 21.0 16.4 9.8 13.3 12.8 21.9 23.2 13.1 18.8 10.7 11.8 30.9 19.1 12.4 7.5 28.1 12.1 21.4 17.6 14.8 12.0 13.4 14.6 8.6 28.6 23.8 23.8 12.8 11.6 18.1 13.7 12.3 22.1 11.7 11.5 16.8 13.8 11.3 13.1 2.1 8.1 7.9 9.5 7.5 10.6 7.1 13.6 9.5 9.9 8.9 12.8 10.3 1.4 16.6 6.6 6.4 9.0 7.9 8.7 11.1 6.4 14.2 7.6 8.6 9.3 7.2 9.3 6.2 TBRG4 "Cpr2, FASTKD4, H_TD2522F11.8, KIAA0948" ENSG00000136270 "Transforming growth factor beta regulator 4" Q969Z0 7 45100100-45112047 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020582, HPA050430" Approved Enhanced Mitochondria Mitochondria "HPA020582: AB_1857804, HPA050430: " "unprognostic (2.22e-1)" "unprognostic (4.75e-2)" "unprognostic (1.19e-1)" "unprognostic (3.46e-3)" "unprognostic (1.41e-2)" "unprognostic (9.29e-3)" "prognostic unfavourable (1.40e-4)" "unprognostic (3.15e-2)" "unprognostic (1.86e-1)" "unprognostic (2.83e-1)" "unprognostic (4.53e-1)" "unprognostic (1.25e-2)" "unprognostic (3.66e-3)" "unprognostic (3.91e-2)" "unprognostic (3.84e-2)" "unprognostic (3.30e-1)" "unprognostic (1.52e-1)" 13.7 16.8 10.8 16.0 15.6 14.9 13.0 12.9 22.1 10.5 20.8 15.6 14.1 21.8 14.2 8.2 20.1 12.8 12.4 26.2 9.8 10.0 20.9 27.7 10.5 17.0 10.6 8.9 15.6 16.9 11.3 10.1 16.2 14.7 13.6 14.1 10.8 14.2 12.4 42.6 16.9 17.8 13.9 9.9 16.2 14.0 22.5 9.5 15.0 13.8 23.7 20.3 14.5 13.3 15.8 20.1 10.9 24.2 9.7 21.0 17.5 12.9 30.1 9.6 21.1 8.7 8.1 19.4 10.5 9.7 20.4 16.9 32.5 18.3 24.7 16.2 10.7 33.9 22.3 23.9 10.4 12.8 20.9 17.0 19.7 22.2 14.6 19.3 17.5 10.7 22.2 19.4 14.0 12.5 46.9 12.5 12.4 21.8 19.6 44.2 30.5 24.0 17.4 12.4 36.0 11.9 13.3 19.1 18.1 10.7 59.6 20.7 26.6 32.1 9.7 15.2 18.4 9.2 17.0 22.4 22.4 36.2 14.0 27.8 34.1 7.4 13.3 10.9 18.4 24.2 17.6 15.8 15.4 17.8 20.1 12.3 21.0 19.9 1.0 9.7 20.4 7.5 14.6 17.5 10.8 15.6 12.9 22.1 9.8 10.0 10.6 8.9 14.7 9.5 TEFM "C17orf42, FLJ22729" ENSG00000172171 "Transcription elongation factor, mitochondrial" Q96QE5 17 30897336-30906820 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023788, HPA053044" Approved Enhanced Mitochondria Mitochondria "HPA023788: AB_1848818, HPA053044: " "unprognostic (1.22e-1)" "unprognostic (1.18e-2)" "unprognostic (1.11e-3)" "unprognostic (3.31e-2)" "unprognostic (7.89e-2)" "unprognostic (3.75e-1)" "prognostic unfavourable (9.20e-4)" "unprognostic (1.25e-1)" "prognostic unfavourable (8.64e-4)" "unprognostic (2.11e-1)" "unprognostic (6.18e-3)" "unprognostic (9.39e-2)" "unprognostic (4.79e-2)" "unprognostic (7.90e-2)" "unprognostic (1.92e-1)" "unprognostic (2.23e-1)" "unprognostic (8.37e-3)" 7.0 9.6 11.8 10.2 13.7 4.0 11.1 23.3 16.6 7.5 8.1 7.4 7.2 10.6 8.6 9.6 9.7 7.6 6.8 12.7 10.1 6.9 13.0 12.3 6.9 10.0 15.4 8.5 10.5 7.3 10.8 16.8 10.4 10.6 10.6 10.3 8.6 7.9 10.4 7.7 8.5 9.1 9.6 11.0 13.7 7.4 5.7 13.3 8.6 10.7 6.7 9.8 7.9 11.8 6.7 6.4 4.9 10.0 4.3 6.7 4.8 6.0 9.7 5.8 7.3 4.5 5.8 5.0 5.9 5.0 13.4 11.2 6.4 2.9 7.7 5.9 4.4 8.6 10.7 4.3 11.7 2.4 13.4 3.7 9.7 6.4 4.8 6.7 4.8 4.4 5.1 7.7 3.0 5.7 8.3 7.0 8.8 4.3 5.8 9.9 4.4 5.0 3.0 10.2 6.1 10.0 5.7 9.9 3.0 5.4 4.3 5.1 9.7 4.6 3.9 5.2 6.1 5.9 5.7 3.4 5.6 5.4 4.2 5.6 5.1 3.5 6.6 4.9 4.6 10.0 5.8 6.7 5.6 4.2 6.4 6.4 6.7 6.6 1.9 4.3 7.3 5.8 5.7 4.8 11.8 13.7 23.3 16.6 10.1 6.9 15.4 8.5 10.6 13.3 TFAM "TCF6, TCF6L2" ENSG00000108064 "Transcription factor A, mitochondrial" Q00059 10 58385022-58399221 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040648, HPA063684" Supported Enhanced Mitochondria "Intracellular and membrane" Mitochondria "HPA040648: AB_10795635, HPA063684: AB_2685089" "unprognostic (5.30e-2)" "unprognostic (1.14e-1)" "unprognostic (6.34e-3)" "prognostic unfavourable (8.73e-4)" "unprognostic (1.10e-2)" "unprognostic (3.40e-2)" "unprognostic (1.54e-2)" "unprognostic (3.23e-2)" "unprognostic (1.24e-2)" "prognostic favourable (2.74e-4)" "unprognostic (1.99e-2)" "unprognostic (5.39e-2)" "prognostic favourable (2.22e-5)" "unprognostic (1.31e-1)" "unprognostic (2.24e-1)" "unprognostic (1.79e-1)" "unprognostic (6.76e-2)" 19.3 21.2 11.1 21.0 12.1 28.5 15.3 15.4 13.9 16.8 21.0 7.7 12.5 17.6 20.7 12.1 17.4 15.3 11.0 15.9 10.2 11.2 22.4 31.4 11.5 21.5 12.5 10.7 18.4 14.3 12.3 23.9 22.2 12.9 17.2 14.7 9.2 16.3 10.6 21.7 10.2 18.7 16.1 10.8 21.0 14.5 40.2 11.6 35.4 22.2 14.8 18.4 16.6 11.8 13.1 14.1 7.2 9.5 14.3 13.1 6.8 21.3 12.2 13.7 14.2 4.1 5.1 15.7 9.7 9.7 12.2 13.6 42.8 22.9 42.5 14.3 4.4 16.7 25.1 13.6 19.4 18.1 22.3 16.1 9.3 15.9 6.3 40.8 13.3 5.0 6.3 14.8 13.6 10.5 38.0 19.6 8.5 11.6 32.2 16.0 26.0 12.7 25.7 29.6 19.1 7.5 14.4 18.4 12.6 19.4 27.0 23.8 29.4 12.2 8.1 9.1 29.1 10.3 26.0 19.9 30.4 53.6 11.6 31.5 6.8 1.0 9.5 3.7 8.5 9.0 11.0 12.2 10.3 8.9 11.5 13.1 13.1 10.4 7.2 14.3 7.2 14.1 8.5 6.8 11.1 12.1 15.4 13.9 10.2 11.2 12.5 10.7 12.9 11.6 TFB2M "FLJ22661, FLJ23182, Hkp1" ENSG00000162851 "Transcription factor B2, mitochondrial" Q9H5Q4 1 246540560-246566324 "Predicted intracellular proteins" "rRNA processing, Transcription, Transcription regulation" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028482, HPA028554, HPA030265" Approved Enhanced Mitochondria Mitochondria "HPA028482: , HPA028554: , HPA030265: AB_10696209" "unprognostic (4.38e-2)" "unprognostic (2.45e-2)" "unprognostic (3.79e-3)" "unprognostic (5.63e-2)" "unprognostic (1.10e-1)" "unprognostic (8.13e-2)" "unprognostic (8.76e-2)" "unprognostic (1.41e-1)" "unprognostic (2.51e-2)" "unprognostic (1.68e-2)" "unprognostic (2.46e-1)" "unprognostic (6.81e-2)" "unprognostic (5.26e-2)" "unprognostic (2.27e-1)" "unprognostic (9.44e-2)" "unprognostic (6.41e-2)" "unprognostic (3.53e-2)" 10.6 23.1 4.2 7.2 8.4 15.5 9.0 8.4 9.9 7.0 8.9 6.5 9.4 8.2 9.5 7.2 9.5 6.9 8.5 11.3 4.3 5.5 15.5 42.3 5.9 8.7 4.8 5.7 6.5 19.7 5.6 7.8 10.5 7.6 8.9 9.6 5.9 13.6 8.9 21.4 8.7 10.3 6.8 6.5 9.0 9.6 8.7 5.7 13.0 15.6 7.3 12.0 9.1 6.5 10.6 11.0 1.2 7.5 12.6 10.4 4.5 12.6 12.2 4.7 8.4 5.9 8.5 16.6 9.3 9.6 10.6 9.7 14.8 12.2 22.6 14.6 9.4 11.0 11.3 9.9 14.6 8.7 4.4 11.4 7.5 12.9 9.7 20.1 10.4 8.4 11.8 9.1 10.2 8.2 33.0 7.7 9.1 5.8 10.1 9.0 21.0 12.4 10.2 9.4 27.4 9.6 14.0 10.5 21.2 9.0 16.3 30.7 11.9 19.4 5.9 7.4 9.0 10.4 24.2 22.5 37.5 17.8 9.1 19.9 9.2 0.2 4.7 1.2 8.4 4.8 10.4 10.6 7.5 8.8 11.0 10.4 9.6 8.2 1.0 12.6 7.5 9.5 10.3 4.5 4.2 8.4 8.4 9.9 4.3 5.5 4.8 5.7 7.6 5.7 TIMM10 "TIM10, TIM10A, TIMM10A" ENSG00000134809 "Translocase of inner mitochondrial membrane 10" P62072 11 57528463-57530803 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039946 Supported Enhanced Mitochondria Mitochondria "HPA039946: AB_10673023" "unprognostic (9.34e-3)" "unprognostic (1.16e-2)" "unprognostic (2.21e-1)" "unprognostic (2.01e-1)" "unprognostic (4.42e-2)" "unprognostic (1.25e-2)" "unprognostic (2.74e-1)" "unprognostic (1.39e-1)" "unprognostic (2.07e-1)" "unprognostic (3.40e-3)" "unprognostic (7.62e-2)" "unprognostic (1.18e-1)" "unprognostic (5.96e-2)" "unprognostic (9.87e-2)" "unprognostic (1.96e-1)" "unprognostic (1.62e-2)" "unprognostic (2.15e-2)" 22.2 19.5 29.1 16.7 28.5 18.3 27.4 14.8 34.3 16.6 21.6 17.1 25.9 16.8 13.7 29.1 20.2 16.0 15.4 25.2 25.1 22.7 26.7 41.3 13.1 25.1 27.2 24.6 13.0 25.8 18.3 14.3 13.8 19.9 14.4 23.1 15.8 23.8 20.2 32.3 15.3 12.4 17.2 21.0 20.1 15.9 20.5 16.1 18.4 18.5 25.9 29.8 13.6 12.1 45.1 38.8 5.9 22.6 16.5 33.4 32.4 26.9 41.2 19.4 18.5 16.8 14.4 24.5 23.1 18.6 37.0 21.1 30.3 23.7 51.4 26.6 20.5 20.7 27.5 26.8 33.5 17.4 20.3 32.6 15.8 38.9 17.8 42.6 36.8 13.5 21.8 35.8 25.0 22.8 36.0 23.5 27.1 57.4 22.9 57.1 20.4 44.4 38.6 40.8 44.8 18.7 18.7 15.7 20.2 24.4 48.7 29.5 36.3 16.3 14.3 21.4 39.9 36.6 44.3 32.9 43.0 41.3 19.7 21.5 35.5 5.9 22.6 5.0 19.9 21.4 22.8 45.1 24.5 21.9 38.7 41.9 33.4 29.1 1.3 16.5 19.8 38.8 21.3 32.4 29.1 28.5 14.8 34.3 25.1 22.7 27.2 24.6 19.9 16.1 TIMM17A "TIM17, TIM17A" ENSG00000134375 "Translocase of inner mitochondrial membrane 17A" Q99595 1 201955491-201970661 "Cancer-related genes, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010083 Approved Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA010083: AB_10602899" "prognostic unfavourable (1.98e-5)" "unprognostic (3.28e-1)" "unprognostic (1.32e-1)" "unprognostic (1.09e-1)" "unprognostic (1.14e-1)" "unprognostic (1.80e-3)" "unprognostic (7.58e-2)" "unprognostic (4.15e-2)" "unprognostic (7.45e-2)" "unprognostic (1.64e-2)" "unprognostic (8.54e-3)" "unprognostic (2.02e-2)" "unprognostic (2.01e-1)" "unprognostic (6.45e-3)" "unprognostic (1.21e-1)" "unprognostic (1.44e-2)" "unprognostic (2.81e-1)" 16.6 27.6 22.7 18.7 23.2 16.9 16.8 16.3 29.3 16.5 19.3 9.9 19.2 17.2 15.0 24.1 17.9 11.8 10.7 39.0 32.3 19.6 25.1 53.7 13.5 15.3 20.6 27.0 11.2 18.7 21.5 14.8 17.4 25.0 14.5 21.8 11.7 24.8 17.1 42.1 11.5 13.0 19.6 13.4 14.4 16.3 13.7 14.2 11.3 21.6 30.4 18.9 15.9 12.7 17.6 28.9 16.0 24.9 15.9 20.6 17.8 25.9 26.5 24.1 28.8 20.3 21.4 40.7 41.6 29.8 34.1 30.7 31.1 27.1 36.1 15.3 35.5 20.8 44.1 24.8 36.9 26.4 27.6 19.9 35.3 29.3 21.0 42.3 21.4 24.6 27.7 34.9 29.2 35.6 50.1 20.3 40.0 16.6 22.7 22.9 30.5 14.3 22.4 28.0 45.1 41.9 24.8 36.4 25.7 25.4 65.2 38.4 36.0 28.8 28.5 22.8 24.2 26.5 43.1 30.7 33.1 30.3 24.3 32.3 25.4 8.9 19.0 16.0 13.6 24.9 17.5 17.6 14.9 17.2 28.9 12.7 14.2 16.7 4.4 15.9 24.7 19.3 20.6 17.8 22.7 23.2 16.3 29.3 32.3 19.6 20.6 27.0 25.0 14.2 TIMM44 TIM44 ENSG00000104980 "Translocase of inner mitochondrial membrane 44" O43615 19 7926718-7943920 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043052 Supported Enhanced Mitochondria Mitochondria "HPA043052: AB_10795713" "unprognostic (1.75e-1)" "unprognostic (7.44e-3)" "unprognostic (2.68e-2)" "unprognostic (1.03e-1)" "unprognostic (1.24e-1)" "unprognostic (1.45e-2)" "unprognostic (5.81e-3)" "unprognostic (8.78e-2)" "unprognostic (2.42e-1)" "unprognostic (8.81e-2)" "unprognostic (2.07e-3)" "unprognostic (8.93e-2)" "unprognostic (1.80e-2)" "unprognostic (6.01e-2)" "unprognostic (6.43e-2)" "unprognostic (2.07e-2)" "unprognostic (4.18e-2)" 12.8 15.3 11.8 13.0 12.4 7.5 12.7 16.2 17.2 10.8 15.3 8.5 14.1 16.1 12.1 11.8 19.4 10.8 12.6 39.2 12.9 10.3 13.5 19.7 9.0 9.2 11.7 7.7 13.8 20.2 7.4 10.3 8.9 12.3 10.8 6.3 8.5 17.3 21.4 48.8 12.6 10.5 17.7 9.0 12.2 12.2 9.4 11.6 5.8 12.5 26.6 8.8 13.0 9.4 9.0 16.2 10.1 12.2 9.6 12.1 8.4 18.2 10.7 5.7 10.0 10.0 9.3 8.4 11.0 9.0 15.3 13.9 23.6 3.9 26.8 12.8 9.2 12.8 23.5 12.4 3.9 12.5 35.8 13.5 9.1 19.8 24.5 16.1 5.6 10.8 15.9 13.0 16.2 9.7 24.7 9.6 6.6 18.6 14.0 10.6 16.6 45.4 14.8 8.2 12.6 6.7 11.8 13.7 7.1 9.8 13.4 31.3 8.2 15.7 5.1 7.3 11.5 18.5 20.8 18.8 23.7 26.1 5.2 23.5 12.3 10.1 11.7 3.7 12.1 12.2 10.7 8.7 11.1 11.2 16.2 9.0 10.7 10.4 0.6 9.6 7.2 13.2 9.4 8.4 11.8 12.4 16.2 17.2 12.9 10.3 11.7 7.7 12.3 11.6 TIMMDC1 "C3orf1, FLJ22597" ENSG00000113845 "Translocase of inner mitochondrial membrane domain containing 1" Q9NPL8 3 119498532-119525090 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053214, HPA055846" Uncertain Enhanced Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA053214: , HPA055846: " "unprognostic (3.95e-2)" "unprognostic (8.85e-2)" "unprognostic (1.73e-1)" "unprognostic (2.53e-2)" "unprognostic (2.88e-1)" "unprognostic (1.60e-1)" "prognostic unfavourable (1.12e-5)" "unprognostic (9.60e-2)" "unprognostic (6.25e-2)" "unprognostic (3.39e-1)" "unprognostic (4.67e-3)" "unprognostic (1.05e-1)" "unprognostic (3.87e-2)" "unprognostic (8.89e-2)" "unprognostic (1.31e-1)" "unprognostic (2.76e-1)" "unprognostic (1.05e-1)" 13.6 17.2 18.1 10.4 16.7 5.9 13.8 8.6 16.2 16.4 12.2 20.4 21.5 9.2 13.3 19.4 18.5 13.6 14.9 43.9 15.9 15.4 22.8 20.5 13.0 15.9 20.9 11.9 11.8 12.5 20.4 17.4 21.4 16.4 15.2 14.5 14.0 14.3 21.6 37.2 16.0 15.3 12.7 21.9 14.3 12.3 13.3 15.6 9.9 19.9 20.3 14.5 16.7 11.1 12.4 13.8 16.3 15.5 8.5 15.8 15.5 14.0 13.2 6.6 5.6 25.7 17.3 14.9 4.1 13.8 12.0 13.8 8.9 8.7 10.3 7.1 14.5 6.6 16.5 13.4 19.6 8.6 5.9 7.6 6.2 10.0 13.5 5.9 5.0 15.1 20.7 9.6 12.5 16.9 10.3 9.9 22.0 17.5 6.1 12.5 8.8 16.5 5.2 4.6 13.5 18.0 7.0 8.8 16.3 4.2 6.4 15.8 10.6 16.2 8.4 6.8 5.1 6.1 7.1 6.4 6.0 14.0 11.5 15.0 10.6 6.8 13.8 16.3 8.4 13.0 10.1 12.2 8.3 10.3 13.8 12.4 10.4 9.0 3.4 8.5 15.5 11.9 15.8 15.5 18.1 16.7 8.6 16.2 15.9 15.4 20.9 11.9 16.4 15.6 TMEM71 FLJ33069 ENSG00000165071 "Transmembrane protein 71" Q6P5X7 8 132685007-132760712 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 65.7;lymphoid tissue: 31.3" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.0;HDLM-2: 32.3;Karpas-707: 6.9;U-937: 19.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 65.7" "Lineage enriched" "Detected in all" 4 "granulocytes: 65.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA058401, HPA070655" Uncertain Enhanced Mitochondria Mitochondria "HPA058401: , HPA070655: " "unprognostic (1.39e-3)" "unprognostic (7.27e-2)" "unprognostic (8.82e-2)" "unprognostic (3.10e-3)" "unprognostic (7.94e-2)" "unprognostic (3.91e-3)" "unprognostic (4.18e-2)" "unprognostic (5.06e-2)" "unprognostic (1.53e-1)" "unprognostic (1.71e-1)" "unprognostic (1.63e-1)" "unprognostic (1.62e-1)" "unprognostic (8.83e-2)" "unprognostic (1.90e-2)" "unprognostic (6.29e-3)" "unprognostic (4.39e-2)" "unprognostic (2.73e-1)" 4.2 1.1 1.4 8.2 1.5 20.8 5.4 0.7 1.2 2.5 9.9 0.8 0.4 1.2 1.0 2.0 4.8 1.9 4.1 25.5 1.8 1.2 1.9 2.3 8.3 20.9 2.2 0.8 1.9 2.9 0.0 1.4 1.0 1.7 2.2 2.2 5.8 5.8 1.3 1.3 1.3 7.2 2.2 4.2 18.2 2.9 0.9 1.4 31.3 2.2 2.5 10.6 7.0 2.8 1.4 8.2 65.7 13.5 2.9 14.8 8.4 0.2 0.0 3.1 0.0 0.0 0.0 0.0 0.7 8.0 0.3 0.5 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.2 0.9 32.3 0.0 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 1.2 0.6 0.0 6.9 1.4 0.0 1.6 1.2 0.7 0.2 0.1 1.1 0.4 2.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.3 0.5 0.7 3.3 0.0 1.6 0.0 5.7 19.1 2.4 12.5 13.5 23.9 8.0 3.9 14.8 1.4 5.9 5.6 8.2 1.3 9.0 6.5 65.7 2.9 3.2 0.2 0.7 8.4 1.4 1.5 0.7 1.2 1.8 1.2 2.2 0.8 1.7 1.4 TNRC18 "CAGL79, KIAA1856, TNRC18A" ENSG00000182095 "Trinucleotide repeat containing 18" O15417 7 5306790-5425414 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 17.6" "Lineage enriched" "Detected in all" 4 "granulocytes: 17.6" "Low region specificity" "Detected in all" "HPA020730, HPA024251" Uncertain Supported "Nucleoplasm,Nuclear membrane,Mitochondria,Cytosol" "Nucleoplasm, Nuclear membrane, Mitochondria" Cytosol "HPA020730: , HPA024251: " "unprognostic (1.66e-1)" "unprognostic (3.17e-3)" "unprognostic (2.67e-3)" "unprognostic (4.44e-1)" "unprognostic (1.81e-1)" "unprognostic (6.67e-2)" "unprognostic (1.13e-2)" "unprognostic (1.79e-1)" "unprognostic (3.01e-1)" "unprognostic (2.11e-2)" "unprognostic (6.08e-2)" "unprognostic (1.36e-1)" "unprognostic (9.29e-3)" "unprognostic (2.14e-1)" "unprognostic (2.94e-1)" "unprognostic (1.02e-1)" "unprognostic (4.34e-2)" 17.9 11.8 18.1 17.9 17.2 29.4 20.6 35.1 23.6 35.0 29.9 16.7 17.9 16.4 36.0 19.5 19.6 27.5 29.2 13.6 14.2 9.6 15.6 11.8 19.2 12.9 15.5 16.7 30.3 18.4 36.9 14.7 19.7 13.2 25.4 15.1 25.2 17.0 24.4 13.6 18.9 16.9 40.1 12.6 15.3 21.4 14.0 16.6 7.2 20.6 12.8 9.4 27.0 21.4 2.0 4.3 17.6 3.2 2.6 1.5 0.1 21.3 19.1 15.9 13.3 13.4 16.0 41.1 15.2 14.4 8.4 9.0 7.8 18.8 14.6 15.0 22.2 23.9 9.1 18.2 7.1 6.4 5.8 9.3 16.3 12.7 11.7 30.5 34.3 16.1 21.5 16.8 19.6 9.5 13.1 8.3 10.7 35.5 7.1 37.3 1.4 14.6 8.0 7.9 10.8 6.9 27.3 6.9 16.6 11.8 31.3 11.3 32.7 31.6 23.6 24.5 34.5 14.5 10.9 11.9 12.3 13.8 13.7 21.7 28.5 9.4 3.2 2.7 1.4 1.2 1.0 1.6 1.0 0.8 1.1 2.0 0.7 1.5 17.6 2.6 1.5 4.3 1.4 0.1 18.1 17.2 35.1 23.6 14.2 9.6 15.5 16.7 13.2 16.6 TOMM20 "KIAA0016, MAS20, MOM19, TOM20" ENSG00000173726 "Translocase of outer mitochondrial membrane 20" Q15388 1 235109336-235128936 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005585, HPA011562" Supported Enhanced Mitochondria Mitochondria "CAB005585: AB_628381, HPA011562: AB_1080326" "unprognostic (1.30e-1)" "unprognostic (3.08e-3)" "unprognostic (1.66e-2)" "unprognostic (4.49e-2)" "unprognostic (8.65e-3)" "unprognostic (1.17e-2)" "unprognostic (7.09e-2)" "unprognostic (3.28e-1)" "unprognostic (3.18e-2)" "unprognostic (1.75e-1)" "unprognostic (1.16e-3)" "unprognostic (5.05e-2)" "unprognostic (7.08e-3)" "unprognostic (2.33e-2)" "unprognostic (1.17e-1)" "unprognostic (1.11e-1)" "unprognostic (3.97e-1)" 27.2 35.0 46.3 15.3 60.2 32.7 52.8 40.0 66.2 36.1 25.5 28.4 29.0 24.4 34.5 39.0 28.0 40.0 27.9 33.9 47.1 48.7 41.2 35.2 24.2 33.6 42.5 40.5 50.9 63.6 38.6 25.4 27.1 48.2 34.0 28.2 23.5 47.8 30.7 33.4 33.0 21.3 33.8 54.5 19.0 27.2 16.3 23.0 18.0 58.7 28.4 21.9 36.2 28.9 15.9 20.9 16.4 13.8 9.8 22.6 14.2 35.9 19.0 25.0 21.0 19.7 39.8 38.8 25.9 22.4 24.4 17.8 24.5 25.4 43.8 34.5 22.4 28.8 27.7 25.1 32.2 10.5 59.2 26.7 25.4 46.3 33.0 59.8 16.1 35.5 34.5 24.4 33.7 26.4 56.0 16.2 26.7 10.5 25.4 27.1 56.2 10.3 31.1 19.1 56.7 27.4 25.9 32.9 77.1 20.1 28.2 55.1 43.6 65.8 23.3 21.5 13.0 27.1 54.9 38.4 36.1 32.1 25.2 28.7 36.2 16.4 12.4 4.1 13.9 12.9 17.1 15.9 18.1 17.3 15.1 12.7 22.6 17.6 3.9 9.8 13.8 20.9 15.5 14.2 46.3 60.2 40.0 66.2 47.1 48.7 42.5 40.5 48.2 23.0 TOMM22 TOM22 ENSG00000100216 "Translocase of outer mitochondrial membrane 22" Q9NS69 22 38681948-38685421 "Predicted membrane proteins" "Protein transport, Translocation, Transport" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003037 Supported Enhanced Mitochondria Mitochondria "HPA003037: AB_1080329" "unprognostic (5.54e-2)" "unprognostic (5.04e-3)" "unprognostic (2.74e-3)" "unprognostic (1.48e-2)" "unprognostic (1.32e-1)" "unprognostic (1.85e-2)" "prognostic unfavourable (2.90e-5)" "unprognostic (1.01e-1)" "unprognostic (4.28e-1)" "unprognostic (7.01e-2)" "unprognostic (1.64e-2)" "unprognostic (7.39e-2)" "unprognostic (5.44e-2)" "unprognostic (5.32e-2)" "unprognostic (1.99e-1)" "unprognostic (7.86e-2)" "unprognostic (1.64e-1)" 27.6 26.2 25.6 30.1 24.3 29.5 29.4 17.6 28.2 22.2 26.8 14.7 22.4 28.0 20.1 25.6 34.1 24.4 23.8 31.6 23.2 21.0 29.4 46.0 18.1 32.1 24.0 19.8 27.8 47.5 10.9 12.6 27.6 18.5 21.0 32.8 15.8 31.4 26.7 38.2 24.6 29.7 22.8 20.0 27.7 23.3 24.7 11.3 44.2 27.4 40.4 33.5 24.1 30.2 22.5 29.7 6.9 22.9 18.0 21.3 28.6 19.6 11.6 17.9 18.9 13.2 12.3 19.3 16.3 11.4 23.9 18.0 21.1 11.8 20.0 13.5 15.9 16.4 27.1 24.7 19.3 17.2 29.8 26.9 9.1 20.2 17.3 71.1 19.1 16.8 17.6 21.5 14.1 17.5 20.3 16.0 15.9 15.3 21.3 33.1 27.3 23.7 23.7 23.2 18.9 15.9 14.5 21.0 13.9 19.1 24.2 18.5 16.8 23.6 17.8 14.7 27.6 13.4 24.6 22.2 26.8 31.0 18.4 24.7 20.0 4.7 22.9 6.9 16.9 22.0 21.3 22.5 18.3 17.8 29.7 18.0 18.7 20.0 2.2 18.0 18.1 25.8 21.1 28.6 25.6 24.3 17.6 28.2 23.2 21.0 24.0 19.8 18.5 11.3 TOMM40 "C19orf1, D19S1177E, PER-EC1, PEREC1, TOM40" ENSG00000130204 "Translocase of outer mitochondrial membrane 40" O96008 19 44890569-44903689 "Predicted intracellular proteins, Transporters" "Ion transport, Protein transport, Transport" Porin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036231, HPA036232" Supported Enhanced Mitochondria,Cytosol Mitochondria Cytosol "HPA036231: , HPA036232: " "unprognostic (2.14e-1)" "unprognostic (9.58e-3)" "unprognostic (1.66e-1)" "unprognostic (6.75e-3)" "unprognostic (2.37e-1)" "unprognostic (2.17e-2)" "unprognostic (1.13e-3)" "unprognostic (1.13e-2)" "unprognostic (7.84e-2)" "unprognostic (1.20e-1)" "unprognostic (1.85e-2)" "unprognostic (1.35e-1)" "unprognostic (5.86e-3)" "unprognostic (5.30e-3)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "unprognostic (2.87e-1)" 16.0 25.3 13.6 16.9 15.6 19.7 20.6 17.7 27.0 10.2 20.5 10.9 10.1 20.0 11.8 10.5 22.9 13.5 11.4 21.5 15.3 14.9 16.5 36.9 15.1 22.3 15.6 13.3 18.2 19.2 16.2 11.9 15.3 20.2 11.2 16.7 11.5 11.5 13.5 32.3 14.7 15.1 11.6 11.9 12.7 12.6 12.3 8.8 14.2 11.6 18.6 15.6 10.9 12.5 7.3 7.0 5.1 6.8 4.7 8.7 2.0 30.8 52.3 19.1 26.3 7.1 6.4 24.3 22.2 12.3 42.1 30.2 56.8 21.4 45.6 23.9 14.6 33.4 49.5 31.9 19.2 17.6 44.9 30.6 20.5 44.7 15.2 39.0 27.5 10.1 18.1 32.6 20.7 14.5 48.2 15.9 16.4 38.5 42.3 28.7 33.4 32.6 43.3 21.7 26.5 19.3 42.9 29.8 19.1 23.6 49.8 15.8 16.7 39.6 11.9 29.2 29.6 20.3 57.9 17.2 35.6 44.7 21.7 41.5 30.7 0.7 5.5 5.1 4.7 6.8 5.2 7.3 4.5 6.5 7.0 4.2 7.9 8.7 1.1 4.7 5.9 6.9 4.8 2.0 13.6 15.6 17.7 27.0 15.3 14.9 15.6 13.3 20.2 8.8 TOMM70 "KIAA0719, Tom70, TOMM70A" ENSG00000154174 "Translocase of outer mitochondrial membrane 70" O94826 3 100363431-100401398 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014589, CAB017156, HPA048020" Enhanced Enhanced Mitochondria 120000 Mitochondria "CAB017156: , HPA014589: AB_1858185, HPA048020: " "unprognostic (2.74e-2)" "unprognostic (2.25e-1)" "unprognostic (2.57e-2)" "unprognostic (2.69e-3)" "unprognostic (2.12e-2)" "unprognostic (5.96e-2)" "unprognostic (2.06e-3)" "unprognostic (5.01e-2)" "unprognostic (9.86e-2)" "unprognostic (1.21e-1)" "unprognostic (9.73e-3)" "unprognostic (5.38e-2)" "unprognostic (2.62e-3)" "unprognostic (1.73e-1)" "unprognostic (3.53e-1)" "unprognostic (3.34e-2)" "unprognostic (6.98e-3)" 21.7 16.1 16.2 12.4 52.4 9.6 21.3 23.6 26.5 16.9 18.2 12.5 13.8 19.4 17.4 15.0 20.8 14.2 12.2 25.2 16.5 19.8 24.9 40.7 10.5 13.5 16.1 20.6 21.7 18.0 20.1 17.1 15.5 29.0 19.0 20.6 13.3 14.5 19.4 42.8 13.3 17.8 22.3 14.0 12.1 14.8 14.7 15.6 18.7 20.5 19.9 16.6 22.3 22.5 4.3 3.0 2.5 2.5 5.6 5.4 1.8 23.6 16.6 14.2 20.3 20.0 21.8 18.4 20.3 17.3 18.5 19.2 23.5 13.6 28.3 17.9 17.1 23.5 25.5 18.5 27.4 10.7 11.8 32.5 11.0 22.8 12.5 39.5 15.0 19.4 17.2 16.5 27.0 13.5 23.1 23.1 22.1 17.5 26.7 16.0 19.5 35.4 24.6 28.7 30.1 15.0 17.9 25.7 21.4 14.7 23.7 26.4 30.7 22.5 12.2 16.4 21.8 9.1 15.1 25.2 35.9 48.1 15.8 23.9 12.4 2.2 2.2 2.5 4.1 2.2 5.1 4.3 5.1 4.5 2.9 3.1 5.3 5.4 0.6 5.6 2.5 3.0 2.0 1.8 16.2 52.4 23.6 26.5 16.5 19.8 16.1 20.6 29.0 15.6 TRAP1 "HSP75, HSP90L" ENSG00000126602 "TNF receptor associated protein 1" Q12931 16 3651639-3717597 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041082, HPA044227" Enhanced Enhanced Mitochondria 1100000 Mitochondria "HPA041082: AB_2677291, HPA044227: AB_2678864" "unprognostic (1.18e-1)" "unprognostic (1.51e-1)" "prognostic favourable (1.80e-4)" "unprognostic (7.10e-2)" "unprognostic (6.80e-2)" "unprognostic (2.76e-2)" "unprognostic (1.52e-2)" "unprognostic (9.61e-2)" "unprognostic (8.58e-2)" "unprognostic (5.71e-3)" "unprognostic (1.54e-1)" "unprognostic (7.69e-3)" "unprognostic (1.01e-2)" "unprognostic (2.24e-2)" "unprognostic (6.68e-2)" "unprognostic (9.90e-2)" "unprognostic (3.82e-2)" 19.1 20.3 19.1 15.9 29.7 14.2 17.5 21.1 38.5 16.8 23.0 18.1 13.1 18.6 17.1 14.2 34.4 28.5 20.8 40.0 22.1 20.4 24.6 62.6 12.3 20.6 17.1 30.7 23.5 54.7 18.3 13.6 15.5 23.2 15.4 17.8 16.4 19.7 13.7 80.3 31.2 14.1 20.9 12.3 15.2 19.7 20.0 15.1 16.4 16.0 39.8 21.2 17.2 18.2 20.0 24.6 1.3 17.0 12.7 22.3 13.8 18.9 47.7 9.9 26.2 11.0 11.3 29.4 11.5 10.5 26.8 16.9 59.2 27.1 61.1 21.9 11.1 35.7 38.6 28.8 11.8 23.4 42.2 17.8 40.9 41.4 18.9 31.9 12.3 13.3 20.1 21.2 33.3 18.3 55.9 22.3 8.7 62.0 22.9 23.7 18.4 24.3 52.7 20.8 84.3 19.8 14.1 47.3 18.0 12.0 44.4 23.1 32.1 23.2 10.3 11.3 20.2 19.7 16.8 23.8 26.2 48.1 7.0 25.8 15.3 0.0 10.8 0.3 11.7 17.0 22.3 20.0 17.1 14.8 24.6 13.9 20.3 17.1 1.3 12.7 12.3 3.6 14.2 13.8 19.1 29.7 21.1 38.5 22.1 20.4 17.1 30.7 23.2 15.1 TTC19 "FLJ20343, MGC19520" ENSG00000011295 "Tetratricopeptide repeat domain 19" Q6DKK2 17 15999380-16045015 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Electron transport, Respiratory chain, Transport" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023010, HPA052380" Enhanced Enhanced Mitochondria "Intracellular and membrane" Mitochondria "HPA023010: AB_1858429, HPA052380: " "unprognostic (1.04e-2)" "unprognostic (4.90e-3)" "unprognostic (2.87e-2)" "unprognostic (4.80e-3)" "unprognostic (8.09e-2)" "unprognostic (2.86e-1)" "unprognostic (1.06e-2)" "unprognostic (2.84e-2)" "unprognostic (8.34e-2)" "unprognostic (1.72e-2)" "unprognostic (2.30e-3)" "unprognostic (5.14e-2)" "prognostic favourable (5.67e-4)" "unprognostic (1.31e-1)" "unprognostic (3.22e-1)" "unprognostic (4.85e-2)" "unprognostic (2.24e-1)" 8.5 13.6 10.3 10.1 16.6 16.4 11.2 16.5 22.6 10.1 13.8 10.3 10.5 18.7 11.1 8.9 9.3 9.9 11.8 13.4 17.0 10.4 15.4 13.2 10.8 7.9 9.2 15.3 12.7 24.8 11.5 15.5 10.1 15.7 12.0 9.6 13.1 14.0 12.7 8.6 13.9 16.1 7.2 8.9 8.3 13.3 6.3 6.8 6.0 18.7 8.0 8.4 10.0 10.9 3.5 2.8 9.0 2.0 1.7 3.3 1.0 7.2 6.1 6.2 10.5 5.3 5.2 4.7 6.1 4.3 2.9 3.2 6.0 12.9 10.2 13.5 3.4 9.2 8.5 7.0 3.6 16.7 14.4 8.4 7.5 5.1 8.1 8.4 13.0 5.3 5.8 2.4 10.1 6.1 4.9 7.3 6.0 6.9 9.0 5.2 10.3 4.2 13.6 7.0 7.3 9.2 8.6 6.5 4.9 7.8 8.4 15.5 7.2 3.7 11.3 4.0 1.7 5.6 7.7 6.0 2.6 4.8 9.5 9.4 9.0 9.0 2.0 3.8 2.0 2.0 3.3 2.8 2.5 3.3 2.5 3.5 2.8 3.1 1.7 1.7 1.6 2.8 2.6 1.0 10.3 16.6 16.5 22.6 17.0 10.4 9.2 15.3 15.7 6.8 TUFM "EF-TuMT, EFTu" ENSG00000178952 "Tu translation elongation factor, mitochondrial" P49411 16 28842411-28846408 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Elongation factor" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018991, HPA024087, CAB075730, CAB075731, CAB075732" Enhanced Enhanced Mitochondria 2800000 Mitochondria "CAB075730: , CAB075731: , CAB075732: , HPA018991: AB_1858458, HPA024087: AB_1858459" "unprognostic (1.40e-1)" "unprognostic (7.56e-2)" "unprognostic (1.29e-1)" "unprognostic (1.73e-2)" "unprognostic (2.36e-1)" "unprognostic (2.55e-2)" "unprognostic (3.39e-1)" "unprognostic (1.23e-3)" "unprognostic (8.05e-2)" "unprognostic (8.47e-2)" "unprognostic (1.80e-1)" "unprognostic (1.33e-1)" "prognostic favourable (2.69e-6)" "unprognostic (5.26e-2)" "unprognostic (1.09e-1)" "unprognostic (6.22e-2)" "unprognostic (7.36e-2)" 27.3 47.8 28.8 32.3 31.3 27.2 40.4 22.3 41.4 25.3 41.7 27.1 34.4 44.0 26.6 22.3 40.0 32.7 37.6 69.2 25.6 25.8 45.6 68.4 28.6 46.2 33.1 24.4 25.9 75.0 48.3 22.7 23.0 27.3 23.4 37.6 25.4 40.9 33.1 77.3 28.1 36.1 26.2 25.8 28.4 36.9 47.0 21.5 32.5 37.0 55.4 33.9 26.8 23.3 30.6 57.3 21.7 44.2 25.5 38.8 45.4 29.1 55.4 17.8 37.1 25.8 23.7 36.5 21.4 24.9 34.1 32.4 59.7 32.3 65.6 39.5 21.4 57.2 42.1 41.4 20.5 26.1 64.4 25.0 44.8 72.2 30.7 44.8 23.3 30.2 32.8 36.9 36.7 40.6 56.1 25.9 24.8 59.4 42.9 43.8 39.8 34.4 59.5 32.3 95.4 29.5 28.6 31.2 38.1 18.7 66.7 29.2 39.7 36.5 25.8 20.4 23.8 25.3 32.6 39.6 40.9 28.5 26.1 56.3 26.7 21.7 44.2 19.5 31.3 42.3 34.8 30.6 29.7 32.7 57.3 27.5 28.5 29.5 9.1 25.5 31.6 34.9 38.8 45.4 28.8 31.3 22.3 41.4 25.6 25.8 33.1 24.4 27.3 21.5 TXN2 MT-TRX ENSG00000100348 "Thioredoxin 2" Q99757 22 36467036-36482030 "Disease related genes, Predicted intracellular proteins" "Electron transport, Transport" "Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000994, CAB008681" Approved Enhanced Mitochondria Mitochondria "CAB008681: AB_1623682, HPA000994: AB_1080267" "unprognostic (5.11e-2)" "unprognostic (4.40e-3)" "unprognostic (4.40e-3)" "unprognostic (1.07e-2)" "unprognostic (5.85e-2)" "unprognostic (4.28e-2)" "unprognostic (4.02e-2)" "unprognostic (5.05e-2)" "unprognostic (2.15e-1)" "unprognostic (1.78e-1)" "unprognostic (3.17e-2)" "prognostic favourable (2.04e-4)" "prognostic favourable (1.17e-6)" "unprognostic (1.49e-2)" "unprognostic (2.78e-1)" "unprognostic (1.06e-1)" "unprognostic (2.05e-1)" 22.1 69.9 33.4 24.7 33.2 23.5 41.9 23.2 51.1 23.0 25.9 20.8 24.5 36.9 19.8 22.7 28.7 26.9 27.6 60.1 28.0 28.6 33.4 51.7 27.9 35.5 30.3 31.7 35.0 51.1 30.8 17.3 19.6 30.4 21.6 26.2 24.6 25.0 27.5 72.3 21.0 28.1 26.3 35.6 25.2 26.7 19.1 21.2 16.2 29.2 37.3 23.0 23.0 19.8 31.7 51.3 14.4 43.3 32.0 30.0 45.1 14.5 19.9 21.8 37.3 32.8 35.7 25.1 20.0 31.4 33.8 38.4 24.1 15.4 36.8 18.6 31.2 22.2 41.7 34.3 19.7 25.2 36.3 42.0 27.2 35.5 27.7 50.4 40.1 47.7 27.3 28.2 22.1 30.6 43.9 30.5 30.2 21.5 22.9 39.1 17.7 26.3 21.0 23.0 25.5 34.2 23.7 30.4 30.7 20.2 44.3 36.1 31.2 49.0 24.0 37.7 29.4 20.7 19.6 24.8 17.6 35.8 34.0 31.5 21.4 5.2 40.8 7.1 25.7 43.3 26.8 31.7 25.6 27.0 51.3 29.0 30.0 27.9 14.4 32.0 35.2 39.1 24.8 45.1 33.4 33.2 23.2 51.1 28.0 28.6 30.3 31.7 30.4 21.2 UQCRC2 "QCR2, UQCR2" ENSG00000140740 "Ubiquinol-cytochrome c reductase core protein 2" P22695 16 21952660-21983660 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007998, HPA019146" Enhanced Enhanced Mitochondria 4000000 Mitochondria "HPA007998: AB_1858648, HPA019146: AB_1858649" "unprognostic (1.33e-1)" "unprognostic (1.32e-1)" "unprognostic (1.49e-3)" "unprognostic (3.35e-1)" "unprognostic (1.26e-2)" "unprognostic (6.91e-2)" "unprognostic (2.71e-2)" "unprognostic (1.32e-1)" "unprognostic (1.72e-1)" "unprognostic (8.87e-2)" "unprognostic (1.67e-2)" "unprognostic (2.43e-2)" "prognostic favourable (6.58e-9)" "unprognostic (2.33e-1)" "unprognostic (9.78e-3)" "unprognostic (4.67e-3)" "unprognostic (7.36e-2)" 22.7 26.8 20.6 17.1 32.7 20.5 21.3 29.2 33.7 17.7 38.4 17.4 19.5 45.0 20.8 18.6 28.7 20.0 19.1 94.9 19.8 19.3 35.1 35.8 15.9 23.6 20.9 28.5 21.9 20.8 36.6 20.2 17.8 29.6 17.7 40.5 18.5 22.1 20.2 103.9 22.2 42.0 30.4 16.5 16.5 29.3 10.3 19.2 25.2 21.4 70.0 22.9 27.9 20.0 20.0 30.6 14.3 29.3 18.7 25.7 27.4 18.9 20.9 12.9 8.6 14.4 20.2 18.3 18.4 15.0 16.9 17.2 33.7 18.8 37.7 16.6 15.8 34.7 20.9 18.5 19.5 17.2 19.4 21.3 18.4 47.6 15.3 27.1 54.0 23.6 23.2 13.2 18.2 22.1 23.0 19.7 18.3 25.2 28.1 17.6 14.1 16.1 32.9 29.9 41.2 25.3 22.4 17.8 13.0 26.1 33.0 19.8 37.8 28.8 19.5 12.0 11.3 11.7 16.4 14.3 10.3 33.4 19.6 28.8 13.7 14.3 24.7 12.8 16.9 29.3 21.9 20.0 20.5 18.6 30.6 15.8 22.8 20.8 9.1 18.7 27.6 13.2 25.7 27.4 20.6 32.7 29.2 33.7 19.8 19.3 20.9 28.5 29.6 19.2 UQCRQ "QCR8, QP-C, UQCR7" ENSG00000164405 "Ubiquinol-cytochrome c reductase complex III subunit VII" O14949 5 132866560-132868031 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 174.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046693, HPA053323" Approved Enhanced Mitochondria Mitochondria "HPA046693: AB_10968453, HPA053323: " "unprognostic (3.22e-1)" "unprognostic (1.06e-1)" "unprognostic (4.92e-2)" "prognostic favourable (4.23e-4)" "unprognostic (1.09e-1)" "unprognostic (9.03e-2)" "unprognostic (1.02e-1)" "unprognostic (3.45e-2)" "unprognostic (1.37e-1)" "unprognostic (3.72e-2)" "unprognostic (7.31e-2)" "unprognostic (3.49e-1)" "unprognostic (1.81e-3)" "unprognostic (1.06e-1)" "unprognostic (1.84e-1)" "unprognostic (2.33e-1)" "unprognostic (3.37e-2)" 26.4 38.4 43.2 24.5 34.2 20.9 30.9 18.0 37.5 22.5 49.7 13.8 44.0 42.5 15.4 41.8 32.1 15.3 42.7 111.1 33.2 31.7 48.8 112.5 18.8 21.5 42.0 30.4 12.3 64.6 14.0 23.1 17.0 30.5 32.0 44.8 19.7 44.6 39.6 174.9 16.4 40.5 21.2 25.4 15.2 37.4 16.1 20.8 14.3 24.6 71.5 16.8 22.6 20.5 56.6 95.8 67.9 99.9 53.8 56.7 106.3 45.6 63.9 37.7 91.2 56.6 46.0 32.7 33.1 46.9 53.1 66.3 89.9 53.4 18.8 70.1 43.4 46.3 34.3 80.8 45.7 34.3 72.2 24.9 100.7 70.6 49.1 28.2 42.9 49.0 56.4 37.9 52.3 41.4 31.8 60.6 55.6 86.5 64.8 65.1 26.7 57.7 42.5 41.8 80.7 68.7 89.2 63.3 52.7 41.0 46.3 70.8 69.0 65.0 25.7 48.7 61.5 39.9 67.0 67.0 88.9 33.6 64.8 52.6 48.4 67.9 99.9 61.1 47.0 76.6 48.3 56.6 54.9 53.5 87.4 46.0 53.6 51.5 47.4 53.8 70.2 95.8 56.7 106.3 43.2 34.2 18.0 37.5 33.2 31.7 42.0 30.4 30.5 20.8